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Figure	   1.1.	   A:	   Schematic	   representation	   of	   the	   typical	   neuronal	   phenotype	  
demonstrating	  cell	  body	  with	  multiple	  dendrites	  and	  a	  single	  axon	  myelinated	  
by	   Schwann	   Cells.	   B:	   Image	   demonstrates	   the	   micro	   and	   macroscopic	  
arrangement	  of	  the	  typical	  peripheral	  nerve	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  30	  
	  
Figure	   1.2:	   Schematic	   representation	   of	   the	   cascade	   of	   events	   at	   the	  
neuromuscular	  junction	  leading	  to	  skeletal	  muscle	  contraction	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  31	  	  
	  
Figure	  1.3:	  Schematic	  representation	  of	  Sunderland’s	  classification	  of	  peripheral	  
nerve	   injury.	  A	   shows	  a	  non-­‐injured	  neuron.	  B	  demonstrates	  a	  neuropraxia	  or	  
compression	   injury.	   This	   is	   the	  mildest	   type	   of	   peripheral	   nerve	   injury,	  which	  
can	   occur	   easily	   during	   manipulation	   of	   a	   nerve	   during	   surgical	   procedures.	  
With	  this	  type	  of	  injury,	  functional	  recovery	  usually	  returns	  within	  days.	  C	  and	  D	  
represent	   degrees	   of	   axonotmesis,	   or	   axonal	   damage	   where	   the	   perineurial	  
layer	   remains	   intact.	   E	   represents	   a	   neurotmesis	   or	   transection	   injury	   where	  
both	   the	   axon	   and	   its	   protective	   myelin	   sheath	   have	   been	   destroyed.	   The	  
functional	  recovery	  achieved	  with	  this	  degree	  of	  injury	  is	  poor	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  32	  
	  
Figure	   1.4:	   Schematic	   diagram	   demonstrating	   the	   basic	   structure	   a	   tubular	  
cylindrical	   superstructure	  where	   the	   stumps	   of	   a	   transected	   peripheral	   nerve	  
are	  fixed	  within	  the	  lumen	  of	  the	  conduit	  to	  promote	  neurogenesis	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  35	  
	  
Figure	   1.5:	   Schematic	   diagram	   demonstrating	   enhancement	   of	   a	   basic	  
cylindrical	  conduit	  with	  luminal	  filler	  (insert	  right),	  growth	  factors	  and	  cells	  	  	  	  	  	  36	  
	  
Figure	  1.6:	  Scanning	  electron	  microscopy	  photograph	  of	  the	  microstructure	  of	  a	  
hyaluronic	  acid	  hydrogel	  scaffold	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  37	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Figure	   1.7:	   Scanning	   electron	   microscopy	   image	   demonstrating	   stem	   cells	  
cultured	   on	   a	   non-­‐functionalised	   HA	   hydrogel.	   HA	   hydrogels	   can	   contain	  
negative	   regulators	   that	   inhibit	   neurite	   outgrowth	   unless	   functionalised	   with	  
molecules	   such	   as	  poly	   L	   lysine	   laminin	  or	   poly	  D	   lysine.	  Arrows	   indicate	   cells	  
entrapped	  within	  the	  scaffold	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Figure	   1.8.	   .	   A:	   Diagram	   representing	   the	   anatomical	   structure	   of	   the	   human	  
olfactory	  neuro	  epithelium.	  B:	  Schematic	  representation	  of	  the	  neuronal	  circuit	  




Figure	   2.1.	   Image	   demonstrating	   the	   site	   of	   the	   olfactory	   neuroepithelium	  
(asterisk)	   in	   the	   right	   side	   of	   the	   human	   nasal	   cavity.	   NS	   identifies	   the	   nasal	  
septum	  and	  ST	  identifies	  the	  superior	  turbinate	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Figure	  2.2.	  Image	  demonstrating	  the	  exposure	  of	  the	  olfactory	  neuroepithelium	  
(asterisk)	  in	  the	  rat	  nasal	  cavity	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Figure	   2.3:	   Image	   demonstrating	   light	   microscopy	   photograph	   of	   olfactory	  
neuroepithelial	  cells	  growing	  in	  a	  confluent	  monolayer	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Figure	   2.4:	   Image	   demonstrating	   light	   microscopy	   findings	   of	   olfactory	  
neurosphere	  aggregates	  (circled)	  on	  PLL	  coated	  flasks	  under	  sphere	  generating	  
conditions	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Figure	   2.5:	   Image	   demonstrating	   light	   microscopy	   findings	   of	   ONS	   cells	   in	  
culture	  on	  T175	  flask	  with	  standard	  growth	  media.	  Observed	  ONS	  cell	  cultures	  
grew	  in	  a	  confluent	  monolayer	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Figure	   2.6:	   Light	   microscopy	   image	   of	   ONS	   cells	   cultured	   on	   poly	   D	   lysine	  
demonstrating	  an	  elongated	  morphology	  (arrows)	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Figure	  2.7:	  Image	  demonstrating	  the	  appearance	  of	  A:	  Nestin	  expression	  and	  B:	  
CD56	  expression	  by	  ONS	  cells	  at	  day	  7	  in	  vitro	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Figure	  2.8.	  Image	  demonstrating	  expression	  of	  GFAP	  (green)	  and	  p75	  (red,	  NGF	  
receptor)	  by	  ONS	  cells	  in	  culture	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Table	  2.1.	  Summary	  of	   flow	  cytometry	  results:	  ONS	  cells	  derived	  from	  6-­‐week	  
old	  donor	  animals	  expressed	  higher	  levels	  of	  nestin	  and	  β-­‐tubulin	  than	  ONS	  cells	  
derived	  from	  12-­‐week	  old	  donor	  animals	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Figure	  2.9.	  :	  Image	  demonstrating	  the	  appearance	  of	  β-­‐tubulin	  stained	  ONS	  cells	  
with	  elongated	  processes	  developing	  (circled)	  when	  cultured	  on	  laminin-­‐coated	  
plates	  (Day	  7	  in	  vitro)	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Figure	  2.9:	  Image	  demonstrating	  the	  appearance	  of	  β-­‐tubulin	  stained	  ONS	  cells	  
with	  elongated	  processes	  developing	  (circled)	  when	  cultured	  on	  laminin-­‐coated	  
plates	  (Day	  7	  in	  vitro)	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Figure	  2.10:	  Image	  demonstrating	  a	  β-­‐tubulin	  positive	  population	  of	  cells,	  which	  
developed	  when	  ONS	  cells	  were	  cultured	  on	  PDL	  coated	  culture	  plates	  with	  NGF	  
supplemented	  media	  (Day	  7	  in	  vitro)	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Table	  2.2:	  Flow	  cytometry	  analysis	  plot	  of	  neuronal	  and	  glial	  marker	  expression	  
of	   young	   rat	   derived	   ONS	   cells	   when	   cultured	   in	   standard	   culture	   media	   on	  
plates	   coated	   with	   Lam	   or	   poly	   D	   lysine	   compared	   to	   uncoated	   culture	  
conditions	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Table	   2.3.	   Summary	   table	   of	   flow	   cytometry	   results:	   Both	   Lam	  and	   PDL	  were	  
found	  to	  have	  had	  a	  positive	  effect	  on	  the	  neuro	  differentiation	  capacity	  of	  ONS	  
cells	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Figure	  2.11:	  Bar	  chart	  showing	  A:	   level	  of	  nestin	  expression,	  and	  B:	   level	  of	  β-­‐
tubulin	  expression	  as	  an	  effect	  of	  Lam	  or	  PDL	  when	  compared	  against	  ONS	  cells	  
cultured	   on	   uncoated	   plates.	   Asterisks	   indicate	   statistically	   significant	  
differences	   in	  nestin	  expression	  as	  a	   result	  of	  PDL	  and	  Lam	  culture	  conditions	  
(p<0.05)	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Table	  2.4:	  Flow	  cytometry	  analysis	  plot	  of	  neuronal	  and	  glial	  marker	  expression	  
of	  young	  rat	  derived	  ONS	  cells	  when	  cultured	  in	  NGF	  enhanced	  media	  on	  plates	  
coated	  with	  Lam	  or	  PDL	  compared	  to	  uncoated	  culture	  conditions	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  78	  
	  
Table	  2.5:	  Expression	  of	  nestin,	  β-­‐tubulin	  and	  GFAP	  in	  ONS	  cells	  cultured	  on	  Lam	  
or	  PDL	  in	  NGF	  supplemented	  media	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Figure	   2.12:	   Bar	   chart	   showing	   A:	   level	   of	   nestin	   expression	   as	   an	   effect	   of	  
biomaterials	  with	  NGF	  supplementation	  and	  B:	  level	  of	  β-­‐tubulin	  expression	  as	  




Figure	   3.1:	   Schematic	   diagram	   demonstrating	   A:	   Severed	   nerve	   with	  
disorganised	  axonal	  outsprouting	  and	  B:	  the	  proposed	  NGC	  comprising	  of	  a	  HA	  
hydrogel	   luminal	   filler	   (insert)	   within	   a	   supportive	   outer	   tubular	   collagen	  
conduit	  (grey)	  for	  peripheral	  nerve	  regeneration	  (image	  adapted	  from:	  Carballo-­‐
Molina	  et	  al).	  Hydrogels	  may	  be	   functionalised	  with	  cells	  such	  as	  ONS,	  growth	  
factors	  such	  as	  NGF	  and	  ECM	  molecules	  such	  as	  Lam	  to	  increase	  their	  bioactivity	  
and	  enhance	  axonal	  growth	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Figure	   3.2:	   Combination	   of	   a	   tubular	   collagen	   conduit	   with	   HA	   hydrogel	   to	  
produce	  a	  biphasic	  construct.	  A:	  the	  tubular	  collagen	  conduit	  prior	  to	  hydration	  
in	  PBS.	  B:	  hydrogel	   injection	  with	  a	  21G	  needle	  and	  1ml	  syringe.	  C:	  hydrogel	   is	  
inserted	   completely	   into	   the	   lumen	   (Image	   obtained	   in	   collaboration	   with	  
Austyn	  Matheson	  and	  Alan	  Ryan	  TERG)	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Table	  3.1.	  Mechanical	  test	  data	  for	  tubular	  collagen	  conduits.	  Asterisk	  indicates	  
statistically	   significant	   difference	   from	   higher	   variants.	   Data	   obtained	   in	  
collaboration	  with	  Austyn	  Matheson	  and	  Alan	  Ryan	  RCSI	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Figure	  3.3:	  Image	  demonstrating	  a	  collagen	  conduit	  of	  2.5%	  w.v	  tubular	  collagen	  
conduit	   soaked	   in	  PBS	  after	  7	  days.	   From	  a	  practical	   and	   surgical	  perspective,	  
the	  2.5%	  w.v	  tubular	  collagen	  conduit	  was	  selected	  as	  the	  optimum	  conduit	  for	  
use	  with	  the	  final	  NGC	  because	  it	  retained	  its	  shape	  during	  handling	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Figure	   3.4:	   Bar	   chart	   demonstrating	   the	   percentage	   viability	   of	   ONS	   cells	  
cultured	  on	   tubular	   collagen	   conduits	   compared	   to	   cells	   cultured	  on	   standard	  
tissue	  culture	  plastic	  plates	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Figure	   3.5:	   Bar	   chart	   demonstrating	   outcomes	   of	   the	   7-­‐day	   MTS	   metabolic	  
activity	   assay	   of	   ONS	   cells	   on	   both	   non-­‐functionalised	   HA	   hydrogels	   and	  
functionalised	  HA	  hydrogels	  (HA-­‐PDL	  and	  HA-­‐Lam)	  against	  a	  positive	  control	  of	  
cells	   cultured	   with	   standard	   media	   on	   tissue	   culture	   plates	   alone.	   Asterisk	  
indicates	  statistically	  significant	  difference	  in	  viability	  between	  HA-­‐Lam	  and	  HA-­‐
PDL	  hydrogels	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  107	  
	  
Figure	   3.6:	   A	   –	   C:	   Spheroidal	   configuration	   of	   ONS	   cells	   on	   unmodified	   HA	  
hydrogel.	  D	  -­‐	  F:	  ONS	  cells	  on	  HA-­‐PDL	  hydrogel.	  In	  comparison	  to	  unmodified	  HA	  
hydrogels,	  ONS	  cells	  demonstrated	  early	  phenotypic	  extension	  (blue	  arrows).	  G	  
–	   I:	   ONS	   cells	   on	   HA-­‐Lam	   hydrogel.	   In	   comparison	   with	   unmodified	   HA	  
hydrogels,	  ONS	  cells	  demonstrated	  more	  phenotypic	  extension	  than	  on	  HA-­‐PDL	  
hydrogels	  (blue	  arrows).	  A,	  D,	  G:	  single	  staining	  for	  nestin,	  B,	  E,	  H	  single	  staining	  
for	  β-­‐	  tubulin	  C,	  F,	  I:	  composite	  images	  with	  nestin	  (red)	  nuclear	  stain	  (blue)	  and	  
β-­‐tubulin	  (green).	  The	  scale	  bar	  for	  all	  images	  is	  20	  µm	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Figure	   3.7:	   A	   –	   C:	   Spheroidal	   configuration	   of	   ONS	   cells	   on	   unmodified	   HA	  
hydrogel	  supplemented	  with	  NGF.	  Matrix	  invasion	  and	  cell	  extension	  were	  not	  
observed.	   D	   -­‐	   F:	   ONS	   cells	   ONS	   cells	   on	   HA-­‐PDL	   hydrogel	   supplemented	  with	  
	   20	  
NGF.	   In	   comparison	   to	   unmodified	   HA	   hydrogels.	   Matrix	   invasion	   and	   cell	  
extension	   were	   not	   observed.	   G	   –	   I:	   ONS	   cells	   on	   HA-­‐Lam	   hydrogel	  
supplemented	  with	  NGF.	  In	  comparison	  to	  to	  the	  other	  HA	  hydrogels,	  ONS	  cells	  
cultured	  on	  HA-­‐Lam	  with	  NGF	  demonstrated	  marked	  phenotypic	  extension	   (G	  
Insert)	   and	   matrix	   invasion.	   A,	   D,	   G:	   single	   staining	   for	   nestin,	   B,	   E,	   H	   single	  
staining	  for	  β-­‐	  tubulin	  C,	  F,	   I:	  composite	   images	  with	  nestin	  (red)	  nuclear	  stain	  
(blue)	  and	  β-­‐tubulin	  (green).	  The	  scale	  bar	  for	  all	  images	  is	  20	  µm	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Figure	   3.8:	   SEM	   photomicrograph	   demonstrating	   the	   cross	   sectional	  
appearance	   of	   the	   biphasic	   NGC.	   The	   dotted	   yellow	   line	   demonstrates	   the	  
tubular	   collagen	   conduit	   –	   HA-­‐Lam	   luminal	   filler	   interface	   (Image	   Courtesy	   of	  
Austyn	  Matheson	  and	  Alan	  Ryan	  TERG)	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Figure	   3.9:	   A:	   Bright-­‐field	   image	   showing	   longitudinal	   section	  of	  NGC	   injected	  
with	   ONS	   cells,	   after	   72	   hrs	   in	   culture.	   Outer	   tubular	   collagen	   conduit	   and	  
luminal	  filler	  (HA-­‐Lam)	  are	  demarcated	  with	  the	  dashed	  line.	  High	  magnification	  
image	  of	  the	  insert	  is	  shown	  in	  B	  and	  C.	  B:	  Image	  shows	  cell	  distribution	  through	  
the	   NGC.	   Cell	   nuclei	   were	   stained	   with	   Hoechst	   nuclear	   stain.	   Image	   was	  
converted	  to	  black	  and	  white	  to	  emphasise	  cells	  position	  of	  the	  cells	  (nuclei	   in	  
white)	   in	   relationship	   to	   the	   biomaterials	   (shown	   in	   black).	   Dashed	   line	  
demarcates	  components	  of	  the	  nerve	  conduit	  as	  in	  A.	  C:	  Image,	  shows	  adherent	  
cells	   in	  the	  HA-­‐Lam	  luminal	  filler	  as	   indicated	  by	  the	  precense	  of	  F-­‐actin	  stress	  
fibers	  (phalloidin).	  Note	  the	  empty	  core	  to	  the	  center	  right	  of	  image	  A	  occurred	  




Figure	  4.1:	  Schematic	   representation	  of	   In	  vivo	  experimental	  design.	   	   	   	  A	  non-­‐
interventional	  negative	  control	  group	  of	  9	  animals	  was	  used	  to	  establish	  the	  size	  
of	  the	  critical	  defect	  prior	  to	  evaluating	  three	  experimental	  treatment	  groups	  	  	  	  	  	  	  	  
	  	  	  	  133	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Figure	   4.2:	   Schematic	   representation	   of	   endpoint	   outcomes	   including	   clinical,	  
functional,	  electrophysiological	  and	  morphologic	  evaluation	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Figure	   4.3:	   Schematic	   representation	   of	   the	   evaluation	   of	   the	   nociceptive	  
withdrawal	  reflex	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Figure	   4.4	   Diagram	   demonstrating	   the	   assessment	   parameters	   of	   the	   static	  
variant	   SFI.	   ITS:	   distance	   between	   the	   second	   and	   fourth	   toe;	   TS:	   spread	  
between	   first	   and	   fifth	   toe	   and	   PL:	   paw	   length.	   The	   SFI	   is	   calculated	   by	   the	  
formula	  SFI=118.9(TSF)	  –	  51.2(PLF)	  –	  7.5.	  A:	  represents	  a	  normal	  rat	  paw	  print.	  
B:	  represents	  a	  denervated	  paw	  print	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Figure	   4.5:	   :	   Placement	   of	   the	   needle	   receptor	   probes	   into	   the	   medial	   and	  
lateral	  bellies	  of	  the	  gastrocnemius	  muscle	  of	  the	  right	  hind	  limb	  is	  shown.	  The	  
biomimetic	   biphasic	   NGC	   can	   be	   seen	   (blue	   dashed	   line)	   with	   intact	   prolene	  
sutures	   (yellow	   arrows)	   fixing	   the	   cuff	   of	   the	   tubular	   collagen	   conduit	  
component	  of	  the	  NGC	  to	  the	  perineurium	  of	  proximal	  and	  distal	  stumps	  of	  the	  
severed	  sciatic	  nerve	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Figure	  4.6:	   Image	  demonstrating	  the	  site	  of	  insertion	  of	  the	  NGC	  in	  a	  cadaveric	  
male	   Sprague	   Dawley	   rat.	   The	   NGC	   was	   fixed	   in	   place	   using	   6.0	   prolene-­‐
unbraided	  sutures	  as	  shown	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Figure	  4.7:	  Clinical	  photograph	  demonstrating	  the	  effects	  of	  a	  critical	  gap	  sciatic	  
nerve	   transection	   injury	   without	   intervention	   following	   16	   weeks	   in	   an	   adult	  
male	  Sprague	  Dawley	  rat.	  Muscle	  wasting	  and	  contracture	  formation	  in	  the	  hind	  
limb	   is	   illustrated	   within	   the	   blue	   square;	   ulceration	   can	   be	   seen	   within	   the	  
yellow	  circle	  and	  the	  blue	  arrow	  demonstrates	  autophagy	  of	   the	   lateral	  digits.	  
The	  red	  arrow	  indicates	  the	  contralateral	  non-­‐operated	  side	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Figure	  4.8:	  A:	  Image	  demonstrating	  the	  typical	  appearance	  of	  normal	  peripheral	  
nerve	  tissue	  on	  TEM	  containing	  densely	  myelinated	  nerve	  fibers	  surrounded	  by	  
several	  unmyelinated	  fibers	  (image	  source:	  Dr.	  D	  Fawcett/Visuals	  Unlimited).	  B:	  
Image	  demonstrating	  the	  accumulation	  of	  amorphous	  collagen	  scar	  in	  a	  critical	  
sciatic	   defect	   zone	   16	   weeks	   after	   resection.	   Scant	   abnormal	   and	   poorly	  
myelinated	  axons	  (circled)	  were	  detected	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Table	  4.1:	  Clinical	  endpoints	  at	  the	  6-­‐week	  time	  point:	  Table	  demonstrates	  the	  
number	  of	  incidents	  per	  group	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Figure	  4.9.	  Clinical	  endpoints	  at	  the	  6-­‐week	  time	  point	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Table	  4.2:	  Clinical	  endpoints	  at	  the	  8-­‐week	  time	  point:	  Table	  demonstrates	  the	  
number	  of	  incidents	  per	  group	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Figure	  4.10.	  Clinical	  endpoints	  at	  the	  8-­‐week	  time	  point	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Figure	  4.11:	  Representative	  images	  showing	  recovery	  of	  the	  nerve	  morphology	  
following	   treatment	   (A	  B	  &	  C)	   compared	   to	   the	  non-­‐operated	  positive	  control	  
(Left	  hind-­‐limb).	  Contractures	  (blue	  squares),	  ulcers	  (yellow	  circles)	  &	  autophagy	  
of	  the	  lateral	  toes	  (blue	  arrows)	  are	  highlighted.	  A:	  Animal	  treated	  with	  the	  NGC	  
alone.	  B:	  Animal	  treated	  with	  NGC	  &	  ONS.	  C:	  Animal	  treated	  with	  NGC,	  ONS	  &	  
NGF	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Figure	   4.12.	   Graph	   demonstrating	   dispersion	   and	  median	   number	   of	   missing	  
digits	   per	   group	   at	   A:	   6	  weeks,	   and	  B:	   8	  weeks.	   Asterisk	   indicates	   statistically	  
significant	  difference	  (p<0.05)	  at	  6	  weeks	  in	  the	  degree	  of	  autophagy	  between	  
the	  negative	  control	  groups	  (no	  intervention)	  and	  the	  ONC	  cell	  treated	  groups	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Table	  4.2:	  Presence	  of	  a	  nocioceptive	  withdrawal	  reflex	  at	  week	  8.	  A	  statistically	  
significant	   difference	   from	   the	   negative	   control	   was	   detected	   in	   ONS	   cell	  
treated	  groups	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  150	  
	  
Table	  4.3:	  SFI	  calculations	  from	  animals	  without	  evidence	  of	  autophagy	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Figure	  4.13:	  Graph	  demonstrating	  dispersion	  CMAP	  values	  (as	  a	  %	  of	  the	  values	  
from	   the	   contralateral	   non-­‐operated	   limb)	   in	   experimental	   treatment	   group	  
animals.	  A	  statistically	  significant	  improvement	  in	  electrophysiological	  recovery	  
was	  detected	   in	  all	   treatment	  groups.	  Asterisk	   indicates	   statistically	   significant	  
difference	  between	  treatment	  groups	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Figure	  4.14:	  A:	  Peak	  tension	  force	  (N	  Force)	  as	  a	  %	  of	  the	  non-­‐operated	  limb.	  B:	  
Peak	  compression	  (N	  Force)	  as	  a	  %	  of	  the	  non-­‐operated	  limb.	  Asterisk	  indicates	  
a	   statistically	   significant	   difference	   in	   the	   force	   generated	   between	   animals	  
treated	  with	  the	  NGC,	  ONS	  &	  NGF	  compared	  to	  the	  NGC	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Figure	  4.15:	  Gastrocnemius	  weight	  loss	  of	  the	  operated	  limb	  in	  grams	  compared	  
to	  the	  non-­‐operated	  limb	  in	  experimental	  animals.	  Tukey	  box	  plot	  demonstrates	  
dispersion	   of	   results	   across	   treatment	   groups.	   Asterisk	   indicates	   statistically	  
significant	  difference	  between	  NGC,	  ONS	  &	  NGF	  treatment	  and	  the	  NGC	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Figure	  4.16:	  Representative	  images	  showing	  recovery	  of	  the	  nerve	  morphology	  
following	  treatment	  with	  NGC	  (B,	  C	  &	  D)	  compared	  to	  the	  non-­‐operated	  positive	  
control	  (A).	  Mid-­‐conduit	  sections	  in	  all	  treatment	  groups	  (NGC,	  NGC	  &	  ONS	  and	  
NGC,	  ONS	  &	  NGF)	  showed	  signs	  of	  morphological	   recovery	  comparable	   to	   the	  
positive	   control.	   Red	  with	   green	   axons	   =	  MBP,	   Green	  with	   red	   axons	   =	   s100.	  
Nuclei	  =	  blue.	  Extracellular	  matrix	   laminin	  =	  red	  and	  fibronectin	  =	  green.	  Scale	  
bar	  in	  all	  images	  –	  50	  µm	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Figure	  4.17:	  Axon	  count	  as	  a	  %	  of	  the	  axon	  counts	  from	  the	  contralateral	  non-­‐
operated	  side	  across	  the	  groups.	  Tukey	  box	  plot	  demonstrates	  the	  dispersion	  of	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results	  across	   treatment	  groups	  and	  median	  values.	   The	  addition	  of	  ONS	  cells	  
with	  or	  without	  NGF	  significantly	  improved	  axonal	  counts	  compared	  to	  the	  NGC	  
alone.	   Asterisk	   indicates	   statistically	   significant	   differences	   in	   axon	   counts	  
compared	  the	  NGC	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Figure	   4.18.	   Axonal	   calibre	   across	   treatment	   groups.	   Tukey	   box	   plot	  
demonstrates	   the	   dispersion	   of	   results	   across	   treatment	   groups	   and	   median	  
values.	   Axonal	   calibre	   in	   NGC	   treated	   animals	   was	   not	   significantly	   different	  
from	  axonal	  calibre	  in	  the	  contralateral	  non-­‐operated	  nerve	  (p	  value	  =	  0.0203)	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Figure	   4.19:	   Axonal	   alignment	   compared	   to	   axonal	   alignment	   of	   the	   non-­‐
operated	   side.	  Mean	  values	  were:	  NGC,	  ONS	  &	  NGF	   treatment	  –	  91%	  aligned	  
axons,	   NGC	   &	   ONS	   treatment	   –	   89	   %	   aligned	   axons,	   NGC	   treatment	   –	   87	   %	  
aligned	  axons.	  The	  Tukey	  box	  plot	  demonstrates	  the	  dispersion	  of	  results	  across	  
treatment	   groups	   and	   median	   values.	   Axonal	   alignment	   in	   NGC,	   ONS	   &	   NGF	  
treated	   animals	   was	   not	   significantly	   different	   from	   axonal	   alignment	   in	   the	  
contralateral	  non-­‐operated	  nerve	  (p	  =	  0.86)	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Table	   4.4:	   Summary	  of	  histomorphologic	   results	  with	  withdrawal	   reflex	  &	  SFI.	  
Asterisk	  indicates	  statistically	  significant	  difference	  from	  the	  NGC	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Table	  4.5:	  Summary	  of	  histomorphologic	  results	  with	  SFI	  from	  recent	  published	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Abstract	  
	  
Peripheral	   nerve	   injury	   is	   a	   life-­‐changing	   problem,	   which	   presents	   significant	  
therapeutic	   challenges	   to	   clinicians	   and	   patients.	   A	   number	   of	   different	  
approaches	  to	  dealing	  with	  the	  issue	  exist	  but	  to	  date	  there	  is	  no	  consensus	  on	  
the	  most	   effective	  method	  of	   treatment.	  With	   large	   gap	   nerve	   transection	   or	  
central	   to	   peripheral	   nervous	   system	   intersection	   injury,	   spontaneous	  
meaningful	   axonal	   recovery	   seldom	  occurs.	   Despite	   surgical	   intervention	  with	  
autografts,	   the	   functional	   outcomes	   are	   often	   unfavorable.	   Tissue	   engineered	  
strategies	   utilising	   scaffolds	   which	   mimic	   the	   properties	   of	   nerve	   grafts,	   but	  
which	   prevent	   the	   need	   for	   the	   secondary	   injury	   associated	   with	   harvesting	  
autografts,	   are	   currently	   being	   investigated.	   Considerable	   interest	   has	   been	  
given	  to	  the	  combined	  use	  of	  biologically	  active	  scaffolds	  with	  progenitor	  cells	  
which	  function	  synergistically	  to	  enable	  functional	  tissue	  growth.	  Combining	  the	  
purely	   surgical	   approach	   with	   contemporary	   developments	   in	   tissue	  
engineering	  offers	  a	  challenging	  but	  potentially	  rewarding	  way	  forward.	  In	  this	  
thesis,	   the	   possibilities	   and	   the	   challenges	   of	   a	   fusion	   between	   surgery	   and	  
tissue	  engineering	  is	  examined.	  While	  much	  of	  the	  analysis	  is	  determined	  by	  the	  
surgical	   background	   and	   training	   of	   the	   author,	   the	   outcome	   of	   the	   research	  
points	  to	  potentially	  very	  exciting	  prospects	  for	  further	  joint	  research.	  
	  
This	  dual	  purpose,	  prospective	  in	  vitro	  and	  in	  vivo	  research	  project	  has	  critically	  
evaluated	  the	  capacity	  of	  stem	  cells	  derived	  from	  the	  olfactory	  neuroepithelium	  
(ONS	   cells)	   to	   act	   with	   a	   purpose	   designed	   collagen-­‐hyaluronic	   acid	   based	  
biological	  nerve	  guidance	  conduit,	  as	  an	  efficient	  graft	  material	  in	  the	  repair	  of	  
surgically	   ablated	   peripheral	   nerve	   tissue.	   The	   approach	   incorporated	   (i)	   an	  
evaluation	  of	   the	  effect	  of	  biomaterials	  and	  growth	   factors	  on	   the	  neurogenic	  
and	  gliogenic	  capacity	  of	  ONS	  cells,	  (ii)	  an	  evaluation	  of	  the	  in	  vitro	  behavior	  of	  
ONS	  cells	  cultured	  within	  a	  purpose	  designed	  collagen-­‐hyaluronic	  acid	  biological	  
nerve	   guidance	   conduit,	   and	   (iii)	   an	   in	   vivo	   evaluation	   of	   the	   capacity	   of	  ONS	  
cells	  combined	  with	   the	  nerve	  guidance	  conduit	   to	  mediate	   functional	  healing	  
following	  critical	  defect	  injury	  in	  a	  rat	  sciatic	  nerve	  model.	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The	  two-­‐dimensional	  in	  vitro	  analysis	  described	  in	  Chapter	  2,	  demonstrated	  that	  
multipotent	   highly	   plastic	   stem	   cells	   with	   the	   potential	   to	   differentiate	   along	  
neural	   and	   glial	   lineage	   could	   be	   harvested	   from	   explants	   taken	   from	   the	   rat	  
nasal	   cavity.	   Interestingly,	   ONS	   cells	   derived	   from	   young	   donor	   animals	   were	  
found	   to	   have	   increased	  multipotentiality	   in	   comparison	   to	  ONS	   cells	   derived	  
from	   older	   animals.	   In	   addition,	   the	   work	   demonstrated	   that	   ONS	   cells	  
proliferation	   and	   differentiation	   potential	   is	   dependent	   on	   biomaterials	   to	  
varying	  degrees.	  Nerve	  growth	  factor	  was	  also	  found	  to	  have	  similar	  effects	  to	  
biomaterials	  on	  the	  differentiation	  capacity	  of	  ONS	  cells.	  
	  
The	   three-­‐dimensional	   in	   vitro	   analysis	   described	   in	   Chapter	   3	   demonstrated	  
that	  an	  ergonomic	  and	  robust	  biphasic	  nerve	  guidance	  conduit,	  produced	  by	  the	  
combination	   of	   a	   tubular	   collagen	   conduit	   with	   a	   biologically	   active,	   laminin	  
functionalised	   hyaluronic	   acid	   hydrogel	   luminal	   filler,	   supported	   ONS	   cell	  
viability	  and	  differentiation	  whilst	  the	  addition	  of	  nerve	  growth	  factor	  promoted	  
both	  differentiation	  and	  morphological	  extension	  of	  ONS	  cells.	  
	  
The	   in	  vivo	  study	  described	  in	  Chapter	  4	  demonstrated	  that	  the	  biphasic	  nerve	  
guidance	  conduit	  promoted	  anisotropic	  peripheral	  nerve	  regeneration	  following	  
critical	   sciatic	   nerve	   injury,	   and	   that	   functional	   and	  morphological	   repair	   was	  
enhanced	   with	   the	   addition	   of	   ONS	   cells.	   Moreover	   the	   addition	   of	   nerve	  
growth	  factor	  was	  found	  to	  mediate	  functional	  healing.	  	  
	  
Collectively,	   this	   thesis	   points	   to	   the	   development	   of	   a	   novel	   biomimetic	  
biphasic	   nerve	   guidance	   conduit	   with	   an	   optimised	   composition	   and	   suitable	  
mechanical	   properties	   with	  which	   to	   deliver	  multipotent	   ONS	   cells	   for	   use	   in	  
peripheral	   nerve	   defects.	   This	   research	   work	   highlights	   the	   importance	   of	  
biomaterials	   and	  growth	   factor	   selection	   in	   the	  design	  of	   cell	   specific	   delivery	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1.1. Introduction	  and	  background	  	  
	  
Millions	  of	   individuals	   suffer	   some	  degree	  of	  nerve	   injury	   leading	   to	  motor	  or	  
sensory	   dysfunction	   each	   year1.	   These	   injuries	   are	   predominantly	   caused	   by	  
laceration	   events,	   crush	   injuries	   or	   burns;	   with	   almost	   3	   %	   of	   critical	   trauma	  
patients	  presenting	  with	  some	  form	  of	  peripheral	  nerve	  deficit,	  but	  deficits	  may	  
also	   arise	   as	   a	   result	   of	   degenerative	   conditions	   such	   as	   Amyotrophic	   Lateral	  
Sclerosis,	  Parkinsons	  disease	  and	  Multiple	  sclerosis2	  3.	  In	  traumatic	  nerve	  injury,	  
for	   example	   iatrogenic	   surgical	   injuries	   lacerations	   or	   gunshot	   wounds,	  
spontaneous	   meaningful	   functional	   recovery	   occurs	   only	   if	   the	   injury	   is	  
incomplete	   or	   if	   the	   injury	   gap	   is	   very	   small4.	   Early	   surgical	   intervention	   is	  
required	   to	   counteract	   effects	  of	   anterograde	  Wallerian	  degeneration	   such	  as	  
axonal	  skeleton	  disintegration,	  myelin	  sheath	  dissolution	  and	  elastic	  retraction	  
of	  the	  nerve	  stump5	  6.	  	  
	  
In	  practise,	   if	  the	  injury	  size	   is	   large	  or	  direct	  suturing	  not	  possible,	  autografts,	  
usually	   from	   sural,	   peroneal	   or	   intercostal	   nerves,	   are	   the	   current	   accepted	  
reference	   standard	   of	   care7.	   Autografting	   however,	   has	   a	   restricted	   role,	   first	  
because	   donor	   tissue	   is	   finite,	   and	   second	   because,	   despite	   advances	   in	  
techniques	  of	  microsurgical	  repair,	  the	  prognosis	  for	  functional	  recovery	  at	  both	  
the	   donor	   and	   recipient	   sites	   remains	   relatively	   poor8.	   The	   frequency	   with	  
which	   patients	   require	   treatment	   for	   the	   poor	   long-­‐term	   outcomes	   typically	  
associated	   with	   peripheral	   nerve	   injury,	   suggests	   that	   there	   remains	   a	  
significant	   need	   for	   the	   identification	   of	   new	   approaches	   in	   peripheral	   nerve	  
repair.	  
	  
Peripheral	  nerve	  injury	  costs	  billions	  in	  healthcare	  costs	  and	  lost	  work	  days	  each	  
year9.	  	  As	  a	   result,	   tissue	  engineering	  based	   research	   into	   the	  development	  of	  
biological	  substitutes	  for	  the	  regeneration	  of	  nerve	  tissues	  has	  become	  a	  major	  
growth	   industry	   and	   is	   the	   subject	   of	   significant	   ongoing	   research10.	   The	  
identification	   of	   the	   optimum	   stem	   cell	   and	   scaffold	   delivery	   system,	   which	  
possesses	   the	   ideal	   equilibrium	   of	   compositional	   and	   structural	   properties	   to	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facilitate	  neuro-­‐regeneration	  to	  an	  acceptable	  standard,	  has	  yet	  to	  be	  achieved.	  
Selecting	  the	  optimal	  approach	  for	  peripheral	  nervous	  system	  neurogenesis	  has	  
created	  a	  new	  set	  of	  challenges	  for	  tissue	  engineering	  groups	  and	  surgeons	  alike	  
because	  of	  the	  vast	  array	  of	  application	  specific	  design	  variables	  available.	  	  
	  
1.2.	  	  Anatomy	  and	  physiology	  of	  the	  peripheral	  nervous	  system	  
	  
One	   of	   the	   reasons	   why	   peripheral	   nerve	   regeneration	   is	   rapidly	   becoming	  
recognised	   as	   a	  major	   translational	   area	   of	   biomedical	   research,	   is	   because	   it	  
requires	   significant	   collaborative	   input	   from	   anatomists,	   physiologists,	  
pathologists,	   surgeons,	  bioengineers	  and	  biomedical	   scientists.	   The	   first	  major	  
challenge	  to	  any	  tissue-­‐engineered	  approach	  to	  nerve	  regeneration	  is	  the	  sheer	  
complexity	  of	  it’s	  structure.	  	  
	  
Briefly,	  the	  peripheral	  nervous	  system	  comprises	  a	  network	  of	  nerves,	  which	  are	  
divided	   by	   function	   into	   the	   somatic	   system	   (responsible	   for	   movement	   and	  
sensation),	  and	  the	  autonomic	  system	  (maintains	  homeostasis)11	  12.	  Neurons	  are	  
the	  basic	  unit	  of	  the	  peripheral	  nervous	  system;	  they	  consist	  of	  a	  cell	  body	  and	  a	  
long	   axon,	   which	   either	   connects	   to	   an	   end	   organ,	   or	   synapses	   with	   other	  
neurons	   depending	   on	   their	   functional	   requirements13.	   Afferent	   neurons	  
transmit	  impulses	  towards	  the	  central	  nervous	  system,	  whilst	  efferent	  neurons	  
transmit	   impulses	  away	  from	  the	  central	  nervous	  system	  towards	  a	  peripheral	  
target	  organ14.	  Structurally,	  peripheral	  nerves	  consist	  of	  bundles	  of	  myelinated	  
insulated	  axons	  within	  connective	  tissue	   layers.	  Nerve	  fibers	  are	  arranged	   into	  
small	   bundles,	   by	   a	   layer	   of	   perineurium	   and	   externally,	   an	   outer	   fibro	  
collagenous	  epineurial	   layer	   joins	   those	  bundles	  of	   axons	   into	  discrete	   trunks.	  
Trunks	  can	  differ	  in	  calibre	  and	  ability	  to	  retain	  electrical	  charges,	  which	  affects	  
the	   velocity	   at	   which	   the	   electrical	   impulses	   they	   transmit	   can	   pass	   to	   their	  
target	  organs15.	  The	  initiation	  of	  a	  neuronal	  impulse	  is	  made	  possible	  because	  of	  
electrical	  gradients,	  present	  along	  the	  axonal	  membrane.	  Ligand	  gated	  channels	  
allow	  ions	  to	  cross	  the	  membrane	  to	  a	  point	  where	  a	  threshold	  potential	  above	  
the	   -­‐70mV	   baseline	   is	   reached16	   17.	   To	   improve	   the	   efficacy	   of	   impulse	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transmission	  along	  a	  given	  axon,	  Schwann	  cells	  produce	  a	  myelin	  sheath,	  which	  
wraps	   around	   the	   axon	   to	   form	   a	   protective	   insulating	   layer,	   punctuated	   by	  
voltage	  gates	  at	  the	  nodes	  of	  Ranvier18.	  The	  basic	  configuration	  of	  a	  neuron	  and	  
its	  myelinated	  configuration	  is	  illustrated	  in	  Figure	  1.1.	  
	  
Figure	   1.1.	   A:	   Schematic	   representation	   of	   the	   typical	   neuronal	   phenotype	  
demonstrating	  cell	  body	  with	  multiple	  dendrites	  and	  a	  single	  axon	  myelinated	  by	  
Schwann	  Cells.	  B:	  Image	  demonstrates	  the	  micro	  and	  macroscopic	  arrangement	  
of	  the	  typical	  peripheral	  nerve19	  20	  	  
	  
The	  somatic	  nervous	   system	  controls	  voluntary	  movement	  by	   interacting	  with	  
skeletal	  muscle	   at	   neuromuscular	   junctions.	   As	   action	   potentials	   pass	   along	   a	  
neurons	  cell	  membrane,	  calcium	  influxes	  into	  the	  terminal	  end	  of	  the	  neuron	  at	  
the	   neuromuscular	   junction.	   This	   enables	   the	   release	   of	   synaptic	   vesicles	  
containing	   acetylcholine	   (Ach)	   as	   demonstrated	   in	   Figure	   1.2.	   ACh	   is	   a	  
neurotransmitter,	   which	   binds	   to	   surface	   receptors	   on	   muscle	   cells	   causing	  
calcium	  release	  at	   the	  sarcoplasmic	  reticulum.	  The	   influx	  of	  calcium	   initiates	  a	  
cascade	  of	   contractions,	  which	  eventually	   result	   in	   gross	  motor	  movement	  by	  
altering	  the	  configuration	  of	  troponin-­‐myosin	  complexes	  within	  muscle	  cells21.	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Figure	   1.2:	   Schematic	   representation	   of	   the	   cascade	   of	   events	   at	   the	  
neuromuscular	   junction	   leading	   to	   skeletal	   muscle	   contraction	   (image	   source:	  
www.drouaib.faculty.mjc)21	  	  
	  
1.3. Historical	  perspectives	  on	  peripheral	  nerve	  pathophysiology	  
	  
Peripheral	  nerve	  injuries	  are	  typically	  categorised	  in	  terms	  of	  severity	  from	  mild	  
neuropraxia	   to	   severe	   neurotmesis.	   Each	   level	   of	   severity	   has	   a	   specific	  
pathological	   pattern	   and	   predictable	   clinical	   course	   as	   outlined	   in	   Figure	   1.3.	  
The	   type	   and	   nature	   of	   a	   given	   injury	   will	   determine	   the	   degree	   of	   recovery	  
according	   to	   Sedon,	   who	   seminally	   classified	   nerve	   injury	   as	   neuropraxia,	  
axonotmesis	   and	   neurotemesis	   in	   1972,	   and	   Sunderland,	   who	   divided	   nerve	  
injury	   into	   five	   groups	   in	   1990	   because	   of	   the	   variable	   prognosis	   of	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axonotmesis22	  23.	  Sedon’s	  classification	  of	  neurotmesis	  corresponds	  to	  complete	  
disruption	  of	  the	  nerve.	  This	   is	  the	  pattern	  of	   injury	  typically	  seen	  with	  a	   large	  
gap	   transection	   injury	   of	   a	   nerve24.	   Typically,	   spontaneous	   recovery	   with	   this	  
degree	   of	   injury	   is	   limited	   because	   of	  Wallerian	   degeneration,	  which	   leads	   to	  
myelin	  sheath	  degradation,	  and	  sealing	  of	  the	  proximal	  stump	  within	  24	  to	  48	  
hours	  of	  the	  initial	  assault25	  26.	  
	  
	  
Figure	  1.3	  Schematic	  representation	  of	  Sunderland’s	  classification	  of	  peripheral	  
nerve	  injury	  (Image	  source:	  http://handclass.xpg.uol.com.br/sunderland.html).27	  
A	   shows	   a	   non-­‐injured	   neuron.	   B	   demonstrates	   a	   neuropraxia	   or	   compression	  
injury.	  This	  is	  the	  mildest	  type	  of	  peripheral	  nerve	  injury,	  which	  can	  occur	  easily	  
during	   manipulation	   of	   a	   nerve	   during	   surgical	   procedures.	   With	   this	   type	   of	  
injury,	   functional	   recovery	   usually	   returns	   within	   days.	   C	   and	   D	   represent	  
degrees	  of	  axonotmesis,	  or	  axonal	  damage	  where	  the	  perineurial	  layer	  remains	  
intact.	  E	  represents	  a	  neurotmesis	  or	  transection	  injury	  where	  both	  the	  axon	  and	  
its	   protective	   myelin	   sheath	   have	   been	   destroyed.	   The	   functional	   recovery	  
achieved	  with	  this	  degree	  of	  injury	  is	  poor.	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Rather	   then	   undergoing	   mitosis,	   which	   is	   how	   other	   cell	   types	   regenerate	  
following	   injury,	   neurons	   can	   regenerate	   by	   means	   of	   axonal	   sprouting	   from	  
growth	  cones28.	  There	  are	  however	  a	  number	  of	   fundamental	   impediments	  to	  
the	  process	  and	  growth	  of	  axons	  will	  only	  occur	  in	  a	  few	  specific	  circumstances,	  
for	  example	   if	   the	  cell	  body	  remains	   intact	  and	   in	  contact	  with	   its	  endoneurial	  
Schwann	  cell30.	   Schwann	  cells	  have	   three	  main	   functions,	  which	  are	  of	   critical	  
importance	   to	   the	   process.	   First,	   they	   remove	  debris	   and	   dying	   cells.	   Second,	  
they	  produce	  growth	  factors,	  which	  promote	  axonal	  out	  sprouting.	  Third,	  they	  
provide	   structural	   support	   to	   regenerating	   axons	   through	   the	   production	   of	  
extra	   cellular	   matrix	   (ECM)	   components.	   In	   complete	   neurotmesis	   or	  
transection	  injury,	  nerve	  regeneration	  can	  be	  promoted	  to	  a	  degree,	  with	  early	  
tension-­‐free	  apposition	  of	   the	   stumps	  but	  when	  prompt	  direct	   anastomosis	   is	  
not	  possible,	  peri	  neural	  fixed	  autografts,	  which	  work	  by	  means	  of	  appropriately	  
aligned	  coaptation,	  or	  drawing	  together	  of	  aligned	  fascicles,	  are	  considered	  the	  
next	  best	  option29	  30.	  	  
	  
In	  the	  trauma	  setting,	  vascular	  injury	  often	  accompanies	  peripheral	  nerve	  injury	  
and	   if	   severe,	   it	   can	   lead	   to	   fibroblast	   migration	   and	   collagen	   deposition.	  
Fibroblast	   migration	   and	   collagen	   deposition	   in	   turn	   can	   result	   in	   the	  
development	   of	   neural	   adhesions,	   compression	   neuropathies,	   traction	  
neuropathies,	   and	   disuse	   contractures	   despite	   the	   application	   of	   meticulous	  
surgical	   techniques,	   which	   reduces	   the	   efficacy	   of	   surgical	   intervention31.	  
Consideration	   must	   also	   be	   given	   to	   the	   potential	   for	   donor	   site	   morbidity	  
associated	  with	  autografts.	  Since	  the	  1800’s,	  scientists	  and	  surgeons	  have	  failed	  
to	   find	   an	   appropriate	   or	   acceptable	   alternative	   approach	   (Artery,	   vein,	  
decalcified	  bone	  and	  xenografts	  have	  all	  been	  used	  as	  acellular	  biological	  nerve	  
guidance	  conduits	  but	  with	  limited	  success)32	  33.	  	  
	  
1.4. Tissue	  engineering	  strategies	  in	  peripheral	  nerve	  regeneration	  
	  
Tissue	  engineering	  offers	  an	  alternative	  approach	  through	  the	  development	  of	  
biological	   substitutes,	   which	   promote	   regeneration	   of	   damaged	   tissues.	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Biological	  scaffolds,	  cells,	  and	  growth	  factors	  are	  the	  key	  components	  of	  tissue-­‐
engineered	   approaches	   to	   peripheral	   neurogenesis,	   known	   as	   “the	   tissue	  
engineering	   triad”34.	   Scaffolds	   for	   tissue	   engineering	   are	   typically	   fabricated	  
from	   polymeric	   biomaterials,	   which	   may	   be	   either	   degradable	   or	   non-­‐
degradable35.	  	  
	  
Scaffolds	   act	   as	   multi	   functional	   three-­‐dimensional	   templates	   which	   facilitate	  
tissue	   regeneration	   by	   providing	   mechanical	   strength,	   resisting	   external	  
compressive	  forces,	  facilitating	  diffusion	  of	  nutrients	  or	  wastes,	  anchoring	  cells	  
and	  providing	  cues	  which	  influence	  cellular	  behaviour36.	  Scaffold	  based	  artificial	  
nerve	  grafts,	  which	  mimic	   the	  properties	  of	  autologous	  grafts,	  whilst	   reducing	  
the	   risk	   of	   secondary	   injury	   associated	   with	   harvesting	   autografts,	   are	   now	  
being	   extensively	   investigated	   although	   none	   has	   yet	   supplanted	   the	   results	  
achieved	  with	  autografts.	  	  
	  
There	   are	   a	   several	   factors	   to	   consider	   when	   designing	   tissue-­‐engineered	  
devices	   for	   peripheral	   nerve	   regeneration.	   Ideally,	   nerve	   graft	   alternatives	  
should	  be	  biocompatible	  with	  the	  surrounding	  tissues	  into	  which	  they	  are	  to	  be	  
implanted.	   Additionally	   they	   should	   be	   biodegradable,	   and	   importantly,	   non-­‐
immunogenic37.	   The	   overall	   structure	   should	   be	   strong	   enough	   to	   withstand	  
surgical	  implantation	  and	  handling,	  and	  the	  biomaterial	  from	  which	  the	  scaffold	  
is	  made	  should	  possess	  pores	  to	  facilitate	  cell	  extension	  and	  nutrient	  diffusion38.	  
In	  addition	  to	  pore	  size,	  scaffolds	  with	  aligned	  architecture	  have	  been	  shown	  to	  
elicit	   a	   contact	   guidance	   response	  when	   used	   as	   a	   template	   for	   regenerating	  
neurons39.	   	   Because	   a	   functional	   nerve	   requires	   the	   presence	   of	   neurons,	  
Schwann	   cells,	   and	   a	   co-­‐existing	   blood	   supply,	   the	   capacity	   of	   biomaterials	   in	  
tissue	  engineered	  nerve	  grafts	  to	  promote	  differentiation	  towards	  multiple	  cell	  
lineages	   is	  also	  critically	   important.	  The	  biomimetic	  approach	  should	  therefore	  
be	   guided	   by	   the	   peripheral	   nervous	   systems	   components	   in	   an	   attempt	   to	  
replicate	  the	  natural	  extracellular	  matrix	  and	  its	  intrinsic	  repair	  mechanisms40	  41.	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1.4.1. Tissue	  engineered	  scaffolds	  in	  peripheral	  nerve	  regeneration	  	  
	  
In	   architectural	   terms,	   the	   superstructure	   of	   a	   scaffold	   refers	   to	   its	   overall	  
configuration	  or	  shape42	  43.	  Historically,	  the	  superstructure	  of	  scaffolds	  in	  nerve	  
regeneration	  was	  that	  of	  a	  cylindrical	  tube,	  which	  immobilised	  the	  two	  ends	  of	  a	  
cut	  nerve	  in	  a	  tension	  free	  environment	  (see	  Figure	  1.4).	  The	  primary	  benefit	  of	  
this	   approach	   is	   that	   tubulisation	   prevents	   surrounding	   tissues	   from	  
compressing	   the	   new	   sprouting	   axons	   and	   inhibiting	   proximal	   to	   distal	   stump	  
union44.	   The	   second	   benefit	   of	   the	   approach	   is	   that	   it	   theoretically	   allows	  
regulatory	  factors	  to	  remain	  in	  contact	  with	  the	  nerve	  stump	  whilst	  at	  the	  same	  
time	  preventing	  an	   influx	  of	   inhibitory	  factors45.	  The	  earliest	  tissue	  engineered	  
scaffolds	   for	   nerve	   regeneration	   were	   made	   from	   non-­‐resorbable	   silicone	  
tubes46	   47.	   Though	   there	   were	   some	   initially	   promising	   results	   with	   the	  
approach,	  the	  side	  effects	  of	  poor	  biomaterial	  to	  tissue	  compatibility	  historically	  
lead	  to	  many	  patients	  requiring	  second	  surgeries	  to	  remove	  the	  devices	  because	  
of	  compression	  syndromes	  and	  local	  tissue	  inflammatory	  reactions48	  49	  50.	  
	  
	  
Figure	   1.4:	   Schematic	   diagram	   demonstrating	   the	   basic	   structure	   a	   tubular	  
cylindrical	  superstructure	  where	  the	  stumps	  of	  a	  transected	  peripheral	  nerve	  are	  
fixed	  within	  the	  lumen	  of	  the	  conduit	  to	  promote	  neurogenesis	  (image	  modified	  
from	  source:	  Daly	  et	  al)51	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In	  recent	  years	  it	  has	  been	  demonstrated	  that	  hollow	  tubes	  in	  isolation	  do	  not	  
effectively	  control	  cell-­‐to-­‐cell	  contact	  or	  the	  arrangement	  of	  axonal	  fibers	  even	  
when	   they	  are	  produced	   from	  a	   suitable	  biomaterial52	   53.	   Studies	  have	   shown	  
improved	  axonal	  and	  alignment	  through	  the	  use	  of	  porous	  luminal	  fillers	  in	  the	  
form	   of	   smaller	   or	   “microstructured”	   scaffolds;	   therefore	   the	   recent	   body	   of	  
work	  has	   focused	  on	  producing	  and	  optimising	  microstructured	   luminal	   Fillers	  
to	  enhance	  axonal	  growth,	  reduce	  the	  risk	  of	  neuroma	  formation,	  and	  improve	  
overall	  functionality	  (demonstrated	  in	  Figure	  1.5)	  54	  55	  	  56	  57	  58	  	  
	  
Figure	   1.5:	   Schematic	   diagram	   demonstrating	   enhancement	   of	   a	   basic	  
cylindrical	   conduit	   with	   luminal	   filler	   (insert	   right),	   growth	   factors	   and	   cells	  
(image	  modified	  from	  source:	  Daly	  et	  al)	  51	  
	  
In	  contrast	  to	  superstructured	  scaffolds,	  size	  and	  spread	  of	  pores	  are	  important	  
within	  microstructured	  scaffolds	  because	  they	  control	  oxygen	  delivery,	  nutrient	  
diffusion	  and	  cell	  migration59	   60	   61	   62	   63.	  Smaller	  pore	  sizes	  mean	   less	  nutrients	  
and	   oxygen	   can	   be	   delivered	   to	   the	   central	   regenerative	   zone	   (potentially	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leading	   to	  cell	   apoptosis	  or	  necrosis),	   yet	   larger	  pore	   sizes	   reduce	  cell	   contact	  
and	  can	  lead	  to	  leaching	  of	  nutrients	  or	  essential	  growth	  factors64	  65	  66.	  A	  best-­‐fit	  
principle	   is	   often	   employed	   in	   scaffold	   design	  where	   a	   balance	   between	  pore	  
size	  and	  distribution	  within	  an	  ideal	  range	  is	  desired67	  68.	  	  
	  
	  
Figure	  1.6:	  Scanning	  electron	  microscopy	  photograph	  of	  the	  microstructure	  of	  a	  
hyaluronic	  acid	  hydrogel	  scaffold	  
	  
1.4.2	   Biomaterials	  selection	  in	  peripheral	  nerve	  regeneration	  	  
	  
In	   addition	   to	   architecture,	   biomaterial	   selection	   is	   key	   to	   the	   design	   of	   a	  
successful	   scaffold	   for	   peripheral	   nerve	   regeneration.	   Biomaterials	   selected	  
must	  be	  both	  biocompatible	  and	  biodegradable.	  They	  must	  also	  be	  capable	  of	  
supporting	  and	  interacting	  with	  implanted	  stem	  cells	  or	  intrinsic	  Schwann	  cells.	  
The	   ideal	   scenario	   leads	   to	   absorption	   and	   replacement	   of	   the	  material,	  with	  
the	   gradual	   replacement	   of	   the	   scaffold	   itself	   by	   neural,	   glial	   and	   angiogenic	  
cells	  which	  incorporate	  into	  the	  normal	  neural	  circuitry69	  70.	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Since	   the	   1970’s,	   considerable	   focus	   has	   been	   given	   to	   the	   development	   of	  
biocompatible	  and	  biodegradable	  natural	  scaffolds	  for	  neuro-­‐regeneration.	  This	  
promotes	  cell	  adhesion,	  ECM	  deposition	  and	  cell	   interaction,	  whilst	  permitting	  
oxygen	  nutrients	  and	  growth	  factor	  transport,	  and	  biodegrades	  at	  a	  controllable	  
rate,	   provoking	  minimal	   inflammation71	   72	   73.	   Numerous	  materials,	   structures,	  
substances	  and	  techniques	   for	  developing	  scaffold	  based	  artificial	  nerve	  grafts	  
are	   now	   available	   which	   promote	   regeneration	   after	   nerve	   injury74	   75.	  
Commercial	   products	   such	   as	  NeuraGen®	   (Integra	   LifeSciences	  Co,	   Plainsboro,	  
NJ,	  USA)	  and	  AxoGuard®	  (AxoGen	  Alachua,	  Florida)	  which	  attempt	  to	  mimic	  the	  
native	  properties	  of	  autologous	  grafts,	  are	  beginning	  to	  emerge	  in	  mainstream	  
use.	   Despite	   the	   intrinsic	   pre-­‐disposed	   tendency	   of	   incomplete	   or	   short	   gap	  
peripheral	  nerve	   injury	   to	   repair	  by	  means	  of	  axonal	  out-­‐sprouting,	  NeuraGen	  
only	   achieves	   results	   below	   2cm	   gaps	   in	   humans.	   This	   is	   still	   probably	   the	  
market	   leader	   for	   biomaterial	   approaches	   while	   AxoGen	   is	   the	   only	   one	  
available	  now	   that	  has	   shown	  potential	   above	   this	   size,	   because	   it	   consists	  of	  
decelluarised	   allograft	   that	   retains	   some	   native	   growth	   factors.	   	   To	   date,	   no	  
scaffold	   or	   biomaterial	   has	   equaled	   or	   surpassed	   the	   results	   achieved	   with	  
direct	  repair	  or	  autografting	  and	  there	  is	  a	  major	  need	  for	  alternative	  strategies	  
to	  treat	  large	  gap	  nerve	  injuries	  above	  3cm.	  
	  
One	  of	  the	  most	  widely	  studied	  biomaterials	  in	  biological	  scaffolding	  is	  collagen.	  
Collagen	  is	  the	  main	  structural	  protein	  found	  in	  connective	  tissue	  in	  mammals.	  
It	  has	  been	  used	  in	  peripheral	  nerve	  regeneration	  applications	  for	  many	  years;	  
in	   1998,	   	   Chamberlain	   et	   al	   reported	   improved	   recovery	   rates	   in	   rats	   treated	  
with	  collagen-­‐GAG	  filled	  tubes	  over	  a	  10	  mm	  gap	  in	  Lewis	  rats76	  77	  	  78	  79.	  Typically	  
synthesized	   by	   fibroblasts	   and	   epithelial	   cells,	   bovine	   or	   porcine	   collagen	   in	  
scaffold	   preparation,	   has	   been	   extensively	   used	   in	   peripheral	   nerve	  
regeneration	  over	   the	   last	  15	  years80	   81	   82	   83.	   The	  Tissue	  Engineering	  Research	  
Group	  at	  RCSI	  has	  over	  a	  decade	  of	  experience	  in	  working	  with	  collagen	  in	  bone,	  
cartilage	  and	  muscle	  applications,	  therefore	  collagen	  type	  1	  was	  identified	  early	  
on	  as	  a	  biomaterial	  of	  choice	  in	  the	  context	  of	  this	  study.	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In	   addition	   to	   collagen,	   other	   naturally	   derived	   bioactive	   materials	   such	   as	  
hyaluronic	   acid	   (HA)	   have	   been	   shown	   to	   promote	   cellular	   attachment	   and	  
facilitate	   axonal	   outgrowth	   in	   central	   and	   peripheral	   nervous	   system	  
applications	  84	  85	  86	  87	  88	  89	  90	  91	  92	  93.	  When	  produced	  in	  microstructured	  hydrogel	  
forms	   (see	   Figure	   1.6),	   bioactive	   materials	   can	   be	   easily	   combined	   with	  
neurotrophic	  factors	  in	  processing,	  facilitating	  a	  controlled	  and	  steady	  release94	  
95	  96.	  In	  the	  context	  of	  this	  study,	  HA	  has	  also	  been	  identified	  as	  a	  biomaterial	  of	  
choice	   for	   peripheral	   nerve	   regeneration.	   Found	  most	   commonly	   in	   the	   ECM,	  
the	  central	  nervous	  system	  and	  the	  peripheral	  nervous	  system,	  HA	  is	  important	  
in	  wound	   healing	   because	   it	   is	   non	   immunogenic	   and	   its	   presence	   favors	   the	  
infiltration	   of	   migratory	   cells	   into	   injured	   tissues97	   98	   99.	   It	   exists	   as	   a	   non-­‐
sulfated,	  high	  molecular	  weight,	  unbranched	  glycosaminoglycan	  that	  comprises	  
a	  series	  of	  repeating	  disaccharide	  units	  linked	  by	  alternating	  beta	  links100	  101.	  In	  
addition	   to	   bioavailability,	   HA	   also	   has	   a	   short	   degradation	   rate.	   Further,	   its	  
degradation	  products	  can	  reduce	  inflammation	  whilst	  stimulating	  angiogenesis	  	  
and	  there	  is	  a	  natural	  affinity	  between	  it	  and	  ONS	  cells102	  103	  104.	  
	  
Overall,	   HA	   based	   scaffolds	   in	   hydrogel	   form	   have	   been	   found	   to	   be	   more	  
biologically	   active	   then	   hydrogels	   based	   on	   other	   polymers105.	   Although	   HA	  
hydrogels	   can	   contain	   negative	   regulators	   that	   inhibit	   neurite	   outgrowth,	  
research	   has	   shown	   that	   implanted	   HA	   minimizes	   glial	   scar	   formation	   and	  
promotes	   vascularization	   into	   damaged	   tissues106	   107.	   Furthermore,	  
functionalising	  HA	  scaffolds	  by	  crosslinking	  with	  molecules	  such	  as	  poly	  L	  lysine	  
laminin	   or	   poly	   D	   lysine	   has	   been	   proven	   to	   improve	   axonal	   growth	   and	  
integration	  within	  damaged	  tissues108	  109	  110	  111	  112.	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Figure	   1.7:	   Scanning	   electron	   microscopy	   image	   demonstrating	   stem	   cells	  
cultured	   on	   a	   non-­‐functionalised	   HA	   hydrogel.	   HA	   hydrogels	   can	   contain	  
negative	   regulators	   that	   inhibit	   neurite	   outgrowth	   unless	   functionalised	   with	  
molecules	   such	   as	   poly	   L	   lysine	   laminin	   or	   poly	   D	   lysine.	   Arrows	   indicate	   cells	  
entrapped	  within	  the	  scaffold	  
	  
In	   addition	   to	   architecture	   and	   biomaterial	   selection,	   an	   important	   design	  
consideration	   is	   the	   method	   of	   fabrication	   of	   a	   given	   scaffold	   because	   the	  
method	  of	  production	  can	   impact	  on	   the	  stiffness	  of	   the	  end	  product.	  HA	  has	  
several	  carboxylic	  acid	  groups	  along	  its	  polymer	  chain,	  which	  makes	  it	  extremely	  
amenable	   to	   cross-­‐linking	   (the	   process	   of	   chemically	   joining	   two	   or	   more	  
molecules	   by	   covalent	   bonds)113	   114	   115.	   Cross	   linking	   reagents	   are	   molecules	  
which	   contain	   two	   or	   more	   reactive	   ends	   and	   are	   capable	   of	   chemically	  
attaching	   to	   specific	   functional	   groups	   on	   other	  molecules116.	   These	   reagents	  
can	   alter	   the	  behavior	   of	   the	   end	  product	   in	   different	  ways117.	   The	  degree	  of	  
attachment	  is	  an	  important	  factor	  depending	  on	  the	  application.	  For	  example,	  a	  
low-­‐to-­‐moderate	   degree	   of	   attachment	   produces	   less	   stiff	   structures,	   which	  
retain	  the	  biological	  activity	  of	  the	  primary	  molecule;	  these	  may	  be	  optimal	   in	  
cell	  delivery	  systems	  aimed	  at	  peripheral	  nerve	  regeneration	  118.	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1.5. Cell	  based	  therapeutics	  in	  peripheral	  nerve	  regeneration	  
	  
Increasingly	  there	   is	  evidence	   in	  the	   literature	  supporting	  the	  use	  of	  biological	  
scaffolds	   seeded	   with	   stem	   cells	   or	   mitogens	   to	   enhance	   peripheral	   nerve	  
regeneration119.	  Denervated	  Schwann	  cells	  are	  well	  recognised	  as	  a	  key	  element	  
in	  promoting	  regeneration	  of	  peripheral	  nerves	  but	  prolonged	  or	  extensive	  loss	  
of	   axonal	   contact	   can	   render	   their	   effects	   obsolete	   through	   the	   loss	   of	   ECM-­‐
integrin	   interactions	   and	   oxidative	   stresses.	   Supporting	   the	   denervated	  
environment	   with	   progenitor	   cells	   in	   a	   cell	   based	   therapeutic	   approach	   is	   a	  
logical	  and	  natural	  progression.	  A	  number	  of	  biologically	  active	   scaffolds	  been	  
successfully	   demonstrated	   to	   function	   synergistically	   with	   neural	   progenitor	  
cells	  to	  enable	  functional	  neural	  tissue	  growth	  120	  121	  122	  123.	  Many	  of	  the	  recent	  
leading	  scaffolds	  for	  peripheral	  nerve	  regeneration	  have	  used	  aligned	  glial	  and	  
stem	  cells	  with	  axonal	  tracts	  to	  direct	  regenerating	  axons	  across	  damaged	  tissue	  
or	   to	  directly	   replace	  the	   function	  of	   lost	  cells124.	  These	  techniques	  have	  been	  
shown	  to	  enhance	  the	  effectiveness	  of	  tissue	  engineered	  scaffolds	  and	  provide	  
evidence	   supporting	   	   a	   case	   by	   case	   tailored	   approach	   to	   neuroregenerative	  
medicine125.	  	  
	  
Cell	   transplantation	   techniques	   facilitate	   regeneration	   through	   the	   controlled	  
delivery	  of	  cells	  and	  neurotrophins	  at	  the	  site	  of	  injury126.	  A	  number	  of	  studies	  
have	   demonstrated	   improved	   functional,	   electrophysiological	   and	   histological,	  
outcomes	   following	   transplantation	   of	   Schwann	   cells,	   embryonic	   stem	   cells	  
(ESCs),	  neural	  stem	  cells	  (NSCs),	  and	  adult	  mesenchymal	  stem	  cells	  (MSCs)	  such	  
as	  bone-­‐marrow-­‐derived	  mesenchymal	  stem	  cells	   (BMSCs)	   in	   in	  vivo	  models127	  
128	  129.	  Typically,	  the	  choice	  of	  cells	  for	  use	  in	  a	  cell	  based	  therapeutic	  approach	  
to	  peripheral	  nerve	  regeneration	  has	  included	  cultured	  Schwann	  cells;	  or	  BMSCs	  
but	  increasingly,	  alternative	  sources	  of	  stem	  cells	  are	  being	  investigated130.	  One	  
important	   aspect	   of	   stem	   cell	   use	   in	   therapeutic	   applications	   is	   the	  means	   of	  
acquisition	   of	   the	   source	   cells.	   In	   practical	   terms,	   the	   location	   of	   many	  
progenitor	   cells	  within	   the	   human	   body	   can	   render	   them	  both	   challenging	   to	  
access	   surgically,	   and	   unacceptable	   for	  many	   patients.	   Procedures	   to	   harvest	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human	  bone	  marrow	  cells	   require	  painful	  bone	  marrow	  aspirates,	  which	  have	  
the	   potential	   to	   result	   in	   a	   significant	   degree	   of	   associated	  morbidity131.	   The	  
acquisition	   of	   peripheral	   Schwann	   cells	   requires	   painful	   nerve	   biopsies,	   and	  
central	   glial	   cell	   precursors	   pose	   their	   own	   challenges.	   For	   example	   where	  
centrally	   derived	   olfactory	   ensheathing	   cells	   (OECs)	   have	   been	   used,	  
researchers	   were	   required	   to	   access	   cells	   from	   the	   base	   of	   the	   forebrain132.	  
Clearly,	   a	   significant	   drawback	   to	   procedures	   acquiring	   explant	  material	   from	  
any	  part	   of	   the	  brain	   is	   the	   inherent	   associated	   risk	   of	   developing	  meningitis,	  
cerebrospinal	  fluid	  leak,	  anosmia,	  cerebrovascular	  accident	  or	  epilepsy133.	  
	  
1.6	   Olfactory	  neuroepithelial	  derived	  stem	  cells	  for	  peripheral	  nerve	  repair	  
The	  olfactory	  system	  was	  the	  first	  sensory	  system	  to	  evolve	  in	  higher	  organisms	  
and	   the	   structure	   of	   its	   neuroepithelium	   is	   similar	   amongst	   vertebrates134.	  
Throughout	  evolution	  it	  has	  served	  a	  number	  of	  important	  functions	  and	  one	  of	  
the	  most	   interesting	  things	  about	  the	  olfactory	  system,	   is	   its	  capacity	  to	  adapt	  
and	   maintain	   internal	   homeostasis	   whilst	   constantly	   responding	   to	   changing	  
groups	   of	   heterogeneous	   stimuli135	   136.	   Prior	   to	   the	   1960s,	   the	   prevailing	  
hypothesis	  of	  neurogenesis	  was	  that	  it	  could	  only	  occur	  during	  embryogenesis.	  
Researchers	   such	   as	   Joseph	   Altman	   first	   challenged	   this	   concept	   in	   1962137.	  
Altman’s	   research	   in	   hooded	   rats	   demonstrated	   neuronal	   development	   from	  
undifferentiated	   stem	   cells	   following	   administration	   of	   Thymidine	   H.	   This	  
concept	   of	   adult	   neurogenesis	   was	   subsequently	   further	   supported	   by	   work	  
produced	   by	   Costanza,	   Graziadei	   and	   MacKay-­‐Sim	   in	   the	   1980s	   and	   1990s.	  
However	  it	  is	  only	  in	  the	  last	  ten	  to	  fifteen	  years,	  that	  the	  regenerative	  capacity	  
of	  olfactory	  neuroepithelial	  tissue	  has	  been	  fully	  investigated	  and	  the	  idea	  of	  a	  
discrete	  population	  of	  stem	  cells,	  which	  exists	  within	  the	  nasal	  neuroepithelium,	  
has	  been	  firmly	  established138.	  	  
	  
The	  olfactory	  neuroepithelium	  comprises	  a	  mucosal	  layer,	  an	  underlying	  lamina	  
propria	   and	   a	   combination	   of	   receptor	   cells,	   basal	   cells,	   progenitor	   cells	   and	  
supporting	  cells	  as	  demonstrated	  in	  Figure	  1.4.A139.	  Mitral	  connecting	  cells	  and	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multipotent	  progenitor	  cells	  have	  been	  found	  to	  exist	  in	  the	  neuroepithelium	  as	  
well	   as	   in	   the	   olfactory	   bulb	   which	   is	   located	   at	   the	   under	   surface	   of	   the	  
forebrain	   in	   the	   anterior	   skull	   base140.	   Olfactory	   neurons	   are	   bipolar	   with	  
dendritic	   extensions141.	   In	   mammals,	   the	   olfactory	   neurons	   project	   from	   the	  
olfactory	   bulb	   into	   the	   neuroepithelium	   in	   the	   superior	   portion	   of	   the	   nasal	  
cavity	   via	   foramina	   within	   the	   anterior	   skull	   base,	   known	   as	   the	   cribiform	  
plate142.	   The	   structure	   of	   the	   human	   olfactory	   system	   is	   demonstrated	  
schematically	   in	   Figure	   1.8	   A	   &	   1.4	   B.	   The	   exposed	   position	   of	   the	   olfactory	  
neuroepithelium	  and	   the	  number	  of	   stimuli	   to	  which	   it	   is	   exposed,	   leaves	   the	  
system	   inherently	   vulnerable	   to	   injury	   by	   noxious	   stimuli,	   viral	   infection,	   para	  
nasal	  sinus	  disease	  and	  trauma143.	  In	  order	  to	  maintain	  sensitivity	  to	  the	  range	  
of	  odorants	   to	  which	   the	  olfactory	   system	   is	  exposed,	   its	   responses	   to	   stimuli	  
must	  be	  highly	  adaptable144.	  The	  ability	  of	  olfactory	  sensory	  tissue	  to	  constantly	  
regenerate	  and	  replenish	   itself	  across	  all	  cell	   types,	   from	  stem	  cells	  derived	  at	  
the	  horizontal	  basal	  cell	  layer	  means	  that,	  spontaneous	  recovery	  from	  acquired	  
anosmia	  unlike	  other	  forms	  of	  sensory	  or	  motor	  deficit	  due	  to	  nerve	  injury	  can	  
occur144.	  
	  
Figure	   1.8.	   A:	   Diagram	   representing	   the	   anatomical	   structure	   of	   the	   human	  
olfactory	  neuro	  epithelium.	  B:	  Schematic	   representation	  of	   the	  neuronal	  circuit	  
of	  the	  olfactory	  bulb	  146	  147.	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Recent	   research	  suggests	   that	   the	  olfactory	   system	   is	  one	  of	   two	  areas	  of	   the	  
mammalian	   brain	   to	   retain	   plasticity	   into	   adulthood148.	   The	   location,	   identity	  
and	  behavior	  of	  cell	  precursor	  basal	  cells	  within	  the	  olfactory	  system;	  including	  
their	   ability	   to	  migrate,	   differentiate,	   and	   integrate	   into	   circuitry	   is	   a	   topic	   of	  
great	   interest	   to	   researchers.	   Graziadei	  et	   al	   first	   reported	   on	   the	   restorative	  
capacity	  of	  olfactory	  neuroepithelial	   tissue	   in	  1978149.	  There	  has	   subsequently	  
has	   been	   increased	   emphasis	   on	   the	   importance	   of	   the	   role	   of	   the	   olfactory	  
system	   in	   neuroregeneration.	   There	   have	   also	   been	   significant	   advances	   in	  
research	   surrounding	   the	   regenerative	   and	   restorative	   capacity	   of	   olfactory	  
neuroepithelial	   derived	   cells	   (ONS)	   and	   olfactory	   bulb	   tissue150.	   	   The	   use	   of	  
olfactory	   derived	   stem	   cells	   and	   their	   progeny	   for	   in	   vivo	   neural	  models	   has,	  
most	  notably	  with	  the	  work	  of	  Tabakow	  et	  al,	  led	  to	  significant	  advances	  in	  our	  
understanding	  of	  the	  processes	  surrounding	  both	  central	  and	  peripheral	  nerve	  
regeneration151.	  	  
In	   addition	   to	   possessing	   an	   unparalleled	   capacity	   for	   regeneration,	   olfactory	  
neuroepithelial	   derived	   stem	   cells	   (ONS)	   were	   shown	   in	   1983	   to	   successfully	  
survive	  transplantation	  into	  non-­‐native	  environments	  by	  Heckroth	  et	  al.	  In	  that	  
study,	   primary	   olfactory	   neuroepithelial	   tissue	   cells	   were	   implanted	   into	   the	  
anterior	   chamber	   of	   the	   eye	   in	   adult	   rats.	   Following	   degeneration	   of	  mature	  
cells,	   the	   authors	   demonstrated	   a	   proliferation	   of	   basal	   elements	   and	  
subsequent	   development	   of	   a	   new	   population	   of	   young	   neurons,	   which	  
acquired	  morphological	  maturity	  and	  neural	  marker	  expression	   in	  the	  absence	  
of	   any	   connection	   with	   a	   central	   nervous	   system	   target152.	  MacKay-­‐Sim	   et	   al	  
have	  reported	  that	  olfactory	  neuroepithelial	  tissue	  possesses	  a	  large	  number	  of	  
neuroactive	   growth	   factors153.	   Additionally,	   stem	   cells	   derived	   from	   the	  
olfactory	   system	   have	   been	   shown	   to	   express	   extracellular	   matrix	   receptors.	  
These	  are	  not	   typically	  present	   in	  other	  neural	   stem	  cells,	   suggesting	   that	   the	  
olfactory	  system	  has	  the	  potential	  to	  be	  one	  of	  the	  most	  plastic	  pathways	  within	  
the	  mammalian	  nervous	  system154.	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In	   2010,	   Delorme	   et	   al	   compared	   the	   potency	   of	   olfactory	   neuroepithelial	  
derived	  stem	  cells	  (ONS)	  with	  bone	  derived	  mesenchymal	  stem	  cells	  (BMSC).	  In	  
that	  paper,	  the	  authors	  showed	  that	  when	  compared	  with	  BMSCs,	  ONS	  possess	  
greater	   clonogenicity,	   higher	   proliferation	   rates	   and	   a	   natural	   inclination	   for	  
differentiation	  towards	  neural	  and	  glial	  lineage155.	  For	  these	  reasons	  and	  those	  
outlined	  above,	  from	  a	  translational	  science	  perspective,	  ONS	  cells	  represent	  a	  
desirable	  source	  of	  progenitor	  cell,	  particularly	  in	  the	  context	  of	  the	  peripheral	  
nerve	   model.	   In	   contrast	   to	   the	   cell	   sources	   described	   above	   in	   Section	   1.5,	  
olfactory	   neuroepithelial	   derived	   explants	   represent	   a	   clear	   opportunity	   to	  
provide	   a	   less	   invasive,	  more	  patient-­‐centered	  means	  of	   sourcing	  multipotent	  
cells	  for	  neuroregenerative	  purposes.	  
	  
1.7	   Role	  of	  neurotrophic	  growth	  factors	  in	  peripheral	  nerve	  regeneration	  
Increasingly	  there	  is	  support	  in	  the	  literature	  for	  the	  inclusion	  of	  growth	  factors	  
within	  nerve	  regeneration	  systems.	  Growth	  factors	  may	  be	  used	  to	  manipulate	  
the	   rates	   of	   degeneration	   and	   regeneration	   of	   cells.	   Research	   suggests	   that	  
improved	   functional	   and	   morphologic	   outcomes	   can	   be	   achieved	   in	   vivo,	  
resulting	  in	  an	  enhanced	  biological	  effect,	  when	  tissue	  engineered	  scaffolds	  are	  
supplemented	  with	  growth	  factors	  such	  as	  NGF,	  BDNF	  and	   Insulin-­‐like	  Growth	  
Factor	   (IGF)	   156	   157	   158	   159	   160	   161.	   For	   example,	   in	   2011,	   Chung	   et	   al	   reported	  
significant	   improvement	   in	   axon	   numbers	   and	   gastrocnemius	   muscle	   mass	  
achieved	  with	  a	  poly	  (ε-­‐caprolactone)	  PCL	  scaffold	  supplemented	  with	  NGF	  in	  a	  
rat	  sciatic	  model.	  Two	  years	  later,	  Hwang	  et	  al	  used	  IGF	  to	  improve	  outcomes	  in	  
spinal	  cord	  injuries	  in	  rats,	  and	  Jin	  et	  al	  reported	  on	  improved	  in	  vitro	  neuronal	  
growth	  with	  a	  composite	  collagen	  hyaluronic	  acid	  hydrogel	  supplemented	  with	  
NGF162	  163.	  	  
	  
Certain	   growth	   factors	   have	   been	   found	   to	   have	   dose	   dependent	   effects	   on	  
peripheral	   nerve	   repair,	   and	   the	   combination	   of	   two	   or	  more	   growth	   factors,	  
are	   thought	   in	   some	   circumstances,	   to	   have	   a	   synergistic	   effect	   on	   neuronal	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outgrowth164	   165.	   For	   example,	   a	   2003	   study	   published	   in	   Neuroscience	   by	  
researchers	   in	   Toronto,	   showed	   that	   NGF	   and	   BDNF	   act	   synergistically	   to	  
promote	  axonal	  development	  in	  a	  dorsal	  root	  ganglion	  model166.	  In	  that	  study,	  
axonal	  growth	  was	  increased	  from	  7.5	  mm	  under	  NGF	  enhanced	  conditions,	  to	  
12.5mm	  under	  combined	  NGF/BDNF	  enhanced	  conditions.	  	  
	  
A	   number	   of	   authors	   have	   reported	   that	   devices,	   which	   contain	   cells	   and	  
growth	  factors,	  are	  now	  showing	  better	  results	  than	  the	  cell	  free	  devices,	  which	  
currently	  dominate	  the	  market167	   168	   169.	  Therefore,	  along	  with	  the	  novel	  stem	  
cell	  source	  described	  in	  Section	  1.6,	  several	  potential	  neurotrophic	  factors	  were	  
considered	   for	   incorporation	   in	   the	   system	   proposed	   in	   this	   project.	   NGF	   is	  
considered	  to	  be	  the	  prototype	  of	  neurotrophins;	  it	   is	  the	  most	  widely	  studied	  
of	  all	  the	  neurotrophic	  factors	  and	  is	  thought	  to	  be	  critical	  to	  both	  the	  survival	  
of	   sensory	  neurons	  and	   to	   the	  promotion	  of	  axonal	  elongation,	   functioning	   to	  
promote	  myelinisation	  and	  prevent	  neuronal	  degeneration	  after	   injury170	  171.	   It	  
has	  been	  shown	  to	  have	  a	  pro	  differentiation	  effect	  on	  olfactory	  cells172	  thus	  its	  
inclusion	  in	  a	  cell	  delivery	  system	  designed	  for	  use	  with	  ONS	  cells	  in	  a	  peripheral	  
nerve	   injury	   model	   makes	   sense.	   The	   second	   neurotrophic	   factor	   to	   be	  
characterised	  after	  NGF	  was	  BDNF173.	  BDNF	  has	  been	  reported	  to	  both	  support	  
existing	   central	   and	   peripheral	   nervous	   system	   cells	   as	   well	   as	   encouraging	  
growth	  and	  differentiation	  of	  new	  neurons	  and	  synapses	  through	  its	  actions	  at	  
tyrosine	  kinase	  receptors174	  175.	  	  
	  
Studies	  have	  also	  shown	  improved	  outcomes	  in	  peripheral	  nerve	  injuries	  using	  
NGF	   in	   the	   absence	   of	   scaffolds	   or	   stem	   cells176.	   This	   suggests	   that	   NGF	  may	  
serve	   two	   distinct	   functions	   in	   tissue	   engineered	   approaches	   to	   peripheral	  
nerve	   repair;	   supporting	   implanted	   stem	   cell	   differentiation,	   and	   promoting	  
out-­‐sprouting	   of	   native	   axons	   from	   the	   proximal	   stump	   in	   vivo.	   	   NGF	   was	  
selected	  as	  a	  growth	  factor	  of	  choice	  for	  this	  study	  mainly	  because	  of	  this	  dual	  
functionality.	  The	  rationale	  is	  explained	  further	  in	  Chapter	  2	  and	  Chapter	  3.	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1.8.	   Animal	  models	  in	  the	  study	  of	  peripheral	  nerve	  regeneration	  
Whilst	   in	   vitro	   analysis	   of	   cell	   or	   biomaterial	   behavior	   provides	   essential	  
information	   on	   the	   neuroregenerative	   capacity	   of	   tissue	   engineered	   systems,	  
pre-­‐clinical	  animal	  studies	  are	  a	  prerequisite	  to	  the	  implementation	  of	  any	  such	  
proposed	  therapy	  in	  clinical	  practice.	  Animal	  studies	  are	  required	  by	  European	  
and	   American	   regulatory	   authorities	   to	   investigate	   safety	   and	   efficacy	   when	  
products	   are	   being	   brought	   to	   the	  market	   for	   clinical	   use.	  Many	  mammalian	  
models	   have	   been	   used,	   but	   the	   majority	   of	   studies	   on	   peripheral	   nerve	  
regeneration	   have	   used	   the	   sciatic	   nerve	   in	   the	   rat	   model.	   This	   is	   mainly	  
because	   the	   rat	   is	   relatively	   cost	   effective,	   and	   it	   provides	   easily	   accessible	  
nerve	  tissue,	  which	  is	  structurally	  very	  similar	  to	  human	  nervous	  tissue177	  178.	  A	  
further	  benefit	   to	  the	  use	  of	   the	  rat	  model	   is	   that	  rodent	  neurons	  elongate	  at	  
rates	   of	   up	   to	   2mm	   per	   day,	   which	  means	   that	   in	   vivo	   studies,	   can	   be	  more	  
expeditiously	   completed	   than	   studies	   on	   higher	   order	   species179.	   As	   in	   other	  
vertebrates,	   the	   rat	   sciatic	   nerve	   is	   a	   large,	   mixed	   function	   nerve,	   which	  
simultaneously	  supplies	  motor	  instructions	  the	  lower	  half	  of	  the	  hind	  limb,	  and	  
sensory	  supply	  to	  the	  skin	  over	  the	  lower	  leg180.	  Damage	  to	  the	  efferent	  motor	  
component	  of	  the	  sciatic	  nerve	  can	  result	  in	  hind	  limb	  muscle	  weakness,	  reflex	  
abnormalities	  and	  inhibition	  of	  locomotion181.	  Similarly,	  damage	  to	  the	  afferent	  
sensory	   component	   of	   the	   sciatic	   nerve	   can	   result	   in	   parasthesia	   or	  
hyperesthesia,	   which	   is	   analogous	   to	   sciatica	   in	   humans.	   As	   in	   humans,	   the	  
sciatic	   nerve	   in	   the	   rat	   arises	   from	   the	   lumbosacral	   region,	   travels	   in	   the	  
posterior	   compartment	   of	   the	   hind	   limb	   behind	   the	   adductor	   muscles	   and	  
divides	   into	   two	   branches,	   the	   tibial	   and	   common	   fibular	   nerves	   supplying	  
muscle	  innervation	  to	  the	  lower	  leg	  182	  183	  184	  185.	  At	  its	  mid	  point	  in	  the	  adult	  rat,	  
the	  sciatic	  nerve	  contains	  up	  to	  27000	  axons,	  and	  is	  comparable	  in	  diameter	  to	  
the	  intrinsic	  nerves	  of	  the	  human	  hand	  or	  the	  recurrent	   laryngeal	  nerve	  in	  the	  
neck186.	  
	  
A	  major	  challenge	  in	  establishing	  a	  pre	  clinical	  animal	  study	  for	  peripheral	  nerve	  
regeneration	   is	   the	   lack	   of	   conclusive	   evidence	   on	   which,	   of	   the	   numerous	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available	  methods	  of	  assessment,	  gives	  the	  most	  accurate	  information	  on	  nerve	  
status187.	   As	   a	   result,	   most	   studies	   combine	   more	   than	   one	   method	   of	  
qualitative	   or	   quantitative	   evaluation,	   which	   may	   include	   clinical,	   functional,	  
electrophysiological,	  mechanical	  or	  morphological	  testing.	  	  
	  
Clinical	   indicators	  provide	   the	   first	  echelon	  of	   readily	  available	   information	  on	  
sciatic	   nerve	   function.	   In	   the	   rat	   sciatic	   model	   the	   main	   clinical	   indicators	   of	  
peripheral	   nerve	   injury	   are:	   autophagy	   (where	   animals	   self	   mutilate	   and	  
amputate	   the	   toes	   following	   peripheral	   nerve	   injury),	   muscle	   wasting	  
(commonly	   presented	   as	   a	   wet	   weight	   ratio	   of	   the	   gastrocnemius	   muscle),	  
pressure	  necrosis	  and	  contracture	  formation188	  189.	  	  Assessment	  of	  locomotion	  is	  
another	   frequently	   used	   non-­‐invasive	   tool	   for	   the	   functional	   evaluation	   of	  
sciatic	  nerve,	   since	   locomotion	   is	   the	  primary	   function	  of	   the	   rat	  hind	   limb190.	  
The	   foot	   print	   analysis	   technique	   of	   Sciatic	   Function	   Index	   (SFI)	   is	   one	   of	   the	  
more	  widely	   used	  methods	   of	   assessing	   the	   rodent	   sciatic	   nerves	   locomotory	  
function191	  192	  193.	  Although	  SFI	  is	  frequently	  used,	  a	  significant	  disadvantage	  of	  
the	   reliance	   on	   foot	   print	   analysis	   as	   a	   measure	   of	   nerve	   recovery	   is	   the	  
presence	   of	   autophagy;	   this	   is	   a	   self-­‐mutilating	   characteristic	   observed	   in	  
certain	  strains	  of	   rats	  where	  the	  animal	  chews	  the	  digits	  of	   the	   limb	  following	  
nerve	  injury.	  It	  can	  lead	  to	  soft	  tissue	  and	  bone	  destruction,	  making	  analysis	  of	  
toe	  spread	  and	  intermediate	  toe	  spread	  challenging	  to	  interpret194.	  Moving	  up	  
the	  ladder	  of	  invasive	  testing,	  a	  further	  qualitative	  method	  of	  sciatic	  evaluation	  
in	   laboratory	   animals	   is	   the	   assessment	   of	   the	   presence	   of	   pain	   using	   the	  
nocioceptive	  withdrawal	  response195	  196.	  The	  nocioceptive	  withdrawal	  response	  
is	  a	  sensory	  and	  motor	  test,	  which	  provides	  evidence	  of	  some	  level	  of	  function,	  
however,	   it	   is	  polysynaptic,	  which	  means	  signals	  can	  be	  also	  be	  susceptible	   to	  
modification197.	   As	   with	   clinical	   and	   locomotor	   testing	   the	   interpretation	   of	  
animal	  withdrawal	  or	  vocalisation	  responses	   is	  a	  user	  dependent	  process,	  one	  
that	  has	  the	  potential	  to	  be	  subject	  to	  observer	  bias198	  199	  200.	  Taken	  together,	  
clinical	   locomotory	   and	   nocioceptive	   reflex	   evaluation	   provide	   qualitative	   but	  
not	  quantitative	  evidence	  of	  nerve	  status.	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Since	   some	   nerves	   have	   an	   ability	   to	   partially	   repair	   if	   left	   untreated,	  
quantitative	  evaluation	  of	  the	  status	  of	  a	  nerve	  post	  intervention	  is	  essential	  to	  
assessing	   the	   success	   of	   the	   treatment	   used201.	   Quantitative	   evaluation	   of	  
sciatic	   nerve	   function	   in	   laboratory	   animals	   may	   take	   the	   form	   of	  
electrophysiological,	   mechanical,	   or	   morphological	   testing.	   Frequent	   methods	  
of	   electrophysiological	   analysis	   in	   peripheral	   nerve	   studies	   include	  
electoneurography,	   where	   multimeter	   electrodes	   are	   used	   to	   measure	   the	  
conducted	  velocity	  and	  latency	  of	  an	  electrical	  potential	  between	  two	  points	  on	  
the	  external	   surface	  of	   the	  nerve	   trunk,	   and	  electromyography	  where	  evoked	  
muscle	  responses	  to	  an	  applied	  stimulus	  are	  measured	  in	  terms	  of	  voltage202	  203	  
204.	  Fisch	  popularised	  the	  technique	  of	  electroneurography	  in	  the	  late	  70’s	  as	  a	  
means	   of	   examining	   the	   integrity	   and	   conductivity	   of	   peripheral	   nervous	  
tissue205	  206	  207.	  In	  clinical	  practice,	  it	  is	  typically	  employed	  in	  the	  early	  analysis	  of	  
facial	   nerve	   injury.	   However,	   its	   accuracy	   can	   be	   reduced	   in	   the	   presence	   of	  
asynchronous	  discharges	  from	  dying	  or	  regenerating	  axons	  and	  electrodes	  can	  
pick	   up	   electrical	   activity	   of	   the	   surrounding	   muscle	   tissue,	   leading	   to	  
discrepancies	   in	   the	   degree	   of	   conductivity	   assessed208	   209.	   Electromyography,	  
by	  comparison,	  provides	  information	  about	  the	  electrophysiological	  status	  of	  a	  
nerve	   by	   determining	   the	   amount	   of	   skeletal	   muscle	   membrane	   electrical	  
activity	  during	  both	  rest	  and	  voluntary	  muscle	  contraction210.	  Although	  at	  first	  it	  
might	   appear	   that	   electrophysiological	   assessment	  would	   be	   the	   best	   way	   to	  
assess	   the	   nerve’s	   function,	   in	   isolation,	   a	   normal	   result	   does	   not	   completely	  
rule	   out	   nerve	   pathology,	   because	   these	   techniques	   cannot	   evaluate	   the	  
presence	  of	  sensory	  deficits211.	  As	  a	  result,	  electrophysiological	  analysis	  results	  
are	   often	   reported	   in	   tandem	   with	   clinical	   observations,	   nocioceptive	  
withdrawal	  reflex,	  locomotor	  assessment	  and	  or	  morphological	  analysis212.	  	  
	  
In	   addition	   to	   clinical	   and	   electrophysiological	   evaluation,	   assessment	   of	   the	  
mechanical	   function	   of	   the	   limb	   may	   be	   used	   as	   an	   indirect	   determinant	   of	  
sciatic	   function.	   Because	   motor	   neurons	   are	   efferent	   nerves,	   which	   carry	  
instructions	  from	  the	  central	  nervous	  system	  to	  their	  target	  end	  organ	  to	  effect	  
movement,	   muscle	   tension	   and	   compression	   responses	   to	   nerve	   conducted	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stimuli	   can	   be	   utilised	   to	   give	   an	   estimation	   of	   the	   degree	   of	   recovery	   in	  
peripheral	   nerve	   regeneration	   studies213	   214.	   In	   reality,	  with	   several	   joints	   and	  
multiple	   muscle	   groups	   within	   the	   rat	   hind	   limb,	   each	   movement	   involves	   a	  
coordinated	  effort	  of	  several	  muscles215.	  Grouping	  all	  the	  individual	  movements	  
of	  the	  limb	  as	  a	  vector	  and	  combining	  elements	  as	  a	  single	  unit	  allows	  a	  more	  
global	   view	   of	   the	   kinematics	   of	   the	   hind	   limb,	   in	   response	   motor	   neuron	  
activity,	  to	  be	  obtained	  when	  evaluating	  the	  hind	  limb216	  217.	  
	  
Morphological	   assessment	   of	   nerve	   regeneration	   can	   be	   performed	   using	  
staining	  techniques	  such	  as	  immunocytohistochemistry,	  hematoxylin	  and	  eosin	  
staining	   or	   transmission	   electron	   microscopy.	   Immunocytohistochemical	  
analysis	  is	  performed	  by	  means	  of	  labeling	  the	  surface	  antibodies	  of	  a	  particular	  
cell	   with	   a	   fluorescent	   dye.	   This	   is	   probably	   the	   most	   widely	   used	   method	  
because	  it	  allows	  both	  visual	  inspection	  of	  the	  appearances	  of	  the	  labeled	  cells,	  
and	  facilitates	  laser	  assisted	  counting	  of	  the	  number	  of	  fluorescent	  labeled	  cells	  
within	   a	   mixed	   cell	   population218.	   Unlike	   the	   other	   methods	   of	   assessment	  
outlined,	   it	   is	   both	   qualitative	   and	   quantitative.	   In	   addition	   to	   qualifying	   the	  
presence	  or	  absence	  of	  neurons,	  it	  can	  quantify	  axonal	  number	  and	  calibre,	  and	  
differentiate	  between	  cell	   types219.	  Transmission	  electron	  microscopy	   (TEM)	   is	  
also	   frequently	   used	   because	   it	   produces	   highly	   detailed	   images	   of	   both	  
unmyelinated	   axons	   and	   the	   laminar	   structure	   of	   myelinated	   axons220.	  
However,	   the	   process	   of	   preparing	   samples	   for	   TEM	   is	   costly	   and	   time	  
consuming	  therefore	  its	  use	  is	  often	  restricted	  to	  confirming	  the	  findings	  of	  the	  
immunocytohistochemical	   assessments,	   and	   characterising	   neurite	   outgrowth	  





	   51	  
1.9	   Thesis	  Objectives	  
The	   principal	   objective	   of	   this	   research	   thesis	   was	   to	   critically	   evaluate	   the	  
capacity	   of	   stem	   cells	   derived	   from	   a	   novel	   source	   (the	   olfactory	  
neuroepithelium)	   to	   act	   in	   conjunction	   with	   a	   purpose-­‐designed	   biomimetic	  
tissue	   engineered	   scaffold	   or	   “nerve	   guidance	   conduit”	   (NGC),	   as	   an	   efficient	  
graft	  material	  in	  the	  repair	  of	  surgically	  ablated	  peripheral	  nerve	  tissue.	  The	  key	  
hypothesis	  proposed,	  was	  that	  the	  use	  of	  olfactory	  neuroepithelial	  derived	  stem	  
cells	   (ONS	  cells),	  with	  potential	   for	  both	  neural	   and	  glial	  differentiation,	   could	  
directly	  or	   indirectly	  enhance	  outcomes	  and	  synergistically	  work	  with	   inherent	  
axonal	  out	  sprouting	  to	  improve	  peripheral	  nerve	  regeneration.	  	  In	  addition,	  the	  
ability	   of	   neurotrophic	   nerve	   growth	   factor	   (NGF)	   to	   be	   delivered	   effectively	  
from	   the	   NGC,	   to	   enhance	   the	   neurogenic	   potential	   of	   the	   ONS	   cells	   and	  
ultimately	  to	  improve	  nerve	  regeneration	  was	  assessed.	  	  
	  
The	  specific	  aims	  of	  the	  overall	  project	  were:	  
	  
• To	  extract	  viable	  ONS	  cells	  from	  nasal	  biopsies	  of	  rats	  
• To	   investigate	   the	   potential	   of	   those	   rat	   ONS	   cells	   to	   promote	  
neurogenesis	  and	  glial	  differentiation	  in	  in	  vitro	  culture	  conditions	  
• To	  evaluate	  the	  effect	  of	  laminin	  and	  poly	  D	  lysine	  on	  the	  differentiation	  
capacity	  of	  ONS	  cells	  by	  means	  of	  neural	  and	  glial	  marker	  expression	  
• To	  evaluate	  the	  effect	  of	  NGF	  on	  the	  differentiation	  capacity	  of	  ONS	  cells	  
by	  means	  of	  neural	  and	  glial	  marker	  expression	  
• To	   develop	   an	   optimised	   biphasic	   collagen	   and	   hyaluronic	   acid	   based	  
biomimetic	  biphasic	  tissue	  engineered	  nerve	  guidance	  conduit	  (NGC)	  for	  
use	  with	  ONS	  cells	  in	  peripheral	  nerve	  regeneration	  
• To	  characterise	  the	  resultant	  response	  of	  ONS	  cells	  to	  the	  biphasic	  NGC	  	  
• To	   incorporate	   NGF	   within	   the	   biomimetic	   biphasic	   tissue	   engineered	  
NGC	  to	  enhance	  peripheral	  nerve	  regeneration	  in	  vitro	  and	  in	  vivo	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• To	  investigate	  the	  capacity	  of	  an	  ONS	  cell	  seeded	  NGC	  to	  enhance	  in	  vivo	  
peripheral	  nerve	  regeneration	  when	  compared	  with	  both	  a	  cell-­‐free	  NGC	  
and	  an	  NGF	  enhanced	  ONS	  cell	  loaded	  NGC	  in	  a	  rat	  sciatic	  nerve	  model	  
• To	   interpret	   the	   different	   techniques	   of	   functional	   evaluation	   in	   a	   rat	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2.1.	  Introduction	  	  
	  
Multipotent	   stem	  cells	  derived	   from	   the	  olfactory	  neuroepithelium	  have	  been	  
shown	   to	   demonstrate	   clonogenicity,	   rapid	   proliferation	   rates,	   and	   a	   natural	  
inclination	  for	  differentiation	  towards	  neural	  and	  glial	   lineage222.	  From	  a	  tissue	  
engineering	   perspective,	   this	   makes	   the	   olfactory	   neuroepithelium	   an	   ideal	  
source	  of	  progenitor	  cell	  in	  the	  context	  of	  the	  peripheral	  nerve	  model.	  From	  the	  
patient’s	   perspective,	   the	   most	   attractive	   benefit	   of	   the	   use	   of	   olfactory	  
neuroepithelial	   derived	   stem	   cells	   (ONS	   cells)	   for	   neuro-­‐regeneration	   is	   most	  
likely	  the	  relative	  ease	  and	  comfort	  of	  access	  of	  the	  explant	  material.	  
	  
	  
Figure	   2.1:	   Image	   demonstrating	   the	   site	   of	   the	   olfactory	   neuroepithelium	  
(asterisk)	   in	   the	   right	   side	   of	   the	   human	   nasal	   cavity.	   NS	   identifies	   the	   nasal	  
septum	  and	  ST	  identifies	  the	  superior	  turbinate223.	  	  
	  
Lane	   et	   al	   identified	   the	   superior	   turbinate	   as	   a	   source	   of	   olfactory	  
neuroepithelium	   2002224.	   This	   view	  was	   supported	   by	   Rezende-­‐Pinna	   et	   al	   in	  
2013225.	  The	  ease	  of	  access	  to	  the	  superior	  nasal	  cavity	  provided	  with	  modern	  
endoscopic	  equipment,	  means	   that	  a	   simple	  nasal	  mucosal	  biopsy	  under	   local	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anesthetic	   has	   the	   potential	   to	   provide	   patients	   with	   a	   personalised	   bank	   of	  
pluripotent	   stem	   cells,	   for	   use	   as	   and	   when	   required,	   without	   the	   need	   for	  
painful	   bone	   marrow	   aspirations	   or	   any	   requirement	   for	   cross	   matching	   or	  
additional	  immune	  suppression	  therapy226.	  
	  
The	   central	   hypothesis	   of	   this	   thesis	   was	   that	   ONS	   cells	   could	   be	   used	   to	  
promote	   peripheral	   nerve	   regeneration	   in	   a	   critical	   sized	   nerve	   transection	  
injury	   in	   rats.	   To	   that	   end,	   the	   core	   elements	   of	   the	   in	   vitro	   study	   design	  
incorporated:	   isolation	   of	   ONS	   cells,	   characterisation	   of	   their	   differentiation,	  
and	   critically,	   the	   development	   of	   a	   suitable	  means	  with	  which	   to	   deliver	   the	  
cells	  to	  the	  injury	  zone.	  In	  terms	  of	  isolation	  and	  characterisation,	  the	  protocols	  
were	  clear,	  but	  in	  regard	  to	  cell	  delivery	  within	  a	  critical	  injury	  zone,	  there	  were	  
two	   possible	   options;	   scaffold	   based	   or	   scaffold	   free227.	   Scaffold	   free	   cell	  
delivery	   systems	   require	   solutions.	   For	  example	  Koshizuka	  et	  al	  demonstrated	  
improved	   functional	   recovery	   in	   mice	   with	   compression	   induced	   spinal	   cord	  
injury	  following	   implantation	  of	  hematopoietic	  stem	  cells	   (HSCs)	   in	  solution228.	  	  
In	  a	  peripheral	  nerve	  critical	  transection	  injury	  model	  however,	  a	  scaffold-­‐based	  
system,	   which	   applies	   physical	   trapping	   techniques,	   might	   represent	   a	   more	  
appropriate	  option229.	  	  
	  
In	  this	  study,	  in	  order	  to	  facilitate	  the	  future	  proposed	  delivery	  of	  the	  ONS	  cells	  
into	   a	   critical	   sized	   sciatic	   defect	   in	   vivo,	   development	   of	   a	   viable	   biomimetic	  
biphasic	   tissue	   engineered	   nerve	   guidance	   conduit	   (NGC)	   was	   envisaged.	  
Hyaluronic	   acid	   (HA)	  was	   chosen	   as	   a	   central	   component	   of	   this	   NGC	   for	   cell	  
entrapment	  and	  delivery	  because	  of	  its	  physical	  and	  chemical	  properties,	  which	  
include	   biocompatibility,	   an	   ability	   to	   biodegrade	   smoothly,	   a	   propensity	   to	  
reduce	  glial	   scar	   formation	  and	   its	   ability	   to	   retain	  moisture	   in	   a	   flexible	  non-­‐
shearing	   configuration230.	   HA	   as	   a	   biomaterial	   for	   cell	   delivery	   in	   peripheral	  
nerve	   regeneration	   studies	   has	   one	   major	   drawback	   -­‐	   its	   inherent	   lack	   of	  
physical	   cues	   for	   cell	   attachment	   and	   extension231.	   The	   principal	   issue	   that	  
needed	  to	  be	  addressed	  prior	  to	  progressing	  to	  three-­‐dimensional	   in	  vitro	  and	  
subsequent	   in	   vivo	   studies,	   was	   the	   selection	   of	   the	   most	   appropriate	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biomolecule	  to	  functionalise	  the	  HA	  component	  of	  the	  NGC,	  and	  provide	  those	  
physical	   cues.	   In	   order	   to	   achieve	   this,	   two	  dimensional	   culture	   assays,	  which	  
allowed	   qualitative	   and	   quantitative	   analysis	   of	   cell	   behavior	   under	   different	  
functionalising	   culture	   conditions	   were	   required.	   There	   are	   many	   potential	  
functionalising	  agents	  for	  this	  purpose,	  including	  the	  natural	  extracellular	  matrix	  
(ECM)	  molecule	  laminin,	  and	  synthetic	  poly	  D	  lysine232.	  	  
	  
Laminin	  (Lam)	  is	  a	  natural	  heterotrimeric	  protein,	  which	  is	  found	  predominantly	  
in	  the	  basement	  membrane	  and	  ECM.	  It	  has	  been	  used	  extensively	  in	  peripheral	  
nerve	   regenerations	   studies.	   Madison	   et	   al	   demonstrated	   L3	   to	   L5	   axonal	  
regeneration	   in	   rodents	   using	   a	   Lam	   modified	   ECM	   based	   gel	   in	   a	   tubular	  
conduit233.	   Lam	  contains	   an	  α-­‐chain,	   β-­‐chain,	   and	   γ-­‐chain	   and	  exists	   as	   a	  high	  
molecular	   weight	   glycoprotein.	   Its	   main	   function	   in	   nerve	   homeostasis	   is	   to	  
promote	   the	   attachment	   of	   cells	   to	   type	   IV	   collagen	   protein,	   and	   promote	  
myelination	  of	  axons	  by	  providing	  a	  basement	  membrane	  for	  Schwann	  cells	  to	  
attach	   to	   in	   a	   β1	   integrin	   dependent	   process.	   Furthermore,	   it	   enhances	  
differentiation	  of	  central	  nervous	  system	  oligodendrocytes	  and	  it	   is	  thought	  to	  
be	  a	  key	  component	  of	  the	  Schwann	  cell	  myelin	  production	  pathway234.	  	  
	  
Poly	  D	   lysine	   (PDL)	   is	   a	   synthetic	  positively	   charged	  amino	  acid,	  which	   can	  be	  
used	   to	   functionalise	   HA	   hydrogels	   by	   providing	   attachment	   sites	   to	   the	  
hyaluronic	  acid	  molecule235.	  In	  2005,	  Tian	  et	  al	  reported	  on	  a	  HA-­‐PDL	  copolymer	  
hydrogel	   as	   a	  biomimetic	   tissue	  engineered	   scaffold	   to	   repair	  brain	  defects	   in	  
rats.	   	   This	   was	   followed	   in	   2009,	   by	   Nisbet	   et	   als	   xyloglucan	   hydrogel,	   which	  
provided	   similar	   mechanical	   properties	   to	   spinal	   cord	   tissue,	   and	   which	   was	  
again	  functionalised	  by	  means	  of	  the	  immobilisation	  of	  PDL	  within	  the	  hydrogel.	  
In	  Nisbets	  study,	  the	  authors	  concluded	  that	  it	  was	  the	  act	  of	  functionalising	  the	  
xyloglucan	  hydrogel	  that	  promoted	  neuronal	  differentiation	  whilst	  the	  structure	  
of	   the	  gel	  controlled	  and	  optimised	  both	  cell	  density,	  and	  the	  directionality	  of	  
neuronal	  out	  growth236.	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As	   outlined	   in	   Chapter	   1,	   nerve	   growth	   factor	   (NGF)	   is	   a	   frequently	   utilised	  
neurotrophic	   factor	   in	   tissue-­‐engineered	   approaches	   to	   peripheral	   nerve	  
regeneration.	  It	  has	  been	  shown	  to	  improve	  in	  vitro	  and	  functional	  outcomes	  in	  
vivo	   in	   peripheral	   nerve	   repair237	   238	   239.	   Studies	   have	   also	   shown	   improved	  
outcomes	  in	  peripheral	  nerve	  injuries	  using	  NGF	  in	  the	  absence	  of	  scaffolds	  or	  
stem	  cells240	  which	  suggests	  that	  NGF	  in	  this	  role,	  possesses	  a	  dual	  function,	  first	  
in	  supporting	  implanted	  stem	  cell	  differentiation,	  and	  second,	  in	  promoting	  out-­‐
sprouting	   of	   native	   axons	   from	   the	   proximal	   stump	   in	   vivo.	   A	   documented	  
negative	  impact	  of	  NGF	  administration	  in	  animals	  is	  hyperalgesia	  which	  can	  be	  
mechanical	   or	   thermal	   in	   origin241	   242.	   Although	   it	   is	   thought	   that	   exogenous	  
NGF	  administration	  has	  a	  short	  half-­‐life	   in	   the	  body,	   there	   is	  a	  paucity	  of	   long	  
term	  studies	  on	  the	  effects	  of	  its	  administration,	  and	  in	  terms	  of	  future	  clinical	  
peripheral	   nerve	   applications	   using	  NGF,	   the	   risk	   of	   associated	   tumor	   genesis	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2.2	  Study	  aims	  and	  objectives	  
	  
The	   objectives	   of	   this	   study	   were,	   to	   isolate	   ONS	   cells	   from	   olfactory	  
neuroepithelial	  explants	  in	  rats,	  to	  assess	  the	  multipotency	  of	  ONS	  cells	  derived	  
from	   young	   donor	   animals	   compared	   to	   ONS	   cells	   derived	   from	   older	   donor	  
animals,	  and	   to	  evaluate	   the	  effect	  of	   Lam,	  PDL	  or	  NGF	  administration	  on	   the	  
capacity	  of	  ONS	  cells	  to	  differentiate	  along	  neural	  and	  glial	  lineages.	  	  
	  
The	  specific	  aims	  were:	  
	  
• To	  isolate	  and	  culture	  ONS	  cells	  from	  6	  week	  and	  12-­‐week-­‐old	  rats	  
• To	  compare	  the	  potential	  for	  neural	  and	  glial	  differentiation	  of	  ONS	  cells	  
derived	   from	   young	   donor	   animals	   (6	   weeks	   old)	   and	   older	   donor	  
animals	  (12	  weeks	  old)	  
• To	   characterise	   the	   effect	   of	   Lam	   and	   PDL	   on	   ONS	   cell	   differentiation	  
patterns	  	  
• To	  evaluate	  the	  effect	  of	  NGF	  administration	  on	  ONS	  cell	  differentiation	  	  
• To	  assess	  whether	  NGF	  administration	  had	  a	  synergistic	  effect	  with	  Lam	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2.3.	  Methods	  and	  materials	  
	  
All	  chemicals	  were	  purchased	  from	  Sigma	  Ireland	  (Arklow,	  Co.	  Wicklow,	  Ireland)	  
or	   BD	   bioscience	   (Dun	   Laoghaire,	   Co.	   Dublin,	   Ireland)	   and	   used	   as	   per	   the	  
manufacturers	   instructions	   unless	   otherwise	   indicated.	   Prior	   to	   in	   vitro	   study	  
commencement,	   full	   ethics	   committee	   approval	  was	   obtained	   from	   the	   Royal	  
College	   of	   Surgeons	   in	   Ireland	   Research	   Ethics	   Committee	   (REC000-­‐754).	  
Additionally,	  appropriate	  project	  licenses	  with	  permits	  for	  the	  import	  of	  animals	  
from	  Harlan	  UK	  from	  the	  Department	  of	  Agriculture	  were	  secured.	  	  
	  
2.3.1.	  Isolation	  and	  characterisation	  of	  multipotent	  ONS	  cells	  from	  6	  week	  and	  
12-­‐week	  old	  rats	  
	  
Olfactory	   neuroepithelial	   explants	  were	  harvested	   from	  6	  week	   and	  12-­‐week-­‐
old	  Sprague	  Dawley	  rats	  (Harlan	  UK,	  Blackthorn,	  UK),	  which	  were	  euthanised	  by	  
cervical	   dislocation	   and	   decapitation.	   Following	   protocols	   developed	   by	  
MacKay-­‐Sim,	   Murrel	   and	   Feraud,	   the	   mandible	   and	   facial	   muscles	   were	  
removed	   using	   a	   heavy	   scissors244.	   The	   hard	   and	   soft	   palates	   were	   removed	  
using	  a	  fine	  tipped	  mosquito	  forceps.	  
	  
The	  olfactory	  neuroepithelium	  was	  identified	  at	  the	  superior	  posterior	  aspect	  of	  
the	   nasal	   septum.	   The	   explant	   was	   removed	   using	   a	   15-­‐blade	   scalpel	   and	   a	  
Freer’s	  nasal	  periosteal	  elevator,	  and	  placed	  directly	  into	  cold	  sterile	  Dulbecco’s	  
Modified	  Eagle	  Medium/F12	  (DMEM/F12)	  media	  for	  transport	  to	  a	  laminar	  flow	  
hood.	  The	  explant	  was	  washed	  twice	  with	  warmed	  DMEM/F12	  and	  incubated	  in	  
Dispase	  2	  solution	  (2.4IU	  per	  ml	  in	  DMEM/F12)	  at	  37°	  C	  for	  one	  hour.	  Next,	  the	  
mucosal	  epithelium	  was	  separated	  from	  the	  underlying	   lamina	  propria	  using	  a	  
Freer’s	   nasal	   periosteal	   elevator	   and	   a	   22-­‐gauge	   needle	   under	   brightfield	  
microscopy.	  The	  mucosal	  epithelium	  in	  solute	  was	  disassociated	  by	  mechanical	  
trituration	  and	  neutralised	  with	  an	  equal	  volume	  of	  PBS.	  The	  lamina	  propria	  was	  
further	   disassociated	   by	   incubation	   for	   ten	   minutes	   in	   0.25%	   collagenase	   1A	  
solution	   in	   DMEM/F12	   with	   foetal	   bovine	   serum	   and	   penicillin	   streptomycin	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(FBS/PS)	   and	   subsequent	  mechanical	   trituration.	   Following	   disassociation,	   the	  
action	   of	   collagenase	   was	   neutralised	   with	   an	   equal	   volume	   of	   PBS	   and	   the	  
lamina	  propria	  derived	  cells	  were	   re-­‐suspended	  with	   the	  previously	   separated	  
mucosal	   epithelial	   derived	   cells	   in	   warmed	   DMEM/F12/FBS/PS.	   The	   isolated	  
primary	   olfactory	   neuroepithelial	   cells	   were	   seeded	   initially	   on	   6-­‐well	   plastic	  
tissue	   culture	   plates	   and	   then	   expanded	   to	   confluent	  monolayers	   to	   create	   a	  
bank	  of	  primary	  culture	  cells,	  which	  could	  be	  used	  as	  required	  to	  generate	  ONS	  
cells	  in	  the	  form	  of	  free	  floating	  neurospheres.	  	  
	  
Primary	  olfactory	  neuroepithelial	  cell	  cultures	  were	  used	  to	  generate	  olfactory	  
neurospheres	   using	   the	   following	   protocol,	   which	   was	   refined	   from	   the	  
protocols	  described	  by	  Murrell,	  MacKay-­‐Sim	  and	  Feraud.	  First,	  primary	  culture	  
stocks	  were	   expanded	   on	   standard	   uncoated	   T175	   tissue	   culture	   flasks.	   Once	  
stocks	  were	  expanded,	  the	  olfactory	  neuroepithelial	  cells	  were	  disassociated	  by	  
exposure	  to	  trypsin	  ethylenediamenetetraacetic	  acid	  (EDTA)	  for	  three	  minutes.	  
The	  trypsin	  was	  then	  neutralised	  with	  an	  equal	  volume	  of	  DMEM/F12/FBS/PS.	  
Next	   the	   cell	   solute	   was	   centrifuged	   in	   an	   Eppendorf	   5810	   centrifuge	   (Fisher	  
Scientific,	   Blanchardstown,	   Ireland)	   at	   1,200rpm	   for	   five	   minutes.	   The	  
supernatant	  was	  discarded	  and	  cells	  were	   resuspended	   in	  DMEM/F12/FBS/PS.	  
Following	   resuspension,	   cells	  were	   counted	   using	   a	   glass	   hemocytometer	   and	  
plated	  at	  a	  concentration	  of	  16,000	  cells/cm2	  on	  poly	  L	  lysine	  (PLL)	  coated	  tissue	  
culture	   flasks.	   The	   coating	   concentration	   for	   PLL	  was	   5g/cm2.	   The	   flasks	  were	  
coated	  for	  2	  hours	  at	  37°	  C	  prior	  to	  air	  drying	  and	  rinsing	  with	  PBS.	  	  	  
	  
Once	  the	  seeded	  cells	  had	  adhered	  to	  the	  culture	  flasks,	  the	  media	  was	  changed	  
to	   sphere	   inducing	  media	   consisting	  of	  DMEM/F12	  with	  1%	   Insulin	   transferrin	  
selenium	   (DMEM/F12/ITS)	   supplemented	   with	   50ng/ml	   epidermal	   growth	  
factor	   (EGF)	   and	   25	   ng/ml	   fibroblast	   growth	   factor	   (FGF)	   as	   per	   the	   protocol	  
reported	   by	   MacKay-­‐Sim	   et	   al.	   After	   three	   to	   four	   days,	   sphere	   shaped	  
aggregates	   formed,	   and	   spheres	   began	   to	   spontaneously	   detach	   from	   the	  
plates.	   These	   free	   floating	   olfactory	   neurospheres	   were	   collected	   from	   the	  
plates	  by	  mechanical	  trituration	  and	  re-­‐plated	  on	  uncoated	  T175	  culture	  flasks	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with	   standard	   DMEM/F12/FBS/PS	   growth	   media	   for	   expansion	   as	   ONS	   cell	  
cultures.	  A	  total	  of	  four	  cycles	  of	  olfactory	  neurosphere	  collection	  from	  each	  PLL	  
coated	  plate	  with	  DMEM/F12/ITS	  sphere-­‐generating	  media	  was	  used.	  ONS	  cell	  
culture	   stocks	   then	   were	   expanded	   and	   banked	   by	   freezing	   in	   10%	   Dimethyl	  
Sulfoxide	  (DMSO)	  with	  90%	  FBS	  in	  liquid	  nitrogen	  to	  allow	  future	  qualitative	  and	  
quantitative	  analysis	  using	  immunofluorescence	  and	  fluorescence-­‐activated	  cell	  
sorting	  (FACs)	  techniques.	  	  
	  
To	  assess	  the	  capacity	  of	   the	  ONS	  cells	   to	  differentiate	  along	  a	  neural	   lineage,	  
brightfield	   microscopy	   images	   were	   taken	   and	   immunofluorescence	   for	   key	  
stem	  cell	  and	  neural	  markers	  along	  with	  the	  NGF	  receptor	  p75	  was	  performed.	  
ONS	   cells	   were	   seeded	   onto	   6-­‐well	   plates,	   which	   had	   been	   coated	   overnight	  
with	  50µg/ml	  PDL.	  Media	  changes	  were	  performed	  every	  48	  hours.	  After	  7	  days	  
in	  vitro,	  Brightfield	   images	  were	  taken	  using	  a	  Leica	  DMIL	  microscope	  and	  LAS	  
V3.8	   camera	   to	   demonstrate	   morphologic	   differences	   from	   the	   parent	   cell	  
population.	  Next,	  cells	  were	  processed	  for	   immunostaining	  using	  the	  following	  
TERG	  refined	  protocol.	  Samples	  were	  fixed	  at	  room	  temperature	  (RT)	  with	  10	  %	  
neutral	   buffered	   formalin	   (NBF)	   for	   15	   minutes	   and	   washed	   with	   PBS.	   Cell	  
membranes	  were	  permeabilised	  by	  incubating	  in	  permeabilisation	  buffer	  (0.3%	  
Triton-­‐X	  100	  in	  PBS)	  for	  five	  minutes	  followed	  with	  a	  wash	  in	  PBS.	  	  Non-­‐specific	  
antibody	   binding	   sites	   were	   blocked	   by	   incubating	   the	   samples	   in	   blocking	  
buffer	   (3	   %	   FBS	   in	   PBS).	   Cells	   were	   incubated	   with	   the	   following	   primary	  
antibody	  dilutions:	  anti-­‐nestin	  PE	  (raised	  in	  rabbit,	  diluted	  at	  1:200),	  anti	  CD56	  
Alexa	  fluor®	  (raised	  in	  mouse,	  diluted	  at	  1:100)	  overnight	  at	  4°C	  followed	  with	  a	  
wash	   in	   PBS.	   prior	   to	   imaging	   using	   a	   Leica	   DMIL	   microscope	   and	   LAS	   V3.8	  
camera.	   Staining	   for	   the	   presence	   of	   NGF	   receptors	   was	   performed,	   by	   the	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2.3.2.	   Analysis	   of	   neural	   and	   glial	   marker	   expression	   as	   an	   effect	   of	   donor	  
animal	  age	  	  
	  
To	  assess	  for	  differences	  in	  the	  multipotency	  of	  ONS	  cells	  as	  an	  effect	  of	  donor	  
animal	   age,	   fluorescence-­‐activated	   cell	   sorting	   (FACS)	   analysis	   on	   a	   BD	   FACS	  
Canto	   II	   with	   a	   BD	   FACS	   Diva	   software	   program	   was	   performed.	   ONS	   cells	  
generated	   from	   explants	   derived	   from	   six-­‐week-­‐old	   Sprague	   Dawley	   rats	   at	  
passage	  4	  or	  5	  were	  compared	  against	  ONS	  cells	  generated	  from	  twelve-­‐week-­‐
old	  rats	  of	  the	  same	  strain	  at	  passage	  5.	  Human	  derived	  ONS	  cells	  at	  passage	  4	  
(gifted	   by	   Dr.	   Melanie	   Focking,	   RCSI	   Beaumont),	   which	   had	   been	   previously	  
characterised	   at	   a	   different	   institution,	   served	   as	   the	   positive	   control	   for	   the	  
experiment.	  
	  
Following	  7	  days	  in	  culture,	  ONS	  cells	  from	  six	  and	  12-­‐week-­‐old	  rats	  along	  with	  
human	   derived	   ONS	   cells	   were	   fixed	   in	   equal	   volumes	   of	   10%	   NBF	   and	   cell	  
culture	  medium	   for	   5	  minutes	   followed	  with	   a	   wash	   in	   warm	   PBS.	   ONS	   cells	  
were	  post-­‐fixed	  with	  0.1%	  formalin	  for	  further	  15	  minutes.	  ONS	  cells	  were	  then	  
gently	  detached	  from	  the	  plates,	  using	  a	  cell	  scraper	  (Sigma	  Aldrich	  Arklow,	  Co.	  
Wicklow,	  Ireland),	  and	  the	  volume	  of	  liquid	  with	  cells	  was	  aspirated	  into	  labeled	  
tubes	   and	   allowed	   to	   fix	   for	   15	   minutes.	   After	   fixation,	   controls	   were	  
established	  and	  the	  cells	  were	  aliquoted	  into	  groups	  (stained	  versus	  unstained).	  
The	   ONS	   cells	   were	   then	   centrifuged	   at	   1200	   rpm	   on	   an	   Eppendorf	   5810	  
centrifuge	   for	   5	   minutes.	   Following	   centrifugation,	   the	   ONS	   cells	   were	  
resuspended	  in	  1ml	  of	  cold	  buffer	  (1%	  FBS,	  99%	  PBS)	  and	  left	  on	  ice	  in	  the	  dark	  
for	   30	   minutes.	   Next,	   the	   ONS	   cells	   were	   centrifuged	   again	   and	   the	   groups	  
selected	  for	  staining	  were	  resuspended	  in	  150µl	  of	  permeabilisation	  buffer	  and	  
incubated	  for	  15	  min	  at	  room	  temperature.	  The	  antibody	  solutions	  were	  made	  
using	  anti-­‐nestin,	  β-­‐tubulin	  and	  CD56	  Alexa	  fluor®	  in	  dilution	  buffer	  (0.3%	  triton	  
x	   in	   PBS	   or	   0.5%	   tween	   10	   in	   PBS).	   The	   groups	   selected	   for	   staining	   were	  
centrifuged	   and	   resuspended	   with	   the	   antibody	   containing	   dilution	   buffer	  
following	  which,	  all	  cell	  groups	  were	  incubated	  on	  ice	  in	  the	  dark	  for	  1	  hour.	  All	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cell	  groups	  were	  then	  centrifuged	  as	  before	  and	  resuspended	  in	  FACS	  buffer	  for	  
analysis	  on	  the	  FACs	  machine.	  All	  FACs	  analysis	  was	  performed	  in	  triplicate.	  	  
	  
2.3.3.	   Analysis	   of	   neural	   and	   glial	  marker	   expression	   as	   an	   effect	   of	   laminin	  
poly	  D	  lysine	  and	  nerve	  growth	  factor	  supplementation	  
	  
To	  evaluate	  the	  differences	  in	  the	  multipotency	  of	  ONS	  cells	  in	  the	  presence	  of	  
laminin	   (Lam)	   and	  poly	  D	   lysine	   (PDL),	   assays	   comparing	   Lam	  and	  PDL	   coated	  
culture	   surface	   conditions	   against	   2D	   uncoated	   plastic	   tissue	   culture	   surface	  
conditions	  were	  performed.	  To	  assess	   the	  effect	  of	  nerve	  growth	   factor	   (NGF)	  
on	   differentiation,	   the	   experimental	   design	   incorporated	   cells	   with	   NGF	  
enhanced	  and	  non-­‐NGF	  enhanced	  media.	  6	  well	  plates	  were	  coated	  overnight	  
with	  either	  50µg/ml	  PDL	  or	  5µg/ml	  Lam.	  ONS	  cells	  were	  seeded	  at	  a	  density	  of	  
150,000	  cells	  per	  well	  and	  the	  media	  was	  changed	  every	  two	  days	  with	  either	  
DMEM/F12/FBS/P/S,	   or	   DMEM/F12	   containing	   5%	   FBS	   and	   100ng/ml	  
recombinant	   rat	   NGF	   for	   a	   period	   of	   seven	   days.	   All	   assays	  were	   repeated	   in	  
triplicate.	  	  
	  
2.3.3.1.	   Qualitative	   analysis	   of	   the	   effect	   of	   laminin	   and	   poly	   D	   lysine	   on	  
differentiation	  capacity	  and	  marker	  expression	  of	  ONS	  cells	  
	  
A	   qualitative	   analysis	   for	   the	   expression	   of	   Nestin,	   Glial	   Filrillary	   Acid	   Protein	  
(GFAP)	   and	   β-­‐tubulin	   by	   ONS	   cells	   in	   2D	   culture	   was	   performed	   using	   the	  
following	   immunostaining	   protocol.	   	   First,	   samples	   were	   fixed	   at	   room	  
temperature	  (RT)	  with	  10%	  Neutral	  Buffered	  Formalin	  (NBF)	  for	  15	  minutes	  and	  
washed	   with	   PBS.	   Cell	   membranes	   were	   permeabilised	   by	   incubating	   in	  
permeabilisation	   buffer	   (0.3%	   Triton-­‐X	   100	   in	   PBS)	   for	   five	   minutes	   followed	  
with	  washing	  with	   PBS.	   	   Non-­‐specific	   antibody	   binding	   sites	   were	   blocked	   by	  
incubating	  the	  samples	  in	  blocking	  buffer	  (3	  %	  FBS	  in	  PBS).	  Cells	  were	  incubated	  
with	   the	   following	   primary	   antibodies	   dilutions:	   anti-­‐nestin	   (raised	   in	   rabbit,	  
diluted	   at	   1:100),	   anti	   β-­‐tubulin	   (raised	   in	   mouse,	   diluted	   at	   1:350;	   anti	   glial	  
fibrillary	  acid	  protein	  (GFAP	  raised	  in	  mouse,	  diluted	  at	  1:40).	  The	  samples	  were	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then	   incubated	   overnight	   at	   4°	   C	   following	   washing	   with	   PBS.	   The	   following	  
secondary	   antibodies	   were	   used:	   AlexaFluor,	   goat	   anti-­‐mouse	   488	   and	   goat	  
anti-­‐rabbit	   546	   in	   1:1000	   dilution	   for	   1	   hr	   at	   room	   temperature.	   Following	  
washing	  with	  PBS,	  nuclear	   stain	  was	  applyied	   for	  15	  minutes	  prior	   to	   imaging	  
using	  a	  Leica	  DMIL	  microscope	  and	  LAS	  V3.8	  camera.	  
	  
2.3.3.2.	   Quantitative	   analysis	   of	   the	   effect	   of	   laminin	   and	   poly	   D	   lysine	   on	  
differentiation	  capacity	  and	  marker	  expression	  of	  ONS	  cells	  	  
	  
Once	   expression	   of	   the	   key	   neural	   and	   glial	   markers	   was	   demonstrated	   by	  
immunofluorescence,	   a	   quantitative	   assessment	   was	   performed	   using	   FACs.	  
ONS	  cells	  were	  cultured	  on	  either	   lam	  or	  PDL	  for	  7	  days	   in	  NGF	  enhanced	  and	  
non-­‐NGF	  enhanced	  culture	  medium.	  Following	  7	  days	  in	  culture	  ONS	  cells	  were	  
fixed	   in	   equal	   volumes	   of	   10%	   NBF	   and	   cell	   culture	   medium	   for	   5	   minutes	  
followed	  with	  a	  wash	  in	  warm	  PBS.	  Cells	  were	  post-­‐fixed	  with	  0.1%	  formalin	  for	  
further	  15	  minutes.	  	  
	  
Cells	  were	  gently	  detached	  from	  the	  plates,	  using	  a	  cell	  scraper	  (Sigma	  Aldrich	  
Arklow,	  Co.	  Wicklow,	  Ireland),	  and	  the	  volume	  of	  liquid	  with	  cells	  was	  aspirated	  
into	  labeled	  tubes	  and	  allowed	  to	  fix	  for	  15	  minutes.	  After	  incubation,	  controls	  
were	   established	   and	   cells	   were	   aliquoted	   into	   groups	   (stained	   versus	  
unstained).	   Cells	   were	   then	   centrifuged	   at	   1,200	   rpm	   on	   an	   Eppendorf	   5810	  
centrifuge	  for	  5	  minutes,	  resuspended	  in	  1ml	  of	  cold	  buffer	  (1%	  FBS,	  99%	  PBS)	  
and	  left	  on	  ice	  in	  the	  dark	  for	  30	  minutes.	  Next,	  the	  cells	  were	  centrifuged	  again	  
as	   before	   and	   groups	   selected	   for	   staining	   were	   resuspended	   in	   150µl	   of	  
permeabilisation	   buffer	   and	   incubated	   for	   15	  min	   at	   room	   temperature.	   	   The	  
antibody	  solutions	  were	  made	  using	  anti	  nestin,	  anti	  β-­‐tubulin,	  and	  anti	  GFAP	  in	  
dilution	   buffer	   (0.3%	   triton	   x	   in	   PBS	   or	   0.5%	   tween	   10	   in	   PBS).	   The	   groups	  
selected	   for	   staining	   were	   centrifuged	   and	   resuspended	   with	   the	   antibody	  
containing	  dilution	  buffer	  following	  which,	  all	  cell	  groups	  were	  incubated	  on	  ice	  
in	   the	   dark	   for	   1	   hour.	   All	   cell	   groups	   were	   then	   centrifuged	   as	   before	   and	  
resuspended	   in	   FACS	   buffer	   for	   analysis	   on	   the	   flow	   cytometry	   machine	   (BD	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FACS	  Canto	  II	  bench	  top	  analyser	  with	  BD	  FACS	  Diva	  software	  program).	  All	  FACs	  
analysis	  was	  performed	  in	  triplicate	  to	  ensure	  comparability	  of	  results.	  	  
	  
2.3.4.	  Statistical	  analysis	  	  
	  
All	  summary	  graphs	  display	  the	  median	  or	  mean	  values	  ±	  the	  standard	  error	  of	  
the	  mean	  where	  applicable.	  All	  statistical	  analysis	  was	  performed	  using	  one-­‐way	  
analysis	   of	   variance	   tests	   (ANOVA).	  Where	   statistically	   significant	   results	  were	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2.4.	  Results	  
	  
ONS	   cells	   were	   isolated	   using	   a	   reproducible	   technique	   based	   on	   operating	  
procedures	  first	  reported	  on	  by	  MacKay-­‐Sim	  et	  al	  as	  described	  above.	  
	  
2.4.1	  ONS	  cells	  were	  successfully	  isolated	  from	  6	  week	  and	  12-­‐week-­‐old	  rats	  
	  
Removal	   of	   the	   facial	   muscles,	   mandible,	   hard	   and	   soft	   palate	   exposed	   the	  
olfactory	  neuroepithelium	  as	  demonstrated	   in	  Figure	   2.2.	   The	  olfactory	  neuro	  
epithelial	  explant	  harvested	  from	  the	  nasal	  cavity	  produced	  a	  culture	  of	  primary	  
olfactory	   neuroepithelial	   cells,	   which	   were	   observed	   to	   grow	   in	   a	   confluent	  
monolayer	  as	  demonstrated	  in	  Figure	  2.3.	  
	  
	  
Figure	  2.2.	  Image	  demonstrating	  the	  exposure	  of	  the	  olfactory	  neuroepithelium	  
(asterisk)	  in	  the	  rat	  nasal	  cavity	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Figure	   2.3	   Image	   demonstrating	   light	   microscopy	   photograph	   of	   primary	  
olfactory	  neuroepithelial	  cells	  growing	  in	  a	  confluent	  monolayer	  
	  
Following	   expansion	   of	   the	   primary	   cell	   stocks,	   the	   olfactory	   neuroepithelial	  
cells	   generated	   olfactory	   neurospheres	   when	   cultured	   on	   PLL	   coated	   flasks	  
under	  sphere	  generating	  conditions.	  After	  three	  to	  four	  days	  in	  culture,	  sphere	  
shaped	   aggregates	   of	   olfactory	   neurospheres	   developed	   and	   began	   to	  
spontaneously	  detach	   from	   the	  plates	  as	  demonstrated	   in	  Figure	  2.4.	   Spheres	  
were	   collected	   by	   mechanical	   trituration	   and	   seeded	   on	   standard	   T175	   flask	  
with	  standard	  growth	  media	  (DMEM/FBS/PS)	  where	  they	  proliferated	  into	  ONS	  
cell	  stocks.	  Similar	  to	  the	  culture	  of	  primary	  olfactory	  neuroepithelial	  cells	  from	  
the	  olfactory	  neuroepithelial	  explant,	  ONS	  cell	  cultures	  were	  observed	  to	  grow	  
in	  a	  confluent	  monolayer	  as	  demonstrated	  in	  Figure	  2.5.	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Figure	   2.4:	   Image	   demonstrating	   light	   microscopy	   findings	   of	   olfactory	  
neurosphere	  aggregates	  (circled)	  on	  PLL	  coated	  flasks	  under	  sphere	  generating	  
conditions	  	  
	  
Figure	   2.5:	   Image	   demonstrating	   light	   microscopy	   findings	   of	   ONS	   cells	   in	  
culture	  on	  T175	   flask	  with	  standard	  growth	  media.	  Observed	  ONS	  cell	   cultures	  
grew	  in	  a	  confluent	  monolayer	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2.4.2.	  ONS	   cells	   possess	   the	   potential	   to	   differentiate	   along	   neural	   and	   glial	  
lineages	  in	  vitro	  
	  
The	  ONS	  cells	  cultured	  on	  PDL	  coated	  culture	  plates	  for	  7	  days	  demonstrated	  bi	  
and	   multipolar	   cells	   with	   a	   small	   cytoplasm	   and	   an	   elongated	   morphology,	  
which	  did	  not	  form	  a	  confluent	  monolayer	  (Figure	  2.6)	  in	  contrast	  to	  ONS	  cells	  
cultured	   on	   uncoated	   culture	   plates,	  which	   propagated	   confluent	  monolayers	  
similar	  to	  those	  illustrated	  in	  Figure	  2.5.	  
	  
	  
Figure	   2.6:	   Light	   microscopy	   image	   of	   ONS	   cells	   cultured	   on	   poly	   D	   lysine	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Immunofluorescence	   imaging	   demonstrated	   that	   rat	   derived	   ONS	   cells	  
propagated	   by	   the	   above	   protocol	   have	   the	   potential	   to	   differentiate	   along	   a	  
neural	  lineage.	  Expression	  of	  stem	  cell	  markers	  including	  nestin	  (which	  is	  a	  key	  
neural	   stem	   cell	  marker245)	   GFAP	   and	   CD	   56	   (which	   is	   neuronal	   cell	   adhesion	  
molecule	  or	  NCAM246)	  was	  detected	  across	  all	  culture	  plates	  as	  demonstrated	  in	  




Figure	  2.7:	  Image	  demonstrating	  the	  appearance	  of	  A:	  Nestin	  expression	  and	  B:	  
CD56	  expression	  by	  ONS	  cells	  at	  day	  7	  in	  vitro	  	  
	  
Figure	  2.8.	  Image	  demonstrating	  expression	  of	  GFAP	  (green)	  and	  p75	  (red,	  NGF	  
receptor)	  by	  ONS	  cells	  in	  culture	  (image	  courtesy	  of	  Dr.	  Tijna	  Alekseeva	  TERG)	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2.4.3.	   ONS	   cells	   derived	   from	   young	   donor	   animals	   possess	   greater	  
differentiation	  potential	  then	  ONS	  cells	  derived	  from	  old	  donor	  animals	  
	  
In	  addition	  to	  the	  findings	  of	  the	  qualitative	  analysis	  described	  in	  section	  2.4.2,	  
comparative	   FACs	   analysis	   of	   ONS	   cells	   derived	   from	   six-­‐week-­‐old	   Sprague	  
Dawley	  rats	  against	  ONS	  cells	  generated	  from	  twelve-­‐week-­‐old	  Sprague	  Dawley	  
rats	   and	   human	   derived	   ONS	   cells,	   provided	   quantifiable	   evidence	   that	   the	  
newly	   generated	   rat	   lines	   expressed	   nestin,	   β-­‐tubulin,	   and	   CD56	   marker	  
positivity.	  The	  rat	  derived	  ONS	  cells	  generated	  by	  the	  above	  protocol	  compared	  
very	  favourably	  with	  the	  human	  positive	  control	  ONS	  cells	  in	  terms	  of	  quantity	  
of	   neural	   surface	   marker	   expressed.	   For	   example,	   the	   human	   ONS	   cells	   on	  
standard	   uncoated	   T175	   culture	   flasks	   expressed	   22.1	  %	   nestin,	   1.3	   β-­‐tubulin	  
and	  7.8	  %	  CD56.	  By	  comparison,	  14.3	  %	  of	  ONS	  cells	  derived	  from	  12-­‐week-­‐old	  
rats	  were	  positive	  for	  Nestin,	  21	  %	  for	  β-­‐tubulin	  and	  4.1	  %	  for	  CD56	  whilst	  the	  
ONS	   cells	   derived	   from	   6-­‐week	   old	   rats	   expressed	   15	   %	   nestin	   positive	   cells,	  
25.9	  %	  β-­‐tubulin	  positive	  cells	  and	  2.2	  %	  CD56	  positive	  cells.	  	  
	  
In	  summary,	  the	  key	  finding	  of	  the	  first	  FACs	  analysis,	  was	  that	  ONS	  cells	  derived	  
from	  6-­‐week-­‐old	  animals,	  expressed	  greater	  quantities	  of	  neural	  markers	   than	  
ONS	   cells	   derived	   from	   12-­‐week-­‐old	   animals.	   Therefore	   they	   have	   a	   greater	  
potential	   for	   differentiation.	   As	   a	   direct	   result	   of	   this	   finding,	   only	   ONS	   cells	  
derived	  from	  6-­‐week-­‐old	  animals	  were	  selected	  for	  use	  in	  the	  subsequent	  two	  
and	  three-­‐dimensional	  in	  vitro	  studies,	  and	  for	  the	  planned	  animal	  study	  phase	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Table	   2.1.	   Summary	   of	   flow	   cytometry	   results:	  ONS	   cells	   derived	   from	  6-­‐week	  
old	  donor	  animals	  expressed	  higher	  levels	  of	  nestin	  and	  β-­‐tubulin	  than	  ONS	  cells	  
derived	  from	  12-­‐week	  old	  donor	  animals.	  
	  
	  
2.4.4.	  Qualitative	  analysis	  with	   immunofluorescence	  demonstrated	   that	  ONS	  
cells	  differentiate	  in	  response	  to	  laminin	  poly	  D	  lysine	  and	  nerve	  growth	  factor	  
	  
Immunofluorescence	   imaging	   demonstrated	   that	   ONS	   cells	   derived	   from	   6-­‐
week-­‐old	   rats	   underwent	   differentiation	   in	   response	   to	   the	   presence	   of	  
biomolecules	   Lam	   and	   PDL.	   Key	   stem	   cell,	   neural	   and	   glial	   markers	   including	  
nestin,	   β-­‐tubulin	   and	   GFAP	   were	   induced	   in	   cells	   cultured	   on	   Lam	   and	   PDL	  
coated	   culture	   plates.	   Markers	   were	   expressed	   by	   cells	   cultured	   in	   both	   the	  
standard	  culture	  medium	  and	  in	  NGF	  enhanced	  culture	  medium.	  Figures	  2.9	  and	  
2.10	   illustrate	  the	  β-­‐tubulin	  expressing	  cell	  populations	  on	  lam	  and	  PDL	  coated	  
plates	  in	  both	  NGF	  and	  non-­‐NGF	  enhanced	  conditions.	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Figure	  2.9:	  Image	  demonstrating	  the	  appearance	  of	  β-­‐tubulin	  stained	  ONS	  cells	  
with	  elongated	  processes	  developing	  (circled)	  when	  cultured	  on	   laminin-­‐coated	  
plates	  (Day	  7	  in	  vitro)	  
	  
Figure	  2.10:	  Image	  demonstrating	  a	  β-­‐tubulin	  positive	  population	  of	  cells,	  which	  
developed	  when	  ONS	  cells	  were	  cultured	  on	  PDL	  coated	  culture	  plates	  with	  NGF	  
supplemented	  media	  (Day	  7	  in	  vitro)	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2.4.5.	   Quantitative	   analysis	   by	   flow	   cytometry	   demonstrated	   varied	  
differentiation	   responses	   of	   ONS	   cells	   cultured	   on	   either	   laminin	   or	   poly	   D	  
lysine	  	  
	  
The	  results	  of	  the	  FACs	  analysis	  quantifying	  the	  expression	  of	  stem	  cell	  markers	  
under	   Lam	   or	   PDL	   enhanced	   culture	   conditions	   indicated	   that	   Lam	   and	   PDL	  
could	   have	   an	   effect	   on	   the	   differentiation	   capacity	   of	   ONS	   cells.	   As	  
demonstrated	   in	   Table	   2.2,	   the	   results	   of	   the	   analysis	   showed	   that	   new	  
populations	  of	  cells	  appeared	  when	  ONS	  cells	  were	  cultured	  under	  the	  different	  
conditions.	   The	   percentage	   values	   shown	   in	   Table	   2.3	   represent	   an	   average	  
result	  over	  three	  separate	  experiments	  on	  stained	  samples.	  	  	  
	  
Table	  2.2:	  Flow	  cytometry	  analysis	  plot	  of	  neuronal	  and	  glial	  marker	  expression	  
of	   young	   rat	   derived	   ONS	   cells	   when	   cultured	   in	   standard	   culture	   media	   on	  




Table	   2.3.	   Summary	   table	   of	   flow	   cytometry	   results:	   Both	   Lam	   and	   PDL	  were	  
found	  to	  have	  had	  a	  positive	  effect	  on	  the	  neuro	  differentiation	  capacity	  of	  ONS	  
cells.	  	  
	  
	   76	  
Overall,	   the	   ONS	   cells	   derived	   from	   6-­‐week	   old	   rats	   cultured	   on	   Lam	   coated	  
culture	   conditions,	   propagated	   28	   %	   Nestin	   positive	   cells	   compared	   to	   PDL	  
coated	  culture	  plates,	  which	  propagated	  38.74	  %	  Nestin	  positive	  cells.	  In	  order	  
to	   examine	   the	   statistical	   significance	   between	   the	   differences	   in	   nestin	  
expression	   across	   the	   culture	   conditions,	   a	   one-­‐way	   ANOVA	   test	   was	  
performed.	   The	   test	   reported	   a	   significant	   difference	   between	   the	   three	  
conditions	   (with	  F(2,6)	  =	  42.41,	  and	  a	  p	  value	  =	  0.0003)	  overall.	  Post-­‐hoc	  pair-­‐
wise	  comparison	  of	  the	  ANOVA	  results	  indicated	  that	  the	  difference	  in	  the	  mean	  
number	  of	  nestin	  positive	  cells	  between	  PDL	  and	  Lam,	  Lam	  and	  uncoated,	  and	  
PDL	  and	  uncoated,	  were	  each	  highly	  significant	  at	  the	  95%	  CI	  (p-­‐values:	  0.026,	  
0.005,	  and	  0.001	  respectively).	  
	  
The	   ONS	   cells	   derived	   from	   6-­‐week	   old	   rats	   cultured	   on	   PDL	   coated	   culture	  
plates	   in	   standard	   growth	  media	   propagated	   18.87	   %	   β-­‐tubulin	   positive	   cells	  
compared	   to	   Lam-­‐coated	   culture	   conditions,	   which	   propagated	   10.77	   %	   β-­‐
tubulin	  positive	  cells	  (Figure	  2.11.B).	  Of	  note,	  the	  error	  bars	  illustrated	  with	  PDL	  
coated	  conditions,	  demonstrated	   less	  variation	   in	   the	   sample	  when	  compared	  
with	  Lam	  or	  uncoated	  culture	  conditions.	  This	  data	  suggested	  that	  PDL	  might	  be	  
superior	   to	   Lam	   in	   terms	   of	   increasing	   β-­‐tubulin	   expression	   in	   2D	   culture	  
conditions,	   however	   the	   one-­‐way	   ANOVA	   test	   reported	   a	   non	   significant	  
difference	  between	  the	  groups	  (with	  F	  (2,6)=2.67	  and	  a	  p-­‐value	  =	  0.148).	  	  
	  
The	   third	   marker	   tested	   for	   was	   GFAP	   and	   culture	   of	   the	   ONS	   cells	   on	   PDL	  
coated	  culture	  plates	   in	  standard	  growth	  media	  was	   found	  to	  propagate	  44	  %	  
GFAP	   positive	   cells.	   This	   compared	   to	   Lam-­‐coated	   culture	   conditions,	   which	  
propagated	  29.41	  %	  GFAP	  positive	  cells.	  From	  the	  data	   illustrated,	   it	  appeared	  
that	   PDL	   was	   superior	   to	   Lam	   in	   terms	   of	   increasing	   GFAP	   expression	   in	   2D	  
culture	   conditions	   but	   during	   processing	   cells	   for	   FACs	   analysis	   Lam	   was	  
observed	   to	   be	   superior	   in	   terms	   of	   overall	   observed	   cell	   proliferation	  
rates.	  	  Statistical	  analysis	  of	  the	  results	  of	  the	  GFAP	  assays	  were	  not	  performed	  
because	  high	  cell	  losses	  during	  processing	  for	  analysis	  precluded	  obtaining	  an	  N	  
of	  3	  which	  was	  achieved	  for	  the	  other	  two	  groups.	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Figure	   2.11:	  Bar	  chart	  showing	   A:	   level	  of	  nestin	  expression,	  and	  B:	   level	  of	  β-­‐
tubulin	  expression	  as	  an	  effect	  of	  Lam	  or	  PDL	  when	  compared	  against	  ONS	  cells	  
cultured	   on	   uncoated	   plates.	   Asterisks	   indicate	   statistically	   significant	  
differences	   in	   nestin	   expression	   as	   a	   result	   of	   PDL	   and	   Lam	   culture	   conditions	  
(p<0.05).	  	  
	   78	  
2.4.6.	   Nerve	   growth	   factor	   administration	   promoted	   neural	   and	   glial	  
differentiation	  of	  ONS	  cells	  	  
	  
NGF	   was	   found	   to	   have	   an	   effect	   on	   marker	   expression	   by	   ONS	   cells.	   The	  
quantitative	  analysis	  suggested	  that	  media	  supplementation	  with	  recombinant	  
rat	  NGF	  at	  a	  concentration	  of	  100ng/ml	  promoted	  marker	  expression	  across	  the	  
same	   three	   culture	   conditions	   described	   above.	   PDL	   supplemented	   culture	  
plates	   with	   NGF	   enhanced	   media	   propagated	   38.84	   %	   nestin	   positive	   cells,	  
25.77	  %	  β-­‐tubulin	   positive	   cells	   and	  44	  %	  GFAP	  positive	   cells.	   The	   addition	  of	  
NGF	  to	  cells	  cultured	  in	  standard	  uncoated	  conditions	  induced	  nestin	  expression	  
to	   a	   similar	   degree	   to	   PDL	   coated	   conditions	   without	   NGF,	   and	   to	   a	   greater	  
degree	  than	  Lam	  coated	  conditions	  without	  NGF	  but	   interestingly,	   it	   increased	  
β-­‐tubulin	  expression	  across	  all	   three	  groups	  compared	   to	  coating	  with	  Lam	  or	  
PDL	  alone	  (demonstrated	  in	  Table	  2.2	  and	  2.3).	  
	  
Table	  2.4:	  Flow	  cytometry	  analysis	  plot	  of	  neuronal	  and	  glial	  marker	  expression	  
of	  young	  rat	  derived	  ONS	  cells	  when	  cultured	  in	  NGF	  enhanced	  media	  on	  plates	  
coated	  with	  Lam	  or	  PDL	  compared	  to	  uncoated	  culture	  conditions	  
	  
	  
Table	  2.5:	  Expression	  of	  nestin,	  β-­‐tubulin	  and	  GFAP	  in	  ONS	  cells	  cultured	  on	  Lam	  
or	  PDL	  in	  NGF	  supplemented	  media	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In	  the	  case	  of	  nestin	  expression,	  ONS	  cells	  cultured	  on	  PDL	  coated	  culture	  plates	  
supplemented	  with	  NGF	  enhanced	  media	  demonstrated	  38.84	  %	  nestin	  positive	  
cells	  compared	  to	  Lam	  coated	  plates,	  which	  propagated	  23.11	  %	  nestin	  positive	  
cells.	  These	  results,	   illustrated	  in	  Table	  2.5,	  demonstrated	  that	  there	  were	  less	  
variations	  in	  the	  samples	  when	  compared	  with	  samples	  from	  Lam	  or	  uncoated	  
culture	  conditions.	  Interestingly,	  the	  only	  scenario	  where	  NGF	  supplementation	  
resulted	   in	   an	   added	  or	   synergistic	   effect	  was	   in	   the	   case	  of	   cells	   cultured	  on	  
PDL	   coated	   plates.	   However,	   in	   the	   case	   of	   nestin	   expression	   as	   a	   result	   of	  
enhancing	   growth	   media	   with	   NGF,	   the	   one-­‐way	   ANOVA	   test	   reported	   an	  
overall	  F	  (2,6)	  =	  0.86	  with	  a	  p-­‐value	  =	  0.468.	  	  
	  
In	   the	   case	   of	   β-­‐tubulin,	   ONS	   cells	   cultured	   on	   PDL	   coated	   culture	   plates	  
supplemented	   with	   NGF	   demonstrated	   25.77	   %	   β-­‐tubulin	   positive	   cells	  
compared	   to	   Lam	   coated	   plates,	   which	   propagated	   17.2	   %	   β-­‐tubulin	   positive	  
cells.	  In	  this	  example	  again	  the	  error	  bar	  illustrated	  with	  PDL	  coated	  conditions,	  
demonstrated	   less	   variation	   in	   the	   sample	   when	   compared	   with	   Lam	   or	  
uncoated	  culture	  conditions.	  From	  the	  data	  illustrated,	  it	  appeared	  that	  PDL	  was	  
superior	   to	   Lam	   in	   terms	   of	   increasing	   β-­‐tubulin	   expression	   in	   2D	   culture	  
conditions	   but	   anecdotally,	   during	   processing	   cells	   for	   FACs	   analysis	   Lam	  was	  
observed	  to	  be	  superior	   in	   terms	  of	  overall	  observed	  cell	  viability.	  	  Here	  again	  
adding	  NGF	  to	  the	  biomaterials	  did	  not	  appear	  to	  have	  an	  additive	  or	  synergistic	  
effect	   on	   β-­‐tubulin	   expression,	   except	   in	   the	   case	   of	   cells	   cultured	   on	   PDL	  
coated	  plates,	  and	  that	  effect	  was	  not	  found	  to	  be	  statistically	  significant.	  	  
	  
As	   with	   NGF	   free	   conditions,	   the	   third	   marker	   evaluated	   was	   GFAP.	   In	   this	  
scenario,	  GFAP	  expression	  was	  actually	   increased	   in	   Lam-­‐coated	   conditions	   to	  
47	  %	  whilst	   its	  expression	   in	  PDL	  coated	  conditions	  remained	  stable	  at	  44%.	  A	  
one-­‐way	  ANOVA	   test	   reported	  an	  overall	   F(2,6)	   =	  1.26	  and	  a	  p-­‐value	  =	  0.348.	  
Taken	  together,	  the	  results	  suggested	  that	  whilst	  NGF	  addition	  to	  culture	  media	  
had	  a	  pro	  differentiation	  effect	  similar	  to	  that	  of	  Lam	  or	  PDL,	  overall	  the	  effects	  
were	  not	  synergistic.	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Figure	   2.12:	   Bar	   chart	   showing	   A:	   level	   of	   nestin	   expression	   as	   an	   effect	   of	  
biomaterials	  with	  NGF	  supplementation	  and	  B:	   level	  of	  β-­‐tubulin	  expression	  as	  
an	  effect	  of	  biomaterials	  with	  NGF	  supplementation	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2.5.	  Discussion	  
	  
The	   analyses	   described	   in	   this	   chapter	   resulted	   in	   a	   number	   of	   key	   findings,	  
which	   influenced	   the	   design	   of	   later	   experiments	   during	   the	   course	   of	   the	  
project.	   First,	   ONS	   cells	   were	   successfully	   derived	   from	   the	   nasal	   explants	   of	  
both	  young	  and	  old	  donor	  animals,	  which	  confirmed	  the	  validity	  of	  the	  refined	  
protocol.	   	   The	   second	   key	   finding	   was	   that	   the	   ONS	   cells	   generated	   from	  
explants	  derived	  from	  six-­‐week-­‐old	  donor	  rats	  were	  more	  multipotent	  than	  ONS	  
cells	  derived	   from	  older	  animals;	   this	  was	  evidenced	  by	   the	   increase	   in	  neural	  
and	   glial	   marker	   expression	   found	   in	   the	   younger	   animal	   cells.	   The	   third	   key	  
finding	  was	   that	   that	  ONS	  cells	  proliferated	  and	  differentiated	   towards	  neural	  
and	  glial	  lineage	  in	  response	  to	  Lam	  and	  PDL.	  The	  NGF	  receptor	  marker	  p75	  was	  
also	   expressed	   on	   ONS	   cells	   in	   culture	   and	   NGF	   was	   found	   to	   promote	  
differentiation	  to	  a	  similar	  degree	  to	  both	  Lam	  and	  PDL.	  
	  
The	  demonstration	  of	  the	  effects	  of	  donor	  age	  on	  the	  multipotency	  of	  ONS	  cells	  
was	   in	   keeping	  with	   evidence	   from	   a	   number	   of	   studies	   (on	   various	   types	   of	  
stem	   cells)	   over	   the	   last	   few	   years,	   which	   have	   indicated	   that	   although	   stem	  
cells	  are	  present	  in	  older	  animals,	  changes	  within	  the	  stem	  cells	  can	  reduce	  their	  
potential	   to	   regenerate	   or	   differentiate247.	   Nakashima	   postulated	   that	   in	  
humans,	   the	   reduced	   regenerative	   capacity	   occurred	   due	   to	   a	   gradual	  
replacement	   of	   neuroepithelial	   tissue	   with	   epithelium,	   which	   was	   more	  
phenotypically	   similar	   to	   respiratory	   epithelium	   in	   1984248.	   Another	   possible	  
explanation	  for	  the	  reduced	  neurogenic	  and	  glial	  potential	  detected	  in	  the	  ONS	  
cells	  derived	   from	  older	  animals,	   is	   that	  stem	  cells	  derived	   from	  older	  animals	  
can	   enter	   a	   phase	   of	   senescence,	   where	   they	   cease	   to	   divide.	   Ahlenius	   et	   al	  
investigated	   this	   hypothesis,	   demonstrating	   that	   an	   age-­‐dependent	   difference	  
between	  stem	  cells	  derived	  from	  animals	  at	  different	  ages	  does	  exist249.	  	  
	  
Although	  stem	  cells	  derived	  from	  older	  donor	  animals	  may	  not	  be	  as	  prolific	  or	  
effective	  as	  those	  derived	  from	  younger	  donors,	  stem	  cells	  derived	  from	  young	  
animals	  may	  still	  be	  successfully	  used	   to	  promote	   tissue	   regeneration	   in	  older	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animals;	  Rossi	  et	  al	   hypothesised	   that	   the	  changes	   in	   regenerative	  capacity	  of	  
haematopoietic	   stem	   cells	   (HSCs)	   were	   cell	   intrinsic	   following	   studies	   which	  
demonstrated	   evidence	   of	   tissue	   genesis	   after	   implantation	   of	   HSCs	   derived	  
from	   young	   animals	   into	   the	   bone	  marrow	  of	   older	   animals250.	   This	   finding	   is	  
highly	  relevant	   in	  terms	  of	  future	  strategies	  for	  the	  development	  of	  cell	  based	  
tissue	  engineered	  techniques	  for	  the	  regeneration	  of	  peripheral	  nerve	  defects	  in	  
adult	  patients	  and	  as	  a	   result,	  all	   subsequent	  analyses	  of	   the	  behavior	  of	  ONS	  
cells	  in	  the	  following	  three	  dimensional	  in	  vitro	  and	  subsequent	  in	  vivo	  phases	  of	  
the	  project	  were	  performed	  using	  cells	  derived	  from	  6-­‐	  week	  old	  animals.	  
	  
In	  addition	   to	   the	  differentiation	  capacity	  of	   the	  cells,	   careful	  consideration	  of	  
the	   application	   specific	   requirements	   was	   required.	   A	   desired	   effect	   of	   the	  
biomaterials	  selection	  for	  use	  in	  the	  biomimetic	  tissue	  engineered	  scaffold,	  was	  
its	  ability	  to	  promote	  cellular	  differentiation	  since	  unmodified	  materials	  such	  as	  
hyaluronic	   acid	   can	   often	   have	   a	   limited	   ability	   to	   promote	   neural	   or	   glial	  
differentiation251.	  Over	   the	  past	  decade,	  a	  number	  of	  studies	  have	   focused	  on	  
identifying	   the	   optimal	   biomolecules	   to	   enhance	   differentiation	   and	  
proliferation	  in	  neural	  stem	  cells.	  Culture	  plates	  coated	  with	  Lam	  and	  PDL	  have	  
been	   used	   extensively	   as	   templates	   for	   neural	   cell	   culture	   because	   of	   their	  
ability	   to	   provide	   improved	   integrin	   expression	   and	   signaling252.	   The	  
immunofluorescence	  and	  FACs	  analyses	  described	  demonstrated	  that	  ONS	  cells	  
cultured	  on	  plates	  coated	  with	  the	  naturally	  derived	  ECM	  component	  Lam	  both	  
proliferated	  and	  differentiated	  towards	  neural	  and	  glial	  lineage	  when	  compared	  
with	  cells	  cultured	  on	  uncoated	  plates.	  	  
	  
Lam	   is	  part	  of	  a	  group	  of	  heterotrimeric	  proteins,	  which	  regulate	  cell	  viability.	  
Smyth	  et	  al	  highlighted	  the	  importance	  of	  Lam	  as	  a	  protein,	  in	  1999,	  in	  a	  study	  
proving	  that	  complete	  disruption	  of	  embryonic	  Lam	  production	  in	  rodents	  lead	  
to	  early	  fetal	  death253.	  	  As	  outlined	  in	  Chapter	  1,	  Lam	  is	  an	  essential	  component	  
of	  the	  ECM	  and	  basement	  membrane.	  Its	  role	  in	  peripheral	  nerve	  regeneration	  
is	  multi	  faceted;	  it	  promotes	  regeneration,	  differentiation	  and	  migration,	  which,	  
though	  closely	  related,	  are	  all	  very	  different	  processes254.	  First,	  as	  with	  all	  ECM	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proteins,	   Lam	   interacts	   with	   cell	   surface	   receptors,	   or	   integrins,	   to	   activate	  
signaling	   pathways,	   which	   regulate	   cell	   function.	   In	   this	   regard,	   its	   pro	  
differentiation	  effect	  is	  intuitive;	  without	  the	  support	  of	  a	  basement	  membrane,	  
cells	  can	  have	  nothing	  to	  attach	  to.	  Without	  attachments,	  cells	  do	  not	  migrate	  
or	  multiply255.	  Second,	   it	  has	  an	   important	   role	   in	  myelination.	  Doyu	  et	  al	  and	  
Yurchenko	   et	   al	   have	   both	   highlighted	   this	   role,	   which	   is	   essential	   for	   both	  
axonogenesis	  and	  for	  effective	   insulation	  therefore	  conductivity	  of	  the	  axon256	  
257.	   Thirdly,	   Lam	   has	   been	   shown	   to	   promote	   axon	   initiation	   by	   stabilising	  
microtubules	   and	   by	   regulating	   the	   microtubule-­‐associated	   protein	   Tau258.	  
Axons	   contain	   densely	   packed	   microtubules,	   which	   facilitate	   extension	   of	  
neuronal	  processes	  and	  enable	   the	   transport	  of	  vesicles	   from	  the	  cell	  body	   to	  
the	  cell	  processes259.	  Microtubule	  formation	  is	  dependent	  on	  Tau	  proteins	  and	  
microtubule	  associated	  proteins	  or	  MAPs260	  261.	  	  
	  
Although	  the	  finding	  that	  Lam	  had	  pro-­‐differentiation	  effects	  on	  the	  ONS	  cells	  in	  
the	   present	   study	   was	   perhaps	   not	   surprising,	   it	   raised	   some	   interesting	  
questions	  as	  to	  the	  exact	  molecular	  mechanism	  by	  which	  it	  occurred.	  Chen	  et	  al	  
investigated	  those	  mechanisms	  in	  2003.	  In	  that	  study	  the	  authors	  disrupted	  the	  
gene	  responsible	  for	  coding	  one	  component	  of	  the	  Lam	  trimer	  (Lam	  γ1),	  which	  
resulted	  in	  reduced	  Schwann	  cell	  differentiation	  and	  myelination,	  and	  impaired	  
sciatic	  function	  in	  mice.	  The	  results	  of	  the	  Chen	  studies	  also	  demonstrated,	  that	  
the	   subunits	   of	   laminins	   could	   act	   in	   different	   ways	   at	   different	   parts	   of	   the	  
nerve.	  They	  also	  found	  that	  Schwann	  cells	  lacking	  Lam	  were	  present	  but	  did	  not	  
migrate,	   differentiate,	   or	   progress	   to	   producing	  myelin	   basic	   protein	   because	  
Lam	  free	  Schwann	  cells	  lacked	  a	  key	  protein	  transcription	  factor	  known	  as	  Krox	  
20,	  which	   is	  necessary	  for	  myelin	  production262	  263.	  Taken	  together,	  the	  recent	  
literature	  suggests	  that	  without	  the	  presence	  of	  Lam,	  stem	  cells	  can	  proliferate	  
but	  not	  differentiate.	  The	  Lam	  γ1	  chain	  is	  essential	  to	  the	  function	  of	  Lam	  as	  a	  
biomolecule	  because	  when	  it	  is	  absent	  (as	  in	  Chen	  et	  als	  study)	  accumulation	  of	  
the	  α	  and	  β	  component	  chains	  will	  not	  occur,	  although	  precise	  reasons	  for	  this	  
co-­‐dependency,	   are	   not	   well	   understood.	   In	   terms	   of	   cell	   to	   biomaterial	  
interactions,	  ONS	  cells	  have	  a	  natural	  affinity	  with	  Lam;	  Carter	  et	  al	  previously	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demonstrated	   that	   they	   express	   key	   ECM	   adhesion	   molecules	   including	  
intercellular	  adhesion	  molecule-­‐1	  (ICAM-­‐1),	  𝛼	  1	  -­‐6	  and	  β	  1-­‐3	  integrins264.	  
	  
Another	   interesting	   point	   from	   the	   FACs	   analysis	   of	   this	   study	   was	   that	   the	  
addition	   of	   Lam	   promoted	   expression	   of	   the	  markers	   GFAP	   (marker	   of	   a	   non	  
myelinating	  producing	  Schwann	  cell)	  as	  well	  as	  β-­‐tubulin.	  This	  result	  contrasted	  
with	  work	  published	  by	  Tarasenko	  et	  al	  and	  Barraud	  et	  al,	  both	  of	  whom	  have	  
suggested	   that	   the	   addition	   of	   Lam	   promotes	   proliferation,	   increases	   cell	   to	  
flask	   adherence	   and	   increases	   neurogenesis	   whilst	   decreasing	   the	   overall	  
expression	   of	   GFAP265	   266	   .	   In	   the	   Tarasenko	   study,	   the	   authors	   demonstrated	  
that	   exposing	   primed	   immortalised	   stem	   cells	   to	   Lam	   increased	   neuronal	  
differentiation	   while	   decreasing	   glial	   GFAP	   expression	   (47	   –	   70	   %	   expressed	  
GFAP	  regardless	  of	  the	  proliferation	  condition	  used).	  	  
	  
In	  contrast	  to	  Lam,	  PDL	  is	  a	  highly	  charged	  synthetically	  produced	  amino	  acid.	  It	  
possesses	  poly	  cationic	  properties,	  which	  allow	  cells	  to	  bind	  to	  anionic	  sites	  on	  a	  
given	  tissue	  or	  culture	  surface	  and	  resists	  the	  effects	  of	  cell	  driven	  hydrolysis267.	  
Unlike	   Lam,	   it	   does	   not	   provide	   a	   framework	   along	   which	   Schwann	   cells	   can	  
migrate,	   providing	   a	   possible	   explanation	   for	  why	   in	   this	   study,	   the	  ONS	   cells	  
cultured	  on	  PDL	  coated	  plates	   tended	   to	  differentiate	   to	  neural	   and	  glial	   cells	  
with	  a	  mature	  phenotype,	  when	  compared	  with	  Lam	  but	  not	  proliferate	  as	  well.	  
It	   appeared	   that	  whilst	  PDL	  was	   superior	   to	   Lam	   in	   terms	  of	   increasing	  nestin	  
and	   β-­‐tubulin	  marker	   expression	   in	   two	   dimensional	   culture	   conditions,	   Lam	  
was	   superior	   in	   terms	   of	   overall	   cell	   viability,	   GFAP	   expression	   (when	  
supplemented	   with	   NGF)	   and	   observed	   proliferation.	  A	   number	   of	   recent	  
studies	   have	   shown	   similar	   patterns	   of	   behavior	   in	   keeping	   with	   the	   results	  
reported	  in	  this	  study	  where	  neural	  stem	  cells	  were	  shown	  to	  differentiate	  to	  a	  
similar	   degree	   on	   natural	   and	   synthetic	   substrates,	   but	   natural	   substrates	  
provided	   improved	   cell	   survival	   -­‐	   Walton	   et	   al	   have	   also	   found	   that	   PDL	  
promoted	   neural	   and	   glial	   differentiation	   in	   studies	   using	   a	   canine	   olfactory	  
derived	  stem	  cell	  model268	  269.	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The	   analysis	   of	   the	   effect	   of	   NGF	   on	   cell	   behavior	   provided	   further	   useful	  
information.	  Nerve	  growth	   factor	   (NGF)	  was	   the	   first	  neurotrophin	  discovered	  
by	   Montalcini	   and	   Cohen	   in	   the	   1950s.	   However	   its	   cysteine	   knot	   structure	  
formed	   by	   β	   strands	   and	   disulfide	   bonds	  was	   not	   identified	   until	   some	   years	  
later.	  NGF	  is	  secreted	  by	  both	  neuronal	  and	  non-­‐neuronal	  cells	  and	  is	  processed	  
at	   the	   endoplasmic	   reticulum	   and	   the	   Golgi	   apparatus270.	   It	   is	   important	   for	  
numerous	   functions	   but	   specifically	   in	   terms	   of	   neuronal	   homeostasis,	   NGF	  
governs	   proliferation	   survival	   and	   intrinsic	   axonal	   elongation	   by	   binding	   two	  
types	  of	  receptor	  on	  the	  surface	  of	  neurons	  and	  neuronal	  precursors	  which	  may	  
be	   low	   or	   high	   affinity.	   The	   tropomyosin	   receptor	   kinase	   A	   (TrKA)	   receptor	   is	  
high	  affinity	  and	  when	  NGF	  binds	  to	  it,	  tyrosine	  kinase	  becomes	  phosphorylated	  
leading	   to	   the	  activation	  of	  phosphatidylinositol	   4-­‐5	  bisphosphonate	  3-­‐	   kinase	  
(P3K),	   which	   is	   a	   group	   of	   intracellular	   cell	   proliferation	   and	   differentiation	  
transducer	   enzymes.	   NGF	   also	   activates	   the	   RAS	   proto-­‐oncogene	   pathway,	  
which	  regulates	  protein	  synthesis	  to	  increase	  cell	  proliferation271.	  Both	  the	  P3K	  
and	  RAS	  pathways	  are	  linked	  with	  tumor	  genesis.	  Despite	  the	  fact	  that	  there	  are	  
few	  long-­‐term	  studies	  on	  the	  potential	  negative	  systemic	  impact	  of	  exogenous	  
NGF	   administration,	   a	   number	   of	   recent	   studies	   have	   endorsed	   its	   use	   in	  
peripheral	   nerve	   regeneration272	   273.	   NGF	   enhances	   neuro	   differentiation,	  
neurite	  outgrowth	  and	  synaptic	  plasticity	  by	  influencing	  axonal	  signals274.	  It	  has	  
also	  been	  shown	  to	  have	  pro	  differentiation	  effects	  on	  olfactory	  stem	  cells275.	  
	  
The	   results	   of	   this	   study	   appeared	   to	   suggest	   that	   although	   NGF	  
supplementation	  has	  a	  pro-­‐differentiation	  effect	  on	  ONS	  cells	  in	  vitro,	  the	  effect	  
is	   similar	   to	   that	   of	   Lam	   or	   PDL.	   However	   its	   addition	   failed	   to	   provide	   any	  
additive	   or	   synergistic	   effect	   when	   combined	   in	   culture	   with	   these	  
biomolecules.	   This	   was	   a	   highly	   relevant	   finding	   with	   potential	   far	   reaching	  
effects	  in	  terms	  of	  future	  clinical	  applications	  because	  it	  suggested	  that	  using	  a	  
natural	   biomimetic	   material	   can	   potentially	   infer	   the	   same	   benefits	   as	   NGF	  
enhancement	  but	  without	  the	  potential	  risks	  associated	  with	  introducing	  a	  cell	  
up	  regulating	  trophic	  agent	  (including	  unchecked	  carcinogenesis).	  	  In	  addition	  to	  
the	   potential	   risks	   and	   long-­‐term	   side	   effects	   associated	   with	   exogenous	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neurotrophin	   administration,	   this	   finding	   could	   have	   an	   impact	   on	   cost	   and	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2.6.	  Conclusions	  
	  
The	   results	   of	   this	   study	   confirm	   and	   extend	   previously	   reported	   data	   that	  
multipotent	   highly	   plastic	   stem	   cells	   with	   the	   potential	   to	   differentiate	   along	  
neural	  and	  glial	  lineage	  can	  be	  harvested	  and	  cultured	  from	  neuroepithelial	  cells	  
derived	   from	   explants	   taken	   from	   the	   rat	   nasal	   cavity.	   The	   findings	   underline	  
the	  importance	  of	  biomaterials	  and	  growth	  factor	  selection	  in	  the	  design	  of	  cell	  
specific	  delivery	  systems	  for	  peripheral	  nerve	  regeneration	  models.	  	  
	  
Overall,	   the	  results	  of	   this	  study	  allowed	  the	   following	  main	  conclusions	   to	  be	  
made.	  	  
	  
• Multipotent	   ONS	   cells	   with	   similar	   neuro	   differentiation	   capacity	   to	  
human	   derived	   ONS	   cells	   may	   be	   isolated	   from	   primary	   olfactory	  
neuroepithelial	  tissue	  explants	  in	  Sprague	  Dawley	  rats	  
• ONS	  cells	  derived	  from	  6-­‐week-­‐old	  animals	  possess	  greater	  capacity	  for	  
differentiation	  then	  12-­‐week-­‐old	  animals	  of	  the	  same	  strain	  	  
• ONS	   cells	   proliferation	   and	   differentiation	   potential	   is	   dependent	   on	  
biomaterials,	  but	  to	  varying	  degrees	  
• Both	  Lam	  and	  PDL,	  have	  a	  positive	  effect	  on	  the	  differentiation	  capacity	  
of	  ONS	  cells	  
• Media	  supplementation	  with	  recombinant	  rat	  NGF	  at	  a	  concentration	  of	  
100ng/ml	   promotes	   the	   expression	   of	   key	   neural	   and	   glial	   stem	   cell	  
markers	  on	  immunofluorescence	  staining	  and	  flow	  cytometry	  analysis.	  
• ONS	   cells	   differentiate	   towards	   neural	   and	   glial	   lineage	   in	   response	   to	  
NGF	  supplementation	  
• PDL	  appears	   to	  have	  a	  superior	  neuro	  and	  glial	  differentiation	  capacity	  
when	  compared	  to	  Lam	  
• Lam	  promoted	  increased	  cell	  proliferation	  
• NGF	  has	  similar	  effects	  to	  Lam	  and	  PDL	  on	  neuro-­‐differentiation	  of	  ONS	  
cells	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• The	   addition	   of	   NGF	   to	   biomolecules	   Lam	   and	   PDL	   does	   not	   have	   a	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3.1.	  Introduction	  	  
	  
Tissue	  engineering	  promotes	  the	  development	  of	  biological	  substitutes	  for	  the	  
regeneration	   of	   damaged	   tissues	   and	   in	   peripheral	   nerve	   applications,	   three-­‐
dimensional	   constructs	  or	   scaffolds	  are	  a	   cornerstone	   concept276	  277.	  Acting	  as	  
interactive	   multi-­‐functional	   templates,	   they	   facilitate	   tissue	   regeneration	   by	  
providing	  mechanical	  strength,	  resisting	  external	  compressive	  forces,	  facilitating	  
diffusion	   of	   nutrients	   or	   wastes,	   anchoring	   cells	   and	   providing	   cues	   which	  
influence	   cellular	   behaviour278.	   Key	   application	   specific	   requirements	   of	  
scaffolds	  for	  peripheral	  nerve	  regeneration	  include	  biocompatibility	  and	  porous	  
microarchitecture	   to	   facilitate	   cell	   infiltration.	   	   The	   expression	   of	   tissue	  
appropriate	   morphological	   features	   in	   tissue-­‐engineered	   approaches	   is	  
dependent	  on	   cell	   to	   environment	   interactions	   such	   as	   shearing	   forces	  or	   the	  
compliance	  of	   the	  biomaterial	   in	  which	   they	  are	   implanted	   279	   280	  281.	   Evolving	  
techniques	   in	   fabrication	   methods	   have	   led	   to	   the	   development	   of	   scaffolds	  
with	  properties	  which	  can	  elicit	  specific	  targeted	  cell	  responses;	  an	  example	  of	  
this	  is	  the	  production	  of	  naturally	  based	  hydrogels	  (three-­‐dimensional	  networks	  
of	  polymers	  swollen	  by	  solvents282)	  which	  closely	  mimic	  the	  functionality	  of	  the	  
ECM283	   284.	   In	   addition	   to	   cell	   delivery,	   combining	   stem	   cells	   in	   an	   interactive	  
three-­‐dimensional	   environment	   now	   has	   the	   potential	   to	   facilitate	   in	   vitro	  
organogenesis,	  which	  makes	  this	  multi-­‐level	  approach	  to	  cell	  culture,	  one	  of	  the	  
most	  exciting	  developments	  in	  cell	  biology	  of	  recent	  times285	  286	  287	  288	  289.	  	  
	  
This	   thesis	   has	   proposed	   a	   novel	   tissue	   engineering	   triad	   of	   olfactory	   derived	  
stem	   cells	   (ONS),	   delivered	   by	   means	   of	   a	   purpose-­‐designed	   nerve	   growth	  
factor	   (NGF)	   enhanced	   collagen-­‐hyaluronic	   acid	   (HA)	   nerve	   guidance	   conduit	  
(NGC)	   for	   the	   purpose	   of	   peripheral	   nerve	   regeneration.	   ONS	   cells	   and	   their	  
progeny,	  olfactory	  ensheathing	  cells	  (OECs)	  have	  previously	  been	  demonstrated	  
to	  express	  both	   the	  ECM	  receptors	  CD44	  and	  β1	   integrin	   (which	   form	   laminin	  
and	  collagen	  receptors),	  and	  NGF	  receptors290.	  They	  have	  been	  used	  extensively	  
in	   spinal/CNS	   injury	  models291	  292	  293	  294.	  One	  of	   the	  most	   intriguing	   aspects	   of	  
olfactory	   derived	   cells	   is	   that	   they,	   unlike	   Schwann	   cells,	   can	   co-­‐exist	   with	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central	   nervous	   system	   astrocytes,	   raising	   the	   possibility	   that	   they	   secrete	  
factors,	   which	   overcome	   axonal	   inhibitors295	   296.	   Although	   they	   have	   been	  
studied	   extensively	   in	   CNS	   models,	   the	   role	   of	   ONS	   cells	   in	   peripheral	   nerve	  
regeneration	  has	  been	  less	  well	  reported	  -­‐	  partly	  because	  the	  optimum	  means	  
of	  delivery	  within	  a	  large	  gap	  peripheral	  nerve	  injury	  has	  yet	  to	  be	  reported.	  A	  
core	   component	   of	   this	   thesis	   was	   the	   development	   and	   optimisation	   of	   a	  
suitable	  NGC	  that	  fulfilled	  the	  above	  outlined	  roles	  and	  promoted	  the	  ability	  of	  
ONS	   cells	   to	   efficiently	   enhance	   peripheral	   neurogenesis	   in	   vivo.	   In	   order	   to	  
utilise	  the	  regenerative	  capacity	  of	  this	  unique	  population	  of	  cells,	  an	  NGC	  that	  
supported	  ONS	  attachment,	   facilitated	  migration	  and	   regulated	  differentiation	  
was	   envisaged.	   There	   are	   numerous	   synthetic	   and	   natural	   biomaterials	   from	  
which	  scaffolds	  for	  nerve	  regeneration	  purposes	  can	  be	  fabricated	  but	  collagen	  
and	  hyaluronic	  acid	  (HA)	  were	  identified	  early	  on	  as	  the	  biomaterials	  of	  choice	  
for	   this	   study.	   As	   outlined	   in	   Chapter	   1,	   they	   were	   selected	   as	   the	   principal	  
components	  of	  the	  proposed	  NGC	  because	  they	  have	  shown	  promising	  results	  
in	   peripheral	   nerve	   regeneration	   studies	   to	   date,	   and	   because	   studies	   have	  
shown	  that	  ONS	  cells	  have	  a	  better	  natural	  affinity	  to	  ECM	  molecules	  then	  other	  
neural	  stem	  cells297	  298.	  	  
	  
Whilst	   the	   use	   of	   the	   traditional	   tubular	   conduit	   has	   merit	   in	   its	   own	   right	  
(Archibald	   et	   al	   previously	   demonstrated	   promising	   results	   using	   hollow	  
collagen	   tubes	   to	   promote	   peripheral	   nerve	   regeneration	   in	   short	   nerve	   gap	  
injury	   in	   rodent	   and	   primate	   studies)299,	   a	   number	   of	   recent	   studies	   have	  
hypothesized	  that	  failure	  to	  provide	  regenerative	  cues	  in	  the	  luminal	  core	  of	  a	  
tubular	   conduit	   will	   result	   in	   sub	   optimal	   results300	   301	   302.	   To	   that	   end,	   the	  
proposed	   design	   incorporated	   an	   outer	   collagen	   superstructured	   tubular	  
conduit,	  with	  a	  biologically	  active	  microstructured	  luminal	  HA	  hydrogel	  filler.	  A	  
schematic	   representation	   of	   the	   design	   is	   provided	   in	   Figure	   3.1.	   The	   main	  
purpose	  of	   the	  outer	   collagen	   conduit	   component	  of	   the	  NCG	  was	   to	  provide	  
mechanical	  strength,	  facilitate	  stump	  entubulation	  and	  allow	  nutrient	  diffusion	  
to	   the	   cells	   entrapped	   within	   its	   luminal	   core	   in	   vivo.	   Although	   its	   role	   was	  
mainly	  mechanical	   and	  permissive,	   it	  was	  also	   important	   to	  ensure	   it	  was	  not	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toxic	  to	  the	  cells	  carried	  within	  the	   luminal	   filler	   (so	  that	   it	  did	  not	  reduce	  the	  
potential	  for	  regeneration	  within);	  thus	  whilst	  the	  roles	  of	  the	  two	  components	  
were	  different,	  they	  were	  required	  to	  be	  compatible.	  	  
	  
A	  hydrogel	  composed	  of	  HA	  was	  selected	  for	  use	  within	  the	  lumen	  of	  the	  outer	  
collagen	   tubular	   conduit	   to	   facilitate	   nutrient	   diffusion	   cell	   entrapment	   and	  
differentiation	  whilst	  preventing	  shearing	  forces	  from	  restricting	  cell	  extension	  
or	  migration.	  Hydrogels	  are	  particularly	  useful	  in	  peripheral	  nerve	  regeneration	  
models	   because	   they	   are	   viscoelastic,	   containing	   both	   viscous	   and	   elastic	  
properties,	  which	  can	  be	  quantified	  by	  rheological	  measurements303.	  One	  of	  the	  
most	  attractive	  characteristics	  of	  HA	   in	  this	  application	   is	   its	  capacity	  to	  retain	  
high	   amounts	   of	   water,	   which	   has	   been	   shown	   to	   promote	   cell	   survival	   and	  
prevent	   desiccation	   of	   other	   ECM	   components	   such	   as	   collagen304.	   A	   further	  
advantage	  to	  its	  use	  is	  the	  relative	  ease	  with	  which	  it	  can	  tolerate	  cross-­‐linking,	  
enabling	  the	  production	  of	  hydrogels	  with	  tuneable	  mechanical	  properties	  that	  
can	  be	  functionalised	  to	  provide	  additional	  binding	  sites	  for	  cell	  attachment	  and	  
extension305.	  As	  described	  in	  Chapter	  2,	  identification	  of	  the	  best	  biomolecule	  to	  
functionalise	  the	  HA	  component	  of	  the	  NGC	  was	  an	  important	  element	  of	  the	  in	  
vitro	   analysis.	   Both	   laminin	   (Lam;	   a	   natural	   heterotrimeric	   protein	   which	  
maintains	  homeostasis	  by	  promoting	  the	  attachment	  of	  cells	  to	  type	  IV	  collagen	  
and	   enhancing	   myelination	   of	   axons),	   and	   synthetic	   poly	   D	   lysine	   (PDL;	   a	  
positively	  charged	  amino	  acid,	  which	  can	  be	  used	  to	  functionalise	  HA	  hydrogels	  
by	  providing	  attachment	  sites	  to	  the	  HA	  molecule)	  were	  identified	  as	  potential	  
functionalising	   agents	   in	   the	   2D	   analysis	   described.	   Further	   to	   functionalising	  
agents,	  nerve	  growth	  factor	  (NGF)	  was	  also	  identified	  as	  a	  potential	  enhancer	  of	  
the	  ONS	  cells	  within	  the	  NGC	  for	  the	  reasons	  outlined	  in	  Chapter	  1	  and	  Chapter	  
2.	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Figure	   3.1:	   Schematic	   diagram	   demonstrating	   A:	   Severed	   nerve	   with	  
disorganised	  axonal	  outsprouting	  and	  B:	  the	  proposed	  NGC	  comprising	  of	  a	  HA	  
hydrogel	  luminal	  filler	  (insert)	  within	  a	  supportive	  outer	  tubular	  collagen	  conduit	  
(grey)	  for	  peripheral	  nerve	  regeneration	  (image	  adapted	  from:	  Carballo-­‐Molina	  
et	  al)306.	  Hydrogels	  may	  be	  functionalised	  with	  cells	  such	  as	  ONS,	  growth	  factors	  
such	  as	  NGF	  and	  ECM	  molecules	   such	  as	   Lam	  to	   increase	   their	  bioactivity	  and	  
enhance	  axonal	  growth	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In	   practical	   terms	   regarding	   the	   clinical	   applicability	   of	   the	   proposed	   NGC,	  
multilevel	  in	  vitro	  analyses	  were	  required	  prior	  to	  progressing	  to	  in	  vivo	  studies.	  
Key	   points	   for	   evaluation	   were	   categorised	   as	   either	   ergonometric,	   including	  
robustness	  and	  manoeuvrability,	  or	  functional,	  including	  the	  end	  NGCs	  ability	  to	  
promote	   differentiation,	   diffusion	   and	   cytoskeletal	   production	   in	   a	   non-­‐
cytotoxic	  environment.	  The	  ergonomic	  design	  of	  the	  proposed	  NGC	  was	  critical	  
since	   an	   unwieldy	   device	   will	   impede	   meticulous	   microsurgery	   and	   prevent	  
optimum	  outcomes	  even	  if	  the	  component	  biomaterials	  are	  well	  functionalised.	  
Particular	  attention	  was	  given	  to	  developing	  a	  robust	  NCG,	  which	  could	  retain	  
its	  overall	  shape	  during	  the	  surgical	  implantation	  process	  whilst	  facilitating	  easy	  
seeding	  with	  ONS	  cells	  and	  nerve	  growth	  factor	  (NGF).	  	  
	  
On	   a	   cellular	   level,	   a	   detailed	   evaluation	   of	   the	   cell-­‐NGC	   interaction	   was	  
required	   because	   three-­‐dimensional	   cultures	   may	   provide	   better	   information	  
about	  the	  in	  vivo	  behaviour	  of	  cells	  within	  a	  given	  tissue-­‐engineered	  NGC307.	  In	  
three-­‐dimensional	   tissues,	   cells	   attach	   to	   the	   ECM	  by	  means	  of	   integrins,	   and	  
loss	   of	   the	   cell-­‐integrin	   bond	   destabilises	   the	   integrity	   of	   core	   intracellular	  
microtubules,	   which	   disrupts	   cytoskeletal	   homeostasis308.	   As	   a	   result,	   cell	  
behaviours	  present	  in	  tissue,	  can	  be	  underestimated	  in	  two-­‐dimensional	  culture	  
conditions309.	   It	   follows	   that	   three-­‐dimensional	   cell	   adhesion	   is	   an	   intrinsically	  
different	   process	   to	   two-­‐dimensional	   cell	   adhesion310	   and	   two-­‐dimensional	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3.2.	  Study	  aims	  and	  objectives	  
	  
The	  overall	  objective	  of	  this	  study	  was	  to	  develop,	  optimise	  and	  characterise	  the	  
resultant	   response	   of	   a	   biomimetic	   biphasic	   collagen-­‐HA	   NGC	   for	   use	   in	   the	  
delivery	  of	  ONS	  cells	  in	  a	  peripheral	  nerve	  regeneration	  model.	  	  
	  
The	  specific	  aims	  were:	  
	  
• To	  select	  an	  optimum	  tubular	  collagen	  conduit	  for	  use	  in	  a	  biphasic	  NGC	  
based	   on	   its	   mechanical	   properties	   and	   ability	   to	   support	   ONS	   cell	  
viability	  	  
• To	  select	  an	  optimum	  HA	  luminal	  filler	  for	  use	   in	  a	  biphasic	  NGC	  based	  
on	   its	   ability	   to	   support	   ONS	   cell	   viability	   and	   neurodifferentiation	  
potential	  	  
• To	  select	  an	  optimum	  HA	  luminal	  filler	  for	  use	   in	  a	  biphasic	  NGC	  based	  
on	  its	  ability	  to	  support	  ONS	  cell	  phenotypic	  changes	  in	  response	  to	  NGF	  
treatment	  
• To	  establish	  an	  optimised	  protocol	  for	  the	  delivery	  of	  ONS	  cells	  into	  the	  
optimum	  functionalised	  HA	   luminal	   filler	  component	  of	  a	  biphasic	  NGC	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3.3.	  Methods	  and	  materials	  	  
	  
All	  chemicals	  were	  sourced	  from	  Sigma	  Ireland	  (Arklow,	  Co.	  Wicklow,	  Ireland)	  or	  
BD	   bioscience	   (Dun	   Laoghaire,	   Co.	   Dublin,	   Ireland)	   and	   used	   per	   the	  
manufacturer’s	   instructions	   unless	   otherwise	   indicated.	   ONS	   cells	   were	  
generated	   using	   the	   protocol	   described	   in	   Chapter	   2.	   Collagen	   conduits	   and	  
functionalised	   HA	   hydrogel	   luminal	   fillers	   were	   fabricated	   in	   the	   Tissue	  
Engineering	  Research	  Group	  (TERG),	  RCSI,	  following	  protocols	  refined	  in	  house.	  
Bovine	  fibrillar	  collagen	  type	  I	  (Integra®	  Life	  Sciences,	  Plainsboro,	  NJ)	  was	  used	  
to	   fabricate	   the	   outer	   tubular	   conduit	   component	   of	   the	   NGC	   and	   this	  
fabrication	   technique	   was	   optimised	   as	   part	   of	   a	   parallel	   taught	  MSc	   project	  
(supervised	  by	  Phoebe	  Roche,	  Alan	  Ryan	  and	  Professor	  O’Brien).	  HA	  sodium	  salt	  
from	  Streptococcus	  equi	  (2.2	  MDa,	  Sigma	  Aldrich)	  was	  used	  to	  fabricate	  the	  HA-­‐	  
hydrogel	   luminal	   filler	   as	   part	   of	   a	   second	   parallel	   taught	   MSc	   project	  
(supervised	  by	  Phoebe	  Roche,	  Alan	  Hibbits	  and	  Professor	  O’Brien)	  
	  
3.3.1.	   Development	   of	   an	   optimal	   tubular	   collagen	   conduit	   for	   use	   in	   a	  
biphasic	  NGC	  for	  the	  delivery	  of	  ONS	  cells	  
	  
3.3.1.1.	  Tubular	  collagen	  conduit	  fabrication	  
Briefly,	  the	  conduits	  were	  fabricated	  using	  the	  following	  protocol.	  A	  suspension	  
of	  collagen	  type	  I	  in	  0.05M	  acetic	  acid	  was	  blended	  at	  4°C	  at	  15000rpm	  for	  one	  
hour	   followed	   by	   degassing	   under	   vacuum.	   The	   following	   concentrations	   of	  
collagen	  type	  I	  were	  investigated:	  1%	  weight	  to	  volume	  (w.v),	  2.5	  %	  w.v,	  and	  5	  
%	  w.v.	  The	  collagen	  suspension	  was	  injected	  into	  custom	  made	  tubular	  stainless	  
steel	  molds	  and	  lyophilized	  in	  a	  freeze	  dryer	  using	  an	  the	  following	  an	  in	  house	  
refined	   lyophillisation	   cycle	  which	   has	   been	   shown	   to	   generate	   scaffolds	  with	  
large	   porosity	   and	   a	   homogenously	   interconnected	   pore	   architecture313.	   The	  
suspensions	   in	   the	   molds	   were	   maintained	   at	   20°C	   to	   normalise	   conditions	  
before	  being	   cooled	   at	   a	   rate	   of	   0.9°C	  per	  minute	   to	   a	   final	   temperature	  of	   -­‐
40°C.	   They	  were	  maintained	  at	   -­‐40°C	   for	  1	  hour,	   followed	  by	   sublimation	  and	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heating.	   	  Once	  the	  tubular	  constructs	  were	  fabricated,	  they	  were	  subjected	  to	  
dehydrothermal	  treatment	  (DHT;	  heating	  scaffolds	  to	  temperatures	  above	  90°C,	  
under	  vacuum	  to	  remove	  bound	  water).	  	  
	  
3.3.1.2.	  Mechanical	  and	  structural	  analysis	  of	  tubular	  collagen	  conduits	  
The	  tubular	  conduits	  were	  evaluated	  in	  terms	  of	  porosity,	  tensile	  strength	  and	  
degradation	  rate	  prior	  to	  in	  vitro	  use.	  Briefly,	  scaffold	  porosity	  was	  determined	  
using	   the	   relationship	   between	   the	   dry	   density	   of	   collagen	   and	   the	   conduit	  
volume	   and	   mass.	   To	   evaluate	   the	   average	   pore	   size	   of	   tubular	   collagen	  
conduits,	   sections	   were	   cut,	   embedded	   in	   JB-­‐4	   glycomethacrylate,	   fixed	   in	  
formalin	  and	  dehydrated	  with	  ethanol,	  following	  which	  they	  were	  embedded	  in	  
JB4-­‐b,	  sectioned,	  mounted	  on	  glass	  histology	  slides,	  stained	  with	  toluidine	  blue	  
and	  imaged	  using	  a	  Nikon	  Eclipse®	  90i	  microscope.	  Digital	  images	  were	  analysed	  
in	   terms	   of	   pore	   size	   with	   a	   MATLAB	   program	   at	   Trinity	   College	   Dublin.	   To	  
evaluate	  the	  effect	  of	  collagen	  density	  on	  the	  tensile	  properties	  of	  the	  tubular	  
collagen	  conduits,	  they	  were	  sectioned,	  soaked	  in	  PBS	  for	  1	  hour	  and	  assessed	  
in	   terms	   of	   thickness	   and	   diameter	   with	   calipers.	   Samples	   were	   then	   pre-­‐	  
strained	  to	  0.01N	  at	  5mm/min	  following	  which	  they	  were	  strained	  to	  failure	  at	  
5mm/min.	   To	   evaluate	   the	   effect	   of	   collagen	   density	   on	   in	   vitro	   degradation	  
rate,	   tubular	   collagen	   conduits	   were	   sectioned	   and	   exposed	   to	   collagenase	  
solution,	   following	  which	  they	  were	  vortexed,	  centrifuged	  and	  separated	  from	  
the	  supernatant	  prior	  to	  freeze	  drying	  and	  re-­‐weighing.	  
To	  examine	  the	  effect	  of	  collagen	  density	  on	  shape	  retention,	  tubular	  collagen	  
conduits	  were	  re	  hydrated	   in	  PBS	  for	  7	  days.	  At	  the	  seven-­‐day	  time	  point,	   the	  
conduits	   were	   removed	   from	   the	   PBS,	   carefully	   blotted	   with	   lint-­‐free	   tissue	  
wipes	  (Kimtech®	  Science,	  UK)	  and	  assessed	  in	  terms	  of	  retention	  of	  shape	  and	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3.3.1.3.	  ONS	  cell	  viability	  study	  
	  
Five	  mm	  sections	  of	  2.5	  %	  collagen	  tubular	  conduit	  were	  pre	  hydrated	  in	  PBS	  for	  
30	   minutes	   and	   partially	   dried	   using	   lint-­‐free	   tissue	   wipes.	   ONS	   cells	   were	  
seeded	  into	  the	  lumens	  at	  a	  density	  of	  1.5	  x	  103	  cells	  per	  section	  with	  ONS	  cells	  
cultured	  on	  standard	  tissue	  culture	  plates	  as	  a	  positive	  control.	  Specimens	  were	  
placed	  into	  48-­‐well	  tissue	  culture	  plates	  and	  incubated	  at	  37°C	  for	  30	  minutes	  to	  
ensure	   attachment	   of	   ONS	   cells,	   after	   which	   the	   wells	   were	   flooded	   with	  
DMEM/F12/FBS/PS.	   The	  ONS	   cell	   seeded	   tubular	   collagen	   conduits	  were	   then	  
incubated	  at	  37°C	  for	  7	  days,	  with	  media	  changes	  every	  48	  hours.	  Following	  7	  
days	   in	   culture,	   100µl	   of	   Alamar	   blue	   reagent	  was	   pipetted	   into	   each	  well	   to	  
achieve	  a	  final	  concentration	  of	  10	  %.	  Plates	  were	  incubated	  for	  3	  hours	  at	  37°	  C	  
on	   an	   orbital	   rocker.	   After	   three	   hours,	   the	   media	   and	   reagent	   solution	   was	  
divided	   into	   a	   96-­‐well	   NUNC	   U-­‐bottom	   polypropylene	   plate	   and	   placed	   in	   a	  
Thermo	   Scientific	   Varioskan®	   Flash	   spectral	   scanning	   multimode	   reader	   for	  
photometric	   assessment	   using	   the	   manufacturer’s	   protocol.	   Average	  
absorbance	  at	  540nm	  and	  620nm,	  was	  tabulated	  and	  graphed	  as	  a	  percentage	  
of	  the	  values	  obtained	  for	  cells	  cultured	  in	  the	  positive	  control	  condition.	  
	  
3.3.2.	  Development	  of	  an	  optimum	  HA	  luminal	  filler	  for	  use	  in	  a	  biphasic	  NGC	  
for	  the	  delivery	  of	  ONS	  cells	  
	  
3.3.2.1.	  HA	  luminal	  filler	  fabrication	  and	  functionalisation	  with	  Laminin	  (Lam)	  
and	  poly-­‐D-­‐lysine	  (PDL)	  
	  
A	   previously	   described	   procedure	   involving	   carbodiimide	   chemistry	   was	  
modified	  and	  employed	  in	  house	  to	  fabricate	  HA	  luminal	  fillers314	  315.	  HA	  sodium	  
salt	  was	  used	  to	  make	  up	  a	  5	  mg/ml	  solution	  in	  dH2O.	  The	  salt	  was	  slowly	  added	  
to	  dH2O	  under	  constant	  stirring	  to	  prevent	  clumping	  and	  falling	  out	  of	  solution.	  
The	   HA	   solution	   was	   subsequently	   chemically	   cross-­‐linked	   with	   ADH	   (adipic	  
dihydrazide;	   9.16	   g/	   100	   ml)	   through	   an	   EDAC	   1-­‐Ethyl-­‐3-­‐(3-­‐
dimethylaminopropyl)	  carbodiimide	  (0.8	  g/	  100	  ml)	  reaction	  in	  acidic	  conditions	  
	   100	  
(pH	  3.5-­‐4.5)	   over	   night.	   The	   reaction	  was	   stopped	  by	   returning	   the	  pH	  of	   the	  
crosslinked	  HA	  to	  7	  by	  adding	  2	  M	  NaOH.	  The	  crosslinked	  HA	  was	  then	  dialysed	  
against	  20%	  ethanol	  and	  deionised	  water	  over	  a	  period	  of	  96	  hours	  to	  remove	  
unwanted	   urea	   derivatives	   in	   dialysis	   tubing	   with	   a	   6000-­‐8000	   Da	   molecular	  
weight	  cut	  off.	  The	  dialysate	  was	  changed	  every	  24	  hours	  as	   follows:	  100	  mM	  
NaCl	  for	  24	  hours,	  100	  mM	  NaCl	  for	  24	  hours	  20%	  EtOH	  for	  24	  hours,	  and	  dH2O	  
for	   24	   hours	   prior	   to	   vacuum	   degassing	   and	   lyophilisation	   by	   freeze-­‐drying.	  
Three	   HA	   hydrogels	   (one	   unmodified	   and	   two	   functionalised	   variants)	   were	  
produced	   for	   potential	   inclusion	   in	   the	   end	   product	   NGC.	   Functionalised	  
variants	  were	  produced	  by	  adding	  either	  Lam	  (5	  μg/ml)	  or	  PDL	  (50	  μg/ml)	  to	  the	  
sol	  prior	  to	  freeze-­‐drying.	  
	  
3.3.2.2.	  Mechanical	  and	  structural	  analysis	  of	  HA	  luminal	  filler	  	  
	  
Prior	  to	  cell	  viability	  and	  differentiation	  assessments,	  the	  physical	  properties	  of	  
the	   hydrogels	   were	   assessed	   and	   characterised	   in	   terms	   of	   microstructure,	  
swelling	   ratio,	   mechanical	   strength	   and	   biodegradability.	   Briefly,	   the	  
microstructure	  was	  evaluated	  by	  cutting	  HA	  hydrogels	  into	  discs,	  coating	  them	  
with	   gold	   (100	   Å	   thickness)	   and	   imaging	   using	   scanning	   electron	   microscopy	  
(SEM)	   at	   the	   Centre	   for	  Microscopy	   and	   Analysis,	   Trinity	   College	   Dublin.	   The	  
swelling	   ratio	   was	   evaluated	   by	   punching	   freeze-­‐dried	   hydrogels	   into	   rounds,	  
weighing	   the	   resulting	   discs	   and	   hydrating	   them	   with	   one	   ml	   DMEM	   for	   24	  
hours	   following	   which,	   the	   swelling	   ratio	   was	   calculated	   by	   dividing	   the	   net	  
weight	  gain	  by	  the	  original	  dry	  weight.	  Mechanical	  testing	  was	  then	  performed	  
with	  an	  AR-­‐1000	  Rheometer	  under	  a	  standard	  oscillatory	  shear	  procedure,	  at	  1	  
Hz	   and	   5	   Pa.	   A	   temperature	   sweep	   gathered	   measurements	   for	   storage	  
modulus	  (G’)	  and	  loss	  modulus	  (G’’),	  from	  25˚C	  to	  55˚C	  at	  1˚C	  intervals	  (a	  large	  
value	   of	   G’	   in	   comparison	   to	  G’’	   indicates	   pronounced	   elastic	   (gel)	   properties	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3.3.2.3.	  ONS	  cell	  viability	  study	  	  
Cell	   viability	  of	   the	   three	  potential	   luminal	   filler	   candidate	   components	  of	   the	  
NGC	   was	   assessed	   at	   day	   7	   using	   a	   3-­‐(4,5-­‐dimethylthiazol-­‐2-­‐yl)-­‐5-­‐(3-­‐
carboxymethoxyphenyl)-­‐2-­‐(4-­‐sulfophenyl)-­‐2H	   tetrazolium	  MTS	   assay	   according	  
to	   the	  manufacturers	   instructions.	  ONS	   cells	  were	   seeded	  onto	   10	  mm	   round	  
punches	  (15	  x	  103/punch)	  of	  freeze-­‐dried	  hydrogels	  (i)	  HA,	  (ii)	  HA	  functionalised	  
with	  Lam	  (HA-­‐Lam)	  and	  (iii)	  HA	  functionalised	  with	  PDL	  (HA-­‐PDL).	  ONS	  cells	  on	  
standard	   tissue	   culture	   plastic	   plates	   served	   as	   positive	   control.	   MTS	   is	   a	  
colorimetric	   assay	   for	   assessing	   cell	   viability	   by	   means	   of	   measurement	   of	  
metabolic	  breakdown	  products316	  317.	   It	   functions	  on	  the	  premise	  that	  NADPH-­‐
dependent	   cellular	   oxidoreductase	   enzymes	   under	   defined	   conditions	   can	  
reflect	  the	  number	  of	  viable	  cells	  present	  in	  a	  given	  experiment318.	  MTS	  reagent	  
was	   added	   to	   the	   media	   and	   incubated	   for	   three	   hours	   at	   37°C.	   After	   three	  
hours,	   the	   media	   and	   reagent	   solution	   was	   divided	   into	   a	   96-­‐well	   NUNC	   U-­‐
bottom	  polypropylene	  plate	  and	  placed	  in	  a	  Thermo	  Scientific	  Varioskan®	  Flash	  
spectral	   scanning	   multimode	   reader	   for	   photometric	   assessment	   using	   the	  
manufacturer’s	   protocol.	   Average	   absorbance	   at	   490nm,	   was	   tabulated	   and	  
graphed	  as	  a	  percentage	  of	  the	  values	  obtained	  for	  cells	  cultured	  in	  the	  positive	  
control	  condition.	  
	  
3.3.2.4.	  ONS	  differentiation	  study	  	  
	  
In	  order	  to	  evaluate	  the	  effect	  of	  HA	  luminal	  filler	  composition	  (unmodified	  or	  
functionalised	   with	   Lam	   or	   PDL)	   and	   NGF	   treatment	   on	   ONS	   cells,	   ONS	   cells	  
were	   seeded	   as	   outlined	   previously	   and	   cultured	   in	   growth	   media	   or	   media	  
containing	   50ng/ml	   recombinant	   rat	   NGF.	   Samples	   were	   fixed	   with	   4	   %	   NBF	  
after	  7	  days	   in	  culture.	  The	  staining	  procedure	  was	  carried	  out	  as	  described	  In	  
Chapter	  2	   (see	  section	  2.4.4.1).	   In	  order	  to	  accommodate	  for	  the	  3D	  structure	  
all	  incubation	  times	  were	  doubled.	  Stained	  samples	  were	  imaged	  using	  a	  Leica®	  
DMIL	  confocal	  microscope	  and	  LAS	  V3.8	  camera..	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3.3.3.	   Evaluation	   of	   the	   optimum	   ONS	   cell	   delivery	   method	   into	   the	   HA	  
luminal	  filler	  component	  of	  a	  biphasic	  NGC	  for	  future	  use	  in	  in	  vivo	  studies	  on	  
peripheral	  nerve	  regeneration	  
	  
Following	  selection	  of	   the	  optimum	  tubular	  conduit	  and	  HA	  hydrogel,	   the	  two	  
were	  combined	  to	  produce	  a	  single	  NGC	  by	  incorporating	  the	  hydrogel	  into	  the	  
lumen	   of	   the	   tubular	   collagen	   conduit	   using	   the	   following	   TERG	   refined	  
protocol.	   Tubular	   collagen	   conduits	   were	   fabricated	   as	   outlined	   above	   and	  
rehydrated	  by	  incubation	  in	  0.025	  M	  acetic	  acid	  for	  1	  hour	  (Figure	  3.2.	  A).	  The	  
HA	   hydrogel	   was	   carefully	   injected	   into	   the	   lumen	   of	   the	   collagen	   tubular	  
conduit	   (Figure	   3.2.	   B).	   The	   filled	   biphasic	   NGCs	   (illustrated	   in	   Figure	   3.2.	   C)	  
were	  freeze	  dried	  in	  custom-­‐made	  molds	  using	  an	  in	  house	  developed	  protocol	  
followed	  by	  DHT	  crosslinking	  and	  sterilisation	  	  
	  
	  
Figure	   3.2:	   Combination	   of	   a	   tubular	   collagen	   conduit	   with	   HA	   hydrogel	   to	  
produce	  a	  biphasic	  construct.	  A:	  the	  tubular	  collagen	  conduit	  prior	  to	  hydration	  
in	  PBS.	  B:	  hydrogel	   injection	  with	  a	  21G	  needle	  and	  1ml	  syringe.	  C:	  hydrogel	   is	  
inserted	  completely	  into	  the	  lumen	  (Image	  obtained	  in	  collaboration	  with	  Austyn	  
Matheson	  and	  Alan	  Ryan	  TERG)	  
	  
In	   this	   study,	   two	   methods	   of	   seeding	   were	   evaluated;	   passive	   seeding	   by	  
pipetting	  the	  cells	  in	  solute	  onto	  a	  dry	  or	  wet	  NGC,	  and	  active	  seeding	  by	  means	  
of	   injection	  of	  the	  cells	   into	  the	  center	  of	  NGCs	  at	  a	  concentration	  of	  50	  x	  104	  
cells	   per	   construct	   using	   a	   24-­‐gauge	   hypodermic	   needle	   and	   a	   5ml	   plastic	  
syringe.	  In	  addition	  to	  dispersion	  of	  cells	  within	  the	  NGC,	  an	  evaluation	  of	  their	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ability	  to	  produce	  cytoskeletal	  proteins	  following	  injection	  was	  performed.	  The	  
cytoskeleton	  is	  the	  mechanical	  support	  structure	  of	  eukaryotic	  cells.	  In	  neuronal	  
and	  glial	  cells,	  it	  comprises	  of	  tubulin	  based	  microtubules,	  actin	  based	  fillaments	  
and	   intermediate	   fillaments	  which	   combine	   to	   promote	   cell	   stability,	   network	  
formation	  and	  cell	  division.	  Tests	  for	  the	  presence	  of	  β-­‐tubulin	  were	  performed	  
previously	   (see	   section	   3.3.2.4).	   To	   evaluate	   the	   presence	   of	   actin,	   ONS	   cells	  
were	  carefully	  injected	  into	  the	  center	  of	  three	  NGCs	  at	  a	  concentration	  of	  50	  x	  
103	   cells	  per	   construct	  using	  a	  24-­‐gauge	  hypodermic	  needle	  and	  a	  5ml	  plastic	  
syringe.	   Position	   of	   and	   actin	   expression	   by	   the	   injected	   ONS	   cells	   were	  
determined	  using	  nuclear	  and	  cytoskeleton	  staining	  as	  follows.	  After	  72	  hours	  in	  
culture,	   the	   cell	   seeded	   constructs	   were	   sectioned	   longitudinally	   at	   20	   um	  
thickness	   and	   stained	   for	   actin	   using	   phalloidin	   conjugated	  
with	  tetramethylrhodamine	   (TRITC)	   for	   20	   minutes	   in	   the	   dark	   followed	   by	  
washing	   in	  PBS	  and	  counterstaining	  with	  Hoechst	  nuclear	   stain.	  Sections	  were	  
imaged	  using	  a	  Leica	  DMIL	  microscope	  and	  LAS	  V3.8	  camera.	  
	  
3.3.4.	  Statistical	  analysis	  	  
	  
All	  summary	  graphs	  display	  the	  median	  or	  mean	  values	  ±	  the	  standard	  error	  of	  
the	  mean	  where	  applicable.	  All	  statistical	  analysis	  was	  performed	  using	  one-­‐way	  
analysis	   of	   variance	   tests	   (ANOVA).	  Where	   statistically	   significant	   results	  were	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3.4.	  Results.	  
	  
3.4.1.	   Collagen	   concentration	   affects	   porosity,	   mechanical	   properties	   and	  
degradation	  rate	  of	  a	  tubular	  collagen	  conduit	  	  
Results	  showed	  that	  low	  concentration	  (1%	  w.v)	  collagen	  	  was	  non	  optimal	  for	  
NGC	   fabrication	   despite	   its	   high	   porosity	   due	   to	   significantly	   lower	   ultimate	  
tensile	   strength	   (UTS)	   and	   high	   degradation	   rate	   compared	   to	   high	  
concentration	   scaffolds	   (p<.05,	   illustrated	   in	   Table	   3.1).	   Moreover,	   during	  
handling	  in	  in	  vitro	  culture,	  the	  1%	  w.v	  tubular	  collagen	  conduit	  disintegrated	  on	  
cell	   seeding.	   Therefore	   it	  was	   excluded	   from	   future	   surgical	   use.	   Although	   no	  
significant	  differences	  in	  the	  parameters	  tested	  were	  found	  between	  the	  higher	  
variants	  (2.5	  %	  w.v	  and	  5%	  w.v),	  during	  handling	  in	  in	  vitro	  culture,	  the	  5	  %	  w.v	  
tubular	   collagen	   conduit	   failed	   to	   retain	   its	   shape	   following	   a	   prolonged	  
hydration	   study	   (data	   not	   shown)	   whilst	   the	   2.5	   %	   w.v	   variant	   retained	   its	  
tubular	  configuration	  (See	  Figure	  3.3)..	  
Table	  3.1.	  Mechanical	  test	  data	  for	  tubular	  collagen	  conduits.	  Asterisk	  indicates	  
statistically	   significant	   difference	   from	   higher	   variants.	   Data	   obtained	   in	  
collaboration	  with	  Austyn	  Matheson	  and	  Alan	  Ryan	  RCSI	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Figure	   3.3:	   Image	   demonstrating	   a	   collagen	   conduit	   of	   2.5%	   w.v	   tubular	  
collagen	   conduit	   soaked	   in	   PBS	   after	   7	   days.	   From	   a	   practical	   and	   surgical	  
perspective,	  the	  2.5%	  w.v	  tubular	  collagen	  conduit	  was	  selected	  as	  the	  optimum	  
conduit	  for	  use	  with	  the	  final	  NGC	  because	  it	  retained	  its	  shape	  during	  handling	  
	  
As	  a	  result,	  in	  view	  of	  the	  surgical	  applicability	  of	  the	  tubular	  conduit,	  the	  2.5%	  
w.v	  tubular	  collagen	  conduit	  was	  selected	  as	  the	  optimum	  conduit	  for	  use	  with	  
the	  final	  NGC	  
3.4.2.	  The	  optimal	  tubular	  collagen	  conduit	  supports	  ONS	  cell	  viability	  	  
Although	  significant	  only	  at	  the	  90	  %	  CI,	   in	  terms	  of	  observed	  cell	  viability,	  the	  
viability	  of	  ONS	  cells	  cultured	  on	  the	  2.5	  %	  w.v	  x	  tubular	  collagen	  conduit	  was	  81	  
%	   compared	   to	   cells	   cultured	   on	   standard	   tissue	   culture	   plastic	   plates	   as	  
illustrated	   in	  Figure	  3.3.	   The	   choice	   to	  use	   the	  2.5	  %	   tubular	   collagen	   conduit	  
was	  made	  because	  it	  because	  it	  handled	  more	  easily	  and	  because	  it	  retained	  its	  
shape	  better	   than	   the	   1%	   and	   5	  %	   variants	   and	   also	   because	   it	   generated	   an	  
acceptable	  cell	  viability	  profile	  although	  the	  difference	  in	  viability	  between	  the	  
three	  variant	  tubular	  collagen	  conduits	  was	  not	  statistically	  significant.	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Figure	   3.4:	   Bar	   chart	   demonstrating	   the	   percentage	   viability	   of	   ONS	   cells	  
cultured	   on	   tubular	   collagen	   conduits	   compared	   to	   cells	   cultured	   on	   standard	  
tissue	  culture	  plastic	  plates	  
3.4.3.	   Mechanical	   properties	   of	   a	   HA	   luminal	   filler	   are	   improved	   through	  
chemical	  and	  thermal	  crosslinking	  	  
HA	   hydrogels	   were	   demonstrated	   to	   have	   a	   highly	   porous	   structure	   upon	  
freeze-­‐drying	  and	  a	  high	  swelling	  ratio,	  which	  implied	  that	  the	  hydrogels	  could	  
absorb	   solvent	   into	   their	   microstructure	   resulting	   in	   a	   low	   solid	   phase.	   The	  
rheological	  evaluation	  and	  temperature	  sweeps	  (20	  –	  50	  °C)	  demonstrated	  that	  
at	   physiological	   temperature,	   37°C,	   the	   structural	   integrity	   of	   the	   biomaterial	  
increased	  significantly	  in	  response	  to	  deformation	  by	  temperature,	  with	  a	  5-­‐fold	  
increase	   and	   a	   2-­‐fold	   increase	   in	   the	   viscous	   and	   elastic	   moduli,	   respectively	  
(P<0.005)	   indicating	   that	   the	   hydrogel	   had	   both	   mechanical	   strength	   and	  
structural	   integrity	   (rheological	   data	   obtained	   in	   collaboration	   with	   Will	  
Lackington	  and	  Alan	  Ryan	  RCSI).	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3.4.4.	   Improved	   cell	   viability	   is	   achieved	   through	   functionalisation	   of	   a	   HA	  
luminal	  filler	  with	  Lam	  (HA-­‐Lam)	  
The	   day	   seven	   MTS	   analysis	   demonstrated	   improved	   metabolic	   activity	   with	  
ONS	   cells	   seeded	   in	   HA-­‐Lam	   hydrogels	   when	   compared	   with	   HA	   or	   HA-­‐PDL	  
hydrogels	   (illustrated	   in	   Figure	   3.4).	   Statistically,	   the	   HA-­‐Lam	   hydrogel	   had	  
comparable	  cell	  viability	  to	  ONS	  cells	  cultured	  on	  standard	  tissue	  culture	  plates	  
and	  significantly	  better	  viability	  than	  was	  found	  with	  the	  unmodified	  HA	  or	  HA-­‐
PDL	   hydrogel	   variants	   indicating	   a	   better	   cell	   viability	   profile	   with	   HA-­‐Lam	  
hydrogels.	  	  
	  
Figure	   3.5:	   Bar	   chart	   demonstrating	   outcomes	   of	   the	   7-­‐day	   MTS	   metabolic	  
activity	   assay	   of	   ONS	   cells	   on	   both	   non-­‐functionalised	   HA	   hydrogels	   and	  
functionalised	  HA	  hydrogels	  (HA-­‐PDL	  and	  HA-­‐Lam)	  against	  a	  positive	  control	  of	  
cells	   cultured	   with	   standard	   media	   on	   tissue	   culture	   plates	   alone.	   Asterisk	  
indicates	  statistically	  significant	  difference	  in	  viability	  between	  HA-­‐Lam	  and	  HA-­‐
PDL	  hydrogels	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3.4.5.	   Differentiation	   potential	   of	   ONS	   cells	   is	   maintained	   in	   both	  
functionalised	  and	  unmodified	  HA	  luminal	  fillers	  
	  
Confocal	  images	  of	  ONS	  cells	  cultured	  on	  HA	  hydrogels	  demonstrated	  that	  they	  
expressed	  the	  neural	  stem	  cell	  marker	  nestin,	  and	  neuronal	  marker	  β-­‐tubulin	  in	  
all	   three	   variants	   (Figure	   3.6).	   However,	  when	   cultured	   in	   the	   unmodified	  HA	  
hydrogel,	  ONS	  cells	  retained	  a	  spheroidal	  configuration	  with	  no	  obvious	  cell	  to	  
material	  interactions	  (Figure	  3.6	  A-­‐	  C).	  By	  comparison,	  ONS	  cells	  cultured	  on	  HA	  
hydrogels	   functionalised	  with	   PDL	   or	   Lam	   demonstrated	   early	   signs	   of	   cell	   to	  
material	   interaction	   as	   illustrated	  by	   the	   short	   processes	  highlighed	   in	   (Figure	  
3.6	   D	   -­‐	   I).	   Therefore,	   fuctionalisation	   of	   HA	   with	   either	   PDL	   or	   laminin	   was	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Figure	   3.6:	   A	   –	   C:	   Spheroidal	   configuration	   of	   ONS	   cells	   on	   unmodified	   HA	  
hydrogel.	  D	  -­‐	  F:	  ONS	  cells	  on	  HA-­‐PDL	  hydrogel.	  In	  comparison	  to	  unmodified	  HA	  
hydrogels,	  ONS	  cells	  demonstrated	  early	  phenotypic	  extension	  (blue	  arrows).	  G	  –	  
I:	  ONS	  cells	  on	  HA-­‐Lam	  hydrogel.	  In	  comparison	  with	  unmodified	  HA	  hydrogels,	  
ONS	  cells	  demonstrated	  more	  phenotypic	  extension	  than	  on	  HA-­‐PDL	  hydrogels	  
(blue	  arrows).	  A,	   D,	   G:	   single	   staining	   for	  nestin,	  B,	   E,	   H	   single	   staining	   for	  β-­‐	  
tubulin	  C,	   F,	   I:	   composite	   images	  with	   nestin	   (red)	   nuclear	   stain	   (blue)	   and	  β-­‐
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3.4.6.	  The	  presence	  of	  laminin	  in	  a	  HA-­‐Lam	  luminal	  filler	  supported	  phenotypic	  
extension	  in	  ONS	  cells	  in	  response	  to	  Nerve	  Growth	  Factor	  (NGF)	  treatment	  	  
	  
Confocal	   images	   of	   ONS	   cells	   cultured	   in	   NGF	   supplemented	  medium	   on	   non	  
functionalised	   HA	   hydrogels	   and	   hydrogels	   functionalised	   with	   PDL	   or	   Lam	  
demonstrated	   that	   NGF	   promoted	   a	   change	   in	   cell	   phenotype	   in	   Lam	  
functionalised	   conditions	   only.	   Whilst	   nestin	   and	   β-­‐tubulin	   were	   again	  	  
expressed	  in	  all	  three	  conditions	  (Figure	  3.7),	  a	  change	  in	  cell	  morphology	  with	  
the	  development	  of	  a	  marked	  degree	  of	  extension	  was	  observed	  in	  the	  HA-­‐Lam	  
subgroup	   alone	   (Figure	   3.7	   G	   -­‐	   I).	   As	   illustrated,	   this	   group	   demonstrated	   a	  
marked	  change	  in	  morphology	  whilst	  retaining	  the	  expression	  of	  the	  nestin	  and	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Figure	   3.7:	   A	   –	   C:	   Spheroidal	   configuration	   of	   ONS	   cells	   on	   unmodified	   HA	  
hydrogel	   supplemented	  with	  NGF.	  Matrix	   invasion	  and	  cell	  extension	  were	  not	  
observed.	  D	   -­‐	   F:	  ONS	   cells	  ONS	   cells	   on	   HA-­‐PDL	   hydrogel	   supplemented	   with	  
NGF.	   In	   comparison	   to	   unmodified	   HA	   hydrogels.	   Matrix	   invasion	   and	   cell	  
extension	   were	   not	   observed.	   G	   –	   I:	   ONS	   cells	   on	   HA-­‐Lam	   hydrogel	  
supplemented	  with	  NGF.	  In	  comparison	  to	  to	  the	  other	  HA	  hydrogels,	  ONS	  cells	  
cultured	   on	  HA-­‐Lam	  with	  NGF	   demonstrated	  marked	   phenotypic	   extension	   (G	  
Insert)	   and	  matrix	   invasion.	  A,	   D,	   G:	   single	   staining	   for	   nestin,	  B,	   E,	   H	   single	  
staining	  for	  β-­‐	   tubulin	  C,	   F,	   I:	  composite	   images	  with	  nestin	   (red)	  nuclear	  stain	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3.4.7.	  Active	  injection	  seeding	  of	  ONS	  cells	  into	  the	  luminal	  filler	  component	  of	  
a	  biphasic	  NGC	  facilitates	  cell	  retention,	  adhesion	  and	  compartmentalization	  
	  
A	  fully	  assembled	  optimised	  biphasic	  NGC	  was	  fabricated	  as	  described	  above.	  As	  
can	   be	   seen	   in	   Figure	   3.8,	   there	  was	   a	   clear	   demarcation	   between	   the	   2.5	  %	  
collagen	  tubular	  conduit	  and	  the	  HA-­‐Lam	  luminal	  filler.	  Seeding	  techniques	  were	  
then	  evaluated	  using	  this	  fully	  assembled	  biphasic	  NGC.	  
	  
	  
Figure	  3.8:	  SEM	  photomicrograph	  demonstrating	  the	  cross	  sectional	  appearance	  
of	   the	  biphasic	  NGC.	  The	  dotted	  yellow	   line	  demonstrates	   the	   tubular	  collagen	  
conduit	  –	  HA-­‐Lam	   luminal	   filler	   interface	   (Image	  Courtesy	  of	  Austyn	  Matheson	  
and	  Alan	  Ryan	  TERG)	  
	  
Passive	  pipetting	  of	  the	  cells	  onto	  the	  dry	  HA-­‐Lam	  hydrogel	  component	  of	  the	  
NGC	  was	  selected	  as	  the	  initial	  method	  of	  seeding	  the	  gel	  in	  vitro.	  Interestingly,	  
dry	   seeding	   of	   the	   HA-­‐Lam	   hydrogel	   component	   was	   found	   to	   produce	   air	  
bubbles,	   which	   made	   staining	   and	   metabolic	   assays	   challenging	   to	   interpret.	  
However	   the	  cells	  were	  noted	  to	  diffuse	  readily	   through	  the	  HA-­‐Lam	  hydrogel	  
component	  when	   it	   had	   been	   pre-­‐hydrated	   by	  means	   of	   placing	   the	   biphasic	  
NGC	  on	   top	   of	   the	   required	   volume	  of	  media.	   Although	   the	   passive	   pipetting	  
technique	  of	  seeding	  the	  biphasic	  NGC	  was	  appropriate	  for	  in	  vitro	  work,	  it	  was	  
unwieldy	   and	   not	   suitable	   for	   future	   use	   in	   in	   vivo	   studies;	   therefore	   active	  
injection	  of	  the	  cells	  using	  a	  24-­‐gauge	  hypodermic	  needle	  and	  syringe	  was	  also	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evaluated.	   Nuclear	   staining	   demonstrated	   that	  migration	   of	   the	   injected	   ONS	  
cells	  occurred	  through	  the	  center	  of	  the	  biphasic	  NGC	  at	  the	  72-­‐hour	  time	  point	  
(Figure	   3.9	   B).	   In	   addition	   to	   providing	   useful	   information	   for	   future	   in	   vivo	  
work,	   this	   experiment	   provided	   two	   main	   pieces	   of	   information.	   First,	   it	  
demonstrated	  that	  the	  HA-­‐Lam	  hydrogel	  was	  porous	  enough	  to	  allow	  migration	  
of	  cells;	  and	  second,	  the	  experiment	  demonstrated	  that	  whilst	  the	  cells	  readily	  
diffused	   through	   the	   hydrogel,	   they	   did	   not	  migrate	   into	   the	   tubular	   collagen	  
conduit	  wall	  of	  device,	  which	  was	  a	  desired	  effect	  of	   the	  design	  ensuring	   that	  
cell	  loss	  to	  the	  external	  environment	  was	  prevented.	  	  
	  
ONS	   cells	   were	   also	   observed	   to	   stain	   strongly	   for	   the	   F-­‐actin	   component	   of	  
cytoskeleton	  with	   phalloidin	   (demonstrated	   in	   Figure	   3.9	   C).	   The	   presence	   of	  
dense	   phalloidin	   staining	   implied	   that	   the	   ONS	   cells,	   which	  migrated	   through	  
the	  gel,	  were	  also	  able	  to	  extend	  processes,	  which	  could	   facilitate	  cell	  contact	  
because	   of	   the	   presence	   F-­‐actin.	   As	   outlined	   above,	   this	   is	   essential	   for	   the	  
formation	  of	  synapses	  and	  for	  neurite	  extension	  along	  with	  the	  presence	  of	  β-­‐
tubulin	  (see	  section	  3.4.5	  and	  section	  3.4.6)	  as	  it	  is	  a	  known	  neural	  microtubule	  
protein319.	   F-­‐actin	   presence	   is	   also	   essential	   since	   it	   facilitates	   synapse	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Figure	   3.9:	  A:	   Bright-­‐field	   image	   showing	   longitudinal	   section	   of	  NGC	   injected	  
with	   ONS	   cells,	   after	   72	   hrs	   in	   culture.	   Outer	   tubular	   collagen	   conduit	   and	  
luminal	  filler	  (HA-­‐Lam)	  are	  demarcated	  with	  the	  dashed	  line.	  High	  magnification	  
image	  of	  the	  insert	  is	  shown	  in	  B	  and	  C.	  B:	  Image	  shows	  cell	  distribution	  through	  
the	   NGC.	   Cell	   nuclei	   were	   stained	   with	   Hoechst	   nuclear	   stain.	   Image	   was	  
converted	   to	  black	  and	  white	   to	  emphasise	   cells	  position	  of	   the	  cells	   (nuclei	   in	  
white)	   in	   relationship	   to	   the	   biomaterials	   (shown	   in	   black).	   Dashed	   line	  
demarcates	  components	  of	  the	  nerve	  conduit	  as	  in	  A.	  C:	  Image,	  shows	  adherent	  
cells	   in	   the	  HA-­‐Lam	   luminal	   filler	  as	   indicated	  by	   the	  precense	  of	  F-­‐actin	  stress	  
fibers	  (phalloidin).	  Note	  the	  empty	  core	  to	  the	  center	  right	  of	  image	  A	  occurred	  
secondary	  to	  the	  injection	  process	  
	  
	   115	  
3.5.	  Discussion	  	  
	  
The	   aim	   of	   the	   present	   study	   was	   to	   develop	   and	   optimise	   a	   biphasic	  
biomimetic	  collagen-­‐HA	  NGC	  for	  use	  in	  the	  delivery	  of	  ONS	  cells	  in	  a	  peripheral	  
nerve	   regeneration	  model.	   The	   results	   described	   herein	   demonstrate	   that	   an	  
ergonomic	  and	  robust	  biphasic	  NGC,	  produced	  by	  the	  combination	  of	  an	  outer	  
2.5	  %	  w.v	  tubular	  collagen	  conduit	  with	  a	  biologically	  active	  functionalised	  HA-­‐
Lam	  hydrogel	   luminal	   filler	  could	  be	  successfully	  used	  as	  a	  delivery	  vehicle	   for	  
ONS	  cells	  for	  peripheral	  nerve	  regeneration.	  
	  
A	   2.5	   %	   w.v	   tubular	   collagen	   conduit	   was	   selected	   based	   on	   its	   mechanical	  
properties	   and	   ability	   to	   support	   ONS	   cell	   viability.	  Whilst	   the	   use	   of	   a	   basic	  
tubular	   conduit	   to	  promote	  peripheral	  nerve	   regeneration	  has	  been	  shown	   to	  
have	  merit	   in	   its	   own	   right,	   in	   the	   context	   of	   this	   study,	   the	   tubular	   collagen	  
conduits	   function	  was	   primarily	   to	   facilitate	   entubulation	   of	   the	   proximal	   and	  
distal	  nerve	  stumps,	  and	  allow	  nutrient	  diffusion	  and	  ONS	  cell	  migration	  within	  
the	   biomimetic	   luminal	   core	   of	   the	   construct.	   As	   a	   component	   of	   tubular	  
conduits,	   collagen	   was	   shown	   to	   have	   good	   mechanical	   properties	   with	   the	  
additional	   benefit	   of	   controllable	   porosity	   (95%	   for	   the	   2.5	   %	   w.v	   tubular	  
collagen	   conduit	   variant),	   which	   could	   facilitate	   nutrient	   diffusion.	   This	   is	   in	  
keeping	   with	   the	   literature	   which	   has	   shown	   that	   collagen	   content	   within	  
suspensions	  influences	  pore	  structure	  and	  mechanical	  properties	  of	  scaffolds323	  
324.	  The	  demonstration	  that	  the	  outer	  tubular	  collagen	  conduit	  could	  withstand	  
prolonged	   hydration	   and	   anchor	   prolene	   surgical	   sutures	   when	  wet	   was	   also	  
critically	  important.	  Although	  other	  methods	  (such	  as	  fibrin	  glue)	  of	  fixing	  nerve	  
tissue	   to	   conduits	   have	   been	   reported,	   consensus	   dictates	   that	   microsurgical	  
repair	   is	   the	   safest	   and	   most	   effective	   method	   of	   doing	   so325.	   Kwan	   et	   al	  
demonstrated	  the	  importance	  of	  a	  scaffolds	  ability	  to	  retain	  sutures	  and	  resist	  
strain	  in	  vivo	  326.	  A	  further	  primary	  focus	  of	  tests	  on	  the	  tubular	  collagen	  conduit	  
was	   the	   identification	   of	   the	   variant	   with	   the	   best	   capacity	   to	   maintain	   its	  
tubular	   shape	   post	   hydration	   whilst	   at	   the	   same	   time	   being	   non-­‐toxic	   to	  
implanted	   cells.	   In	   this	   investigation,	   the	   tubular	   collagen	   conduit	   variant	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produced	   with	   a	   2.5%	   w.v	   suspension	   was	   found	   to	   possess	   the	   greatest	  
potential	  to	  retain	  its	  shape	  following	  the	  prolonged	  hydration	  study.	  This	  was	  
an	  important	  finding	  for	  two	  reasons;	  first,	  because	  maintenance	  of	  the	  shape	  
and	   structure	   of	   a	   scaffold	   keeps	   pores	   patent	  which	   is	   essential	   for	   nutrient	  
diffusion327,	  and	  second,	  because	  in	  nerve	  injury,	  the	  healing	  process	  results	  in	  
an	   influx	   of	   myofibroblasts.	   Myofibroblasts	   have	   been	   shown	   to	   form	   a	  
contractile	  capsule	  that	  reduces	  the	  caliber	  of	  the	  regeneration	  zone	  leading	  to	  
early	   stump	   sealing	   and	   hampering	   the	   potential	   for	   functional	   recovery328.	  
Tubular	  collagen	  conduits	  that	  maintain	  their	  shape	  have	  the	  potential	  to	  resist	  
the	  formation	  of	  this	  contractile	  capsule,	  facilitating	  axonal	  extension	  within329.	  
In	  addition	  to	  the	  structural	  stability,	  the	  viability	  of	  seeded	  cells	  was	  also	  a	  key	  
concern.	  Williams	  reviewed	  this	  theory	  in	  2008,	  concluding	  that	  the	  key	  to	  the	  
success	  of	  biocompatible	  structure	  is	   its	  ability	  to	  perform	  its	  function	  without	  
eliciting	   negative	   or	   abnormal	   responses	   within	   tissues	   with	   which	   it	   is	  
implanted330.	  In	  this	  regard,	  the	  tubular	  collagen	  conduit	  variant	  produced	  with	  
a	   2.5%	   w.v	   suspension	   performed	   well	   (demonstrated	   by	   the	   findings	   of	   the	  
MTS	  assay	  which	  showed	  81	  %	  viability	  of	   seeded	  ONS	  cells	  against	  a	  positive	  
control	   of	   cells	   cultured	   on	   standard	   tissue	   culture	   plastic	   plates).	   Taken	  
together,	   the	   results	   of	   the	   analyses	   on	   the	   collagen	   conduit	   justified	   the	  
inclusion	  of	  the	  2.5	  %	  w.v	  variant	  in	  the	  final	  biphasic	  NGC.	  
	  
The	  optimised	  HA-­‐Lam	   luminal	   filler	  was	   selected	   for	  use	   in	   the	  biphasic	  NGC	  
based	   on	   its	   ability	   to	   support	   ONS	   cell	   viability	   and	   neurodifferentiation	  
potential.	  The	  hydrogel	  form	  of	  HA	  was	  selected	  for	  the	  luminal	  filler	  because	  of	  
desirable	   biological	   characteristics	   that	   have	   been	   previously	   described331.	  
Much	  of	  the	  recent	  research	  on	  peripheral	  nerve	  regeneration	  has	  focused	  on	  
mimicking	   the	   natural	   ECM	   and	   the	   synergy	   between	   physical	   and	   natural	  
biomolecular	   guidance	   cues332.	   This	   is	   a	   concept	  which	   is	   particularly	   relevant	  
for	   cell	   based	   therapeutic	   approaches	   to	   peripheral	   nerve	   regeneration	   using	  
ONS	   cells.	   The	   identification	   of	   the	   best	   variant	   for	   incorporation	   in	   biphasic	  
NGC	  was	  dependent	  on	  a	  number	  of	  factors.	  First,	  the	  stiffness	  of	  the	  hydrogel	  
and	   its	   ability	   to	  withstand	  handling	  and	  prolonged	  hydration	  were	   important	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elements	  because	   it	  had	  to	  retain	   is	  gelatinous	  configuration	  to	  remain	  within	  
the	   lumen	   of	   the	   outer	   tube	   long	   enough	   for	   neurogenesis	   to	   occur	   without	  
inhibiting	   neuronal	   extension.	   Mechanical	   stiffness	   has	   also	   been	   proven	   to	  
affect	  the	  differentiation	  capacity	  of	  stem	  cells333	  334.	  Whilst	  the	  native	  HA	  exists	  
in	   a	   non-­‐rigid	   configuration,	   mechanical	   testing	   at	   the	   TERG	   laboratory	  
demonstrated	  that	  modification	  with	  ADH	  and	  freeze-­‐drying	  caused	  a	  change	  to	  
a	   regular	   porous	   configuration	   (the	   porous	   structure	   is	   demonstrated	   in	   the	  
SEM	  image	  shown	  in	  Figure	  3.3);	  additionally	  it	  was	  found	  to	  absorb	  significant	  
amounts	  of	  solvent	  and	  retain	   its	  gel	   like	  phase	  at	  physiological	  temperatures.	  
One	  of	  the	  advantages	  of	  using	  HA	  in	  hydrogel	  applications	  is	  that	  it	  has	  several	  
carboxylic	   acid	   groups	   along	   its	   polymer	   chain;	   this	   makes	   it	   extremely	  
amenable	   to	   cross-­‐linking	   (the	   process	   of	   chemically	   joining	   two	   or	   more	  
molecules	   by	   covalent	   bonds)335	   336	   337.	   Cross	   linking	   reagents	   are	   molecules	  
which	  contain	  multiple	  reactive	  ends	  capable	  of	  chemically	  attaching	  to	  specific	  
functional	  groups	  other	  molecules338.	  They	  can	  alter	  the	  behavior	  of	  the	  parent	  
molecule	   in	  different	  ways339.	  The	  degree	   to	  which	  conjugation	  occurs	  was	  an	  
important	   factor	   in	   the	   fabrication	   of	   the	   hydrogels	   since	   stiffness	   has	   been	  
shown	  to	  affect	  biological	  activity.	  Studies	  have	  shown	  that	  a	  low-­‐to-­‐moderate	  
degree	   of	   conjugation	   is	   optimal	   in	   cell	   delivery	   systems	   aimed	   at	   peripheral	  
nerve	   regeneration340.	   In	   this	   study,	   cross-­‐linking	   HA	   with	   ADH	   provided	   gels	  
with	  a	  chemical	  backbone	  that	  gave	  them	  viscoelastic	  properties,	  facilitating	  cell	  
dispersion	  and	  extension	  in	  keeping	  with	  the	  recent	  literature341.	  	  
	  
The	   capacity	   of	   the	   hydrogel	   luminal	   filler	   to	   support	   cell	   extension,	   and	  
promote	   differentiation	   was	   of	   critical	   importance	   since	   the	   end	   device	   was	  
envisaged	  as	  a	  cell	  delivery	  device	  with	  co-­‐existing	  potential	  for	  neurogenesis.	  A	  
limiting	   factor	   in	   the	   success	   of	   HA	   as	   a	   biomaterial	   in	   peripheral	   nerve	  
regeneration	   is	   its	   inherent	   lack	   of	   structural	   cues	   for	   embedded	   cells342	   343.	  
Therefore,	   in	   order	   to	   facilitate	   cell	   entrapment,	   the	   HA	   hydrogel	   required	  
functionalisation	  in	  order	  to	  present	  sufficient	  attachment	  sites	  and	  a	  key	  target	  
of	   the	   project	   was	   the	   identification	   of	   the	   optimum	   biomolecule	   to	  
functionalise	  HA	  by	  providing	  such	  sites	  to	  facilitate	  this.	  As	  outlined	  in	  Chapter	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2,	  both	  Lam	  and	  PDL	  functionalised	  hydrogels	  have	  been	  recognised	  to	  facilitate	  
regeneration	   in	   both	   central	   and	   peripheral	   nerve	   applications	   and	   have	  
demonstrated	   a	   pro	   differentiation	   capacity	   in	   the	   two	   dimensional	   assays	  
described344	   345.	   In	   the	   investigation	   described	   in	   this	   chapter,	   the	   three	   HA	  
hydrogel	  variants	  (HA,	  HA-­‐PDL	  and	  HA-­‐Lam)	  were	  assessed	  first	  in	  terms	  of	  cell	  
viability.	   The	   results	   of	   the	   seven-­‐day	   test	   demonstrated	   a	   statistically	  
significant	   trend	   towards	   improved	  metabolic	   activity	   with	   HA-­‐Lam	   hydrogels	  
when	  compared	  with	  the	  other	  two	  variants.	  Furthermore,	  fluorescence	  images	  
obtained	  demonstrated	  that	  HA-­‐Lam	  hydrogels	  promoted	  better	  cell	  extension	  
than	  HA-­‐PDL	  hydrogels	  or	  non-­‐functionalised	  HA	  hydrogels	  alone.	  
	  
The	   HA-­‐Lam	   luminal	   filler	   was	   also	   found	   to	   support	   changes	   in	   ONS	   cell	  
morphology	   in	   response	   to	  NGF	   treatment.	   The	   addition	   of	  NGF	   to	  ONS	   cells	  
cultured	  on	  HA-­‐Lam	  hydrogels	  promoted	  marked	  phenotypic	  extension	   (Dodla	  
et	  al	  have	  also	  reported	  improved	  functional	  and	  morphologic	  outcomes	  in	  long	  
nerve	  gap	  injuries	  in	  rats	  with	  the	  use	  of	  a	  Lam	  and	  NGF	  functionalised	  agarose	  
hydrogel346).	   In	   HA-­‐Lam	   hydrogels,	   the	   seeded	   ONS	   cells	   were	   observed	   to	  
demonstrate	  developing	  extensions	  whilst	  retaining	  expression	  of	  the	  stem	  cell	  
markers.	   This	   finding	   contrasted	   with	   the	   results	   of	   the	   two-­‐dimensional	  
analysis	   reported	   in	   Chapter	   2,	   and	   re	   affirmed	   the	   fact	   that	   cells	   behave	  
differently	   in	   2D	   culture	   in	   comparison	   to	   a	   third	   dimensional	   hydrogel	  
environment.	  Taken	  together,	  the	  findings	  provided	  a	  strong	  motivation	  for	  the	  
inclusion	  of	  the	  NGF	  enhanced	  HA-­‐Lam	  hydrogel	  within	  the	  proposed	  NGC	  and	  
clearly	   highlighted	   the	   importance	  of	   three	  dimensional	   evaluation	  with	  multi	  
level	  assessment	  prior	  to	  progressing	  to	  in	  vivo	  studies.	  	  
	  	  
Once	   the	   optimum	   individual	   components	   were	   identified,	   the	   outer	   tubular	  
collagen	  conduit	  was	  combined	  with	  HA-­‐Lam	  luminal	  filler	  using	  a	  novel	  freeze-­‐
drying	  technique	  to	  form	  a	  biphasic	  biomimetic	  NGC	  for	  ease	  of	  surgical	  use	  and	  
to	  ensure	  consistency	  and	  uniformity	  of	  the	  biomaterials	  used	  in	  subsequent	  in	  
vivo	  testing.	  This	  process	  produced	  a	  single	  construct	  for	  use	  as	  an	  off	  the	  shelf	  
product	  which	  could	  be	  easily	  stored,	  provided	  a	  standardised,	  uniform	  10mm	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bridge	   for	   insertion	   into	   a	   critical	   nerve	   gap	   in	   vivo,	   and	   enhanced	   the	  
expression	  of	  key	  cytoskeletal	  components.	  	  
	  
The	   establishment	   of	   an	   optimised	  protocol	   for	   the	   delivery	   of	  ONS	   cells	   into	  
the	   functionalised	   HA-­‐Lam	   luminal	   filler	   component	   of	   the	   biphasic	   NGC	   to	  
ensure	  adequate	  spatial	  distribution	  of	  cells,	  cell	  density,	  cell	  extension	  and	  cell	  
migration	  throughout	  was	  an	  important	  issue	  to	  address	  since	  in	  addition	  to	  cell	  
entrapment,	  the	  method	  of	  seeding	  can	  affect	  the	  function	  of	  a	  given	  scaffold.	  
There	   are	   a	   number	   of	   methods,	   which	   may	   be	   used	   to	   seed	   cells	   including	  
active,	   passive	   or	   bioreactor	   based	   seeding347	   348	   349.	   Passive	   seeding	   is	  
advantageous	   since	   it	   does	   not	   subject	   cells	   to	   the	   deleterious	   effects	   of	  
shearing	   forces	  but	   it	   can	   result	   in	   inadequate	  cell	  distribution350.	  Bioreactors,	  
on	  the	  other	  hand,	  can	  use	  centrifugal	  forces	  to	  embed	  cells	  within	  a	  scaffold;	  
they	   can	   be	   time	   consuming	   therefore	   potentially	   can	   lead	   to	   cell	   losses	  
because	   of	   heat	   loss	   during	   the	   transition	   from	   the	   laboratory	   to	   in	   vivo	  
implantation351.	  In	  terms	  of	  hydrogels,	  cells	  can	  also	  be	  seeded	  at	  the	  sol	  stage	  
(a	  sol	  is	  a	  mixture	  in	  which	  two	  phases	  –	  solid,	  liquid	  or	  gas	  form	  of	  a	  substance	  
–	  are	  combined	  at	  the	  nanolevel)	  of	  production	  if	   lyophilisation	  is	  not	  used.	   In	  
this	   study,	   active	   seeding	  by	   injection	  using	   a	   hypodermic	  needle	   and	  passive	  
seeding	   techniques	  whereby	   cells	  were	   pipetted	  onto	   the	   surface	   of	   the	  NGC	  
and	   allowed	   to	   diffuse	   through	   it,	   were	   evaluated.	   Initial	   concerns	   about	   the	  
challenges	   of	   seeding	   the	   NGC	   with	   cells	   were	   assuaged	   with	   results	  
demonstrating	  that	  the	  pore	  size	  of	  the	  HA-­‐Lam	  hydrogel	  facilitated	  the	  passage	  
of	   cells	   whilst	   also	   demonstrating	   that	   cell	   loss	   through	   the	   collagen	   conduit	  
wall	  of	   the	  device	   could	  be	  prevented;	   it	   acted	  as	  a	  protective	  barrier	  against	  
cell	   losses	   to	   the	   external	   environment.	   The	   presence	   of	   dense	   phalloidin	  
staining	  showed	  that	  the	  ONS	  cells	  extended	  through	  the	  hydrogel	  lumen	  of	  the	  
construct	   and	   formed	   connections.	   These	   are	   relevant	   findings	   in	   terms	   of	  
future	   clinical	   applications	   because	   they	   suggest	   that	   using	   ONS	   cells	   with	  
biomolecules	  and	  growth	  factors	  can	  increase	  the	  bioactive	  effects	  of	  the	  basic	  
collagen	  NGC.	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3.6.	  Conclusions	  
	  
This	  study	  has	  demonstrated	  that	  ONS	  cells	  derived	  from	  the	  nasal	  explants	  of	  
young	  donor	  animals	  can	  be	  used	  in	  conjunction	  with	  a	  novel	  biomimetic	  tissue	  
engineered	  biphasic	  NGC	  to	  promote	  neurogenesis	  and	  gliogenesis	  of	  ONS	  cells	  
in	   vitro.	  When	   supplemented	   with	   NGF	   enhanced	   culture	  medium,	   ONS	   cells	  
seeded	  on	  the	  HA-­‐Lam	  hydrogel	  component	  of	  the	  NGC	  demonstrated	  a	  distinct	  
elongated	   morphology	   and	   expressed	   cytoskeletal	   proteins	   which	   was	   not	  
observed	  in	  HA	  or	  HA-­‐PDL	  hydrogels	  
	  
The	  key	  conclusions	  from	  the	  study	  were	  as	  follows:	  
	  
• The	   density	   of	   an	   optimal	   tubular	   collagen	   scaffold	   affects	   both	  
retention	  of	  shape	  and	  the	  viability	  of	  seeded	  ONS	  cells;	  ultimately	  the	  
2.5	   %	   w.v	   variant	   provided	   the	   optimal	   mechanical,	   structural	   and	  
viability	  profile	  
• Functionalising	   HA	   hydrogels	   with	   either	   PDL	   or	   Lam	   promotes	  
expression	  of	   neuro	  differentiation	  markers	   by	  ONS	   and	   cell	   extension	  
but	  Lam	  functionalisation	  promoted	  better	  cell	  extension.	  
• NGF	   supplementation	   promotes	   expression	   of	   neuro	   differentiation	  
markers	  by	  ONS	  cells	  on	  HA-­‐Lam	  hydrogels	  	  
• A	  2.5%	  w.v	  tubular	  collagen	  scaffold	  can	  be	  successfully	  combined	  with	  a	  
HA-­‐Lam	  hydrogel	  to	  produce	  a	  biphasic	  NGC	  
• Active	  seeding	  of	  ONS	  cells	  on	  the	  resultant	  biphasic	  NGC	  facilitates	  cell	  
diffusion	  and	  migration	  	  
• The	  biphasic	  NGC	  produced	  by	   combining	   the	   tubular	   collagen	  conduit	  
and	   HA-­‐Lam	   hydrogel	   facilitated	   luminal	   migration	   of	   ONS	   cells	   and	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Chapter	  4:	  Olfactory	  neuroepithelial	  derived	  stem	  cells	  (ONS	  cells)	  delivered	  in	  
a	   novel	   biomimetic	   biphasic	   nerve	   guidance	   conduit	   (NGC)	   promote	   clinical	  
functional	   and	  morphologic	   neurogenesis	   in	   a	   critical	   sized	   rat	   sciatic	   nerve	  
Injury	  model	  in	  vivo	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4.1.	  Introduction	  	  
	  
Peripheral	   nerve	   injury	   is	   an	   intricate	   and	   life-­‐altering	   problem	  which	   affects	  
millions	  of	  patients	  each	  year	  resulting	  in	  reduced	  quality	  of	  life,	  and	  billions	  of	  
euro	  in	  healthcare	  costs	  and	  lost	  work	  days352	  353.	  Although	  there	  is	  an	  intrinsic	  
healing	  mechanism	  that	  facilitates	  recovery	   in	  minor	   injuries	  (the	  regenerative	  
capacity	  can	  be	  retained	  by	  means	  of	  outsprouting	  from	  growth	  cones),	  in	  large	  
gap	   transection	   injuries	   where	   endoneurial	   tubes	   are	   disrupted,	   nerve	   fibers	  
face	  significant	  obstacles	  in	  re-­‐innervating	  the	  end	  organ	  because	  axons	  are	  no	  
longer	   confined	   to	   their	   original	   sheaths.	   As	   a	   result,	   nerve	   fibers,	   which	   do	  
attempt	   to	   regenerate,	   can	   meander	   into	   the	   surrounding	   tissue	   or	   into	  
inappropriate	   endoneurial	   sheaths,	   resulting	   in	   failure	   of	   innervation	   of	   the	  
correct	  target	  organ	  and	  compromised	  neurological	  outcomes354.	  	  
	  
In	   order	   for	   any	   approach	   to	   large	   gap	   transection	   injury	   to	   be	   successful,	  
efferent	  neurons	  are	  required	  to	  not	  only	  regenerate,	  but	  also	  efficiently	  carry	  
instructions	   from	   the	   central	   nervous	   system	   to	   their	   target	   end	   organ355.	   In	  
clinical	   practice,	   autografting	   is	   the	   current	   accepted	   reference	   standard	   for	  
peripheral	  nerve	  reconstruction.	  The	  use	  of	  autografting,	  however,	  is	  limited	  by	  
donor	   site	   morbidity,	   finite	   sources	   of	   donor	   tissue	   and	   mismatch	   problems	  
such	   as	   axonal	   size	   and	   alignment.	   A	   key	   example	   of	   this	   occurs	   in	   head	   and	  
neck	   surgery	  where	   procedures	   involving	   nerves	   such	   as	   the	   facial	   nerve,	   the	  
recurrent	   laryngeal	   nerve	   or	   the	   accessory	   nerve	   can	   result	   in	   compromised	  
neurological	   function,	   with	   significant	   impact	   on	   the	   patient’s	   post-­‐operative	  
quality	  of	  life.	  	  
	  
Despite	  recent	  advances	  with	  techniques	  in	  microsurgical	  repair,	  the	  prognosis	  
for	   functional	   recovery	   following	   peripheral	   nerve	   injury	   remains	   relatively	  
poor356.	  The	  frequency,	  with	  which	  such	  patients	  require	  treatment	  for	  the	  poor	  
long-­‐term	  outcomes	  typically	  associated	  with	  peripheral	  nerve	  injury,	  highlights	  
the	  need	  for	  the	  identification	  of	  new	  approaches	  in	  peripheral	  nerve	  repair.	  To	  
that	  end,	  tissue	  engineering	  offers	  an	  alternative	  approach	  by	  the	  development	  
	   125	  
of	  biological	   substitutes,	  which	  combine	  biological	   scaffolds	   seeded	  with	   stem	  
cells	  or	  mitogens	  to	  enhance	  peripheral	  nerve	  regeneration.	  Cell	  transplantation	  
within	  scaffolds	  has	  been	  shown	  to	  facilitate	  peripheral	  nerve	  regeneration.	  The	  
precise	  mechanism	  by	  which	  stem	  cells	  impart	  their	  neurogenic	  potential	  is	  not	  
yet	   well	   understood;	   Oliviera	   et	   al	   have	   hypothesized	   that	   the	   use	   of	  
undifferentiated	  stem	  cells	  promotes	  neurogenesis	  by	  the	  production	  of	  growth	  
factors,	   whilst	   others	   have	   suggested	   that	  multipotent	   cells	   differentiate	   into	  
neural	   or	   supporting	   cells	   that	   promote	   intrinsic	   outsprouting	   of	   axons	   from	  
growth	  cones357.	  Increasingly,	  there	  is	  evidence	  in	  the	  literature	  supporting	  the	  
use	   of	   biological	   scaffolds	   seeded	   with	   stem	   cells	   or	   mitogens	   to	   enhance	  
peripheral	  nerve	  regeneration.	  
	  
The	   present	   study	   has	   investigated	   a	   cell	   and	   biomaterial	   based	   therapeutic	  
approach	   to	   peripheral	   nerve	   regeneration	   using	   olfactory	   derived	   stem	   cells	  
(ONS	  cells),	  delivered	  by	  means	  of	  a	  purpose-­‐designed	  collagen-­‐hyaluronic	  acid	  
(HA)	  biomimetic	  biphasic	  nerve	  guidance	  conduit	  (NGC).	  As	  outlined	  in	  Chapter	  
2,	  ONS	  cells	  represent	  a	  desirable,	  source	  of	  progenitor	  cell,	  particularly	   in	  the	  
context	   of	   the	   peripheral	   nerve	   model	   for	   two	   reasons.	   First	   the	   harvesting	  
process	  has	  a	  low	  morbidity	  profile,	  and	  second,	  ONS	  cells	  demonstrate	  better	  
clonogenicity,	   higher	   proliferation	   rates	   and	   a	   more	   natural	   inclination	   for	  
differentiation	  towards	  neural	  and	  glial	  lineage	  than	  other	  neural	  derived	  stem	  
cells.	   In	   terms	   of	   the	   biomaterials	   used,	   Chapter	   3	   of	   this	   thesis	   has	  
demonstrated	   that	   ONS	   cells	   cultured	   in	   the	   purpose-­‐designed	   biomimetic	  
biphasic	   NGC	   represent	   a	   feasible	   option	   for	   nerve	   regeneration	   in	   vitro.	  
Enhanced	  outcomes	  were	  demonstrated	  in	  vitro	  when	  ONS	  cells	  were	  cultured	  
with	  NGF	  in	  a	   laminin	  (Lam)	  functionalised	  HA	  hydrogel	  (HA-­‐Lam)	  luminal	  core	  
of	   the	   NGC.	   For	   this	   reason,	   the	   potential	   of	   NGF	   to	   enhance	   the	   in	   vivo	  
outcomes	  was	  also	  investigated.	  Whilst	  the	   in	  vitro	  analyses	  provided	  essential	  
information	  on	  the	  neuro	  regenerative	  capacity	  of	  the	  ONS	  cells	  and	  identified	  
the	  optimal	  biomaterial	  composition	  with	  which	  to	  deliver	   them,	  a	  pre-­‐clinical	  
animal	   pilot	   study	   was	   required	   to	   investigate	   the	   safety	   and	   efficacy	   of	   the	  
proposed	  system.	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Pre-­‐clinical	  animal	  studies	  are	  an	  essential	  prerequisite	   to	   the	   implementation	  
of	   tissue-­‐engineered	   therapies	   in	   clinical	   practice.	   In	   peripheral	   nerve	  
regeneration	  studies,	  the	  rat	  sciatic	  nerve	  is	  a	  frequently	  used	  model	  because	  of	  
its	  structural	  similarities	  to	  human	  nervous	  tissue358	  359.	  The	  sciatic	  nerve	  in	  the	  
rat	   is	  a	  major	  mixed	  function	  nerve,	  which	  arises	   from	  the	   lumbosacral	   region	  
and	  travels	  in	  the	  posterior	  compartment	  of	  the	  hind	  limb	  behind	  the	  adductor	  
muscles	  to	  supply	  motor	  efferent	   instructions	  to	  the	  muscles	  of	  the	  lower	  half	  
of	  the	  hind	  limb,	  and	  sensory	  afferent	  supply	  to	  the	  skin	  over	  the	  lower	  leg	  and	  
sole	  of	   the	   foot360.	   At	   the	  mid-­‐thigh	   level	   in	   the	   adult	   rat,	   the	   sciatic	   nerve	   is	  
comparable	   in	   diameter	   to	   the	   intrinsic	   nerves	   of	   the	   human	   hand	   or	   the	  
recurrent	  laryngeal	  nerve	  in	  the	  neck361.	  
	  
Further	  to	  species	  and	  strain	  selection,	  the	  age	  of	  animals	  selected	  for	  use	  in	  the	  
in	  vivo	  study	  was	  an	  important	  factor	  to	  consider	  in	  the	  study	  design362.	  Studies	  
have	  shown	  that	  motor	  neuron	  ablation	  in	  neonatal	  rats	  can	  lead	  to	  premature	  
death	   but	   on	   reaching	   maturity,	   rats	   demonstrate	   elevated	   rates	   of	   growth	  
cone	  outsprouting	  following	  axonotmesis	  and	  neurotemesis	  compared	  to	  higher	  
order	  animals363	  364	  365.	  As	  a	  result,	  8-­‐week-­‐old	  rats	  were	  selected	  for	  use	  in	  the	  
in	  vivo	  study	  over	  an	  8-­‐week	  time	  frame.	  Following	  selection	  of	  species,	  strain,	  
age	   of	   the	   model	   and	   study	   duration,	   the	   next	   variable	   to	   consider	   was	   the	  
positive	   control.	   The	   current	   reference	   standard	   treatment	   for	   the	  
reconstruction	   of	   large	   gap	   peripheral	   nerve	   defects	   is	   the	   autologous	   nerve	  
graft.	   Therefore	   many	   groups	   use	   this	   as	   the	   positive	   control	   for	   pre-­‐clinical	  
animal	   studies	   evaluating	   engineering	   approaches	   to	   peripheral	   nerve	  
regeneration.	   In	   the	  approach	  used	   in	   this	   study,	   the	   intact	   contralateral	  non-­‐
operated	   side	   of	   each	   animal	   served	   as	   the	   positive	   control.	   This	   was	   to	  
facilitate	  a	  more	  comprehensive	  assessment	  of	  the	  true	  value	  of	  the	  functional,	  
electrophysiological	  and	  histomorphometric	  outcomes	  following	  intervention.	  	  
	  
Assessment	  methods	  in	  rats	  are	  notoriously	  challenging	  to	  interpret	  and	  to	  date	  
there	   has	   been	   no	   clear	   consensus	   as	   to	   which	   method	   provides	   the	   most	  
reliable	   information366	   367.	   As	   a	   result,	   in	   formulating	   the	   hypothesis	   for	   this	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study,	   careful	   consideration	   was	   given	   to	   the	   various	   available	   methods	   for	  
testing	   regeneration.	   The	   study	   design	   incorporated	   multiple	   assessment	  
methods	   to	   maximise	   the	   use	   of	   each	   animal.	   Histological	   analysis	   is	   a	   well-­‐
accepted	  method	  of	  qualitative	  and	  quantitative	  morphological	  assessment	  and	  
analysis	  of	  axonal	  marker	  stained	  images	  is	  probably	  the	  most	  frequent	  means	  
of	  assessing	  peripheral	  nerve	   regeneration	   in	   terms	  of	  axonal	  number,	   calibre	  
and	   alignment368.	   In	   this	   study,	   in	   order	   to	   practically	   evaluate	   the	   degree	   of	  
clinical	   and	   functional	   recovery	   associated	  with	   axonal	   regrowth,	   assessments	  
such	   as,	   Sciatic	   Function	   Index	   (SFI)369,	   nocioceptive	   withdrawal	   reflex,	  
electrophysiological	   assessment	   of	   conductivity	   and	   gross	   motor	   force	   and	  
gastrocnemius	  muscle	  weight	  were	  also	  utilised.	  	  
	  
The	   central	   hypothesis	   of	   this	   thesis	   was	   that	   ONS	   cells	   could	   be	   used	   to	  
promote	  peripheral	  nerve	  regeneration	  in	  a	  critical	  sized	  defect	  in	  rats.	  To	  that	  
end,	  the	  in	  vivo	  study	  design	  incorporated	  two	  core	  phases.	  The	  first	  phase	  was	  
the	   establishment	   of	   a	   baseline	   defect	   of	   a	   length	   above	  which	   spontaneous	  
regeneration	   of	   a	   tissue	   would	   not	   occur370.	   In	   the	   rodent	   sciatic	   nerve,	   the	  
critical	  defect	  size	  has	  been	  the	  subject	  of	  considerable	  debate	  as	   researchers	  
attempt	  to	  regenerate	  nerve	  tissue	  across	  increasingly	  greater	  gap	  lengths371	  372	  
373.	   A	   number	   of	   authors	   have	   reported	   that	   spontaneous	   regeneration	   of	  
peripheral	   nerve	   defects	   will	   occur	   in	   gaps	   below	   5	   mm,	   but	   not	   if	   the	   gap	  
exceeds	  5	  mm	  in	  transection	  injuries.	  This	  can	  lead	  to	  a	  greater	  than	  anticipated	  
gap	   size	   because	   of	   retraction	   of	   nerve	   end	   stumps	   due	   to	   the	   effects	   of	  
myoelastic	   recoil374	   375	   376.	   Therefore	   in	   this	   study	   a	   critical	   gap	  of	   10mm	  was	  
evaluated.	  The	  second	  element	  of	  the	  study	  was	  the	  evaluation	  of	  the	  impact	  of	  
treatment	   with	   ONS	   cell	   seeded	   NGCs	   with	   and	   without	   NGF	   compared	   to	  
treatment	  with	   the	  NGC	  alone.	  Although	  establishment	  of	   the	  baseline	  critical	  
defect	   in	   peripheral	   nerve	   regeneration	   models	   was	   clearly	   important,	   the	  
bigger	  scientific	  question	   for	   this	   study	  was	  how	  the	  ONS	  cells	  might	  enhance	  
regeneration	   in	  vivo.	  There	  are	  a	  number	  of	  possible	  mechanisms	   for	   this	  and	  
although	  the	  exact	  means	  by	  which	  stem	  cells	   infer	  their	  neurogenic	  potential	  
are	   not	   yet	   well	   understood	   the	   results	   of	   recent	   studies	   suggest	   that	   their	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inclusion	   in	   tissue	   engineered	   approaches	   to	   peripheral	   nerve	   regeneration	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4.2.	  Study	  aims	  and	  objectives	  	  
	  
The	   principal	   aim	  of	   this	   study	  was	   to	   critically	   evaluate	   the	   capacity	   of	   stem	  
cells	   derived	   from	   the	   olfactory	   neuroepithelium	   (ONS	   cells),	  when	   combined	  
with	   the	   biomimetic	   biphasic	   NGC	   described	   in	   Chapter	   3,	   to	   promote	  
peripheral	  nerve	   regeneration	   following	  a	   critical	  gap	   transection	   injury	   in	   the	  
rat	   sciatic	   nerve.	   	   In	   addition,	   the	   ability	   of	   NGF	   to	   enhance	   ONS	   mediated	  
healing	   was	   evaluated.	   Particular	   emphasis	   was	   placed	   on	   morphologic	  
indicators	   of	   recovery	   including	   axonal	   number,	   axonal	   diameter	   and	   axonal	  
alignment	   since	   these	   parameters	   play	   a	   vital	   role	   in	   electrophysiological	   and	  
functional	  recovery.	  
	  
The	  specific	  goals	  were	  to:	  
	  
• Evaluate	  the	  degree	  of	  clinical	  recovery	  achieved	  following	  implantation	  
of	   ONS	   cells	   alone	   or	   in	   combination	   with	   NGF	   within	   a	   biomimetic	  
biphasic	  NGC	  in	  comparison	  to	  the	  degree	  of	  clinical	  recovery	  found	  with	  
the	  NGC	  alone.	  
• Evaluate	   the	   degree	   of	   functional	   and	   electrophysiological	   recovery	  
achieved	   following	   implantation	   of	   ONS	   cells	   alone	   or	   in	   combination	  
with	  NGF	  within	  a	  biomimetic	  biphasic	  NGC	  in	  comparison	  to	  the	  degree	  
of	   functional	   and	   electrophysiological	   recovery	   found	   with	   the	   NGC	  
alone.	  
• Evaluate	   the	   degree	   of	   morphological	   recovery	   achieved	   following	  
implantation	   of	   ONS	   cells	   alone	   or	   in	   combination	   with	   NGF	   within	   a	  
biomimetic	  biphasic	  NGC	  in	  comparison	  to	  the	  degree	  of	  functional	  and	  
electrophysiological	   recovery	   found	   with	   the	   NGC	   alone	   in	   terms	   of	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4.3.	  Methods	  and	  materials	  	  
	  
Prior	  to	  study	  commencement,	  approval	  was	  obtained	  from	  the	  Royal	  College	  of	  
Surgeons	   in	   Ireland	   Research	   Ethics	   Committee	   (REC000-­‐754).	   Appropriate	  
project	   licenses	   from	  the	  Department	  of	  Health	  and	  permits	   for	   the	   import	  of	  
animals	   (from	  Harlan	  UK)	   from	   the	  Department	  of	  Agriculture	  were	  obtained.	  
All	  animals	  were	  maintained	  in	  the	  existing	  Biomedical	  Research	  Facilities	  (BRF)	  
at	   the	   Royal	   College	   of	   Surgeons	   in	   Ireland	   in	   accordance	   with	   the	   research	  
license	  from	  the	  Department	  of	  Health.	  
	  
4.3.1.	   Preparation	   of	   ONS	   cells	   and	   NGCs	   for	   implantation	   within	   a	   critical	  
sciatic	  defect	  
	  
Multipotent	  ONS	  stem	  cells	  with	  the	  potential	  to	  differentiate	  along	  neural	  and	  
glial	   lineage	  were	  harvested	   and	   cultured	   from	  explants	   taken	   from	   the	  nasal	  
cavities	   of	   6-­‐week-­‐old	   Sprague	  Dawley	   rats.	   	   These	   cells	  were	   combined	  with	  
the	  NGC	  comprising	  of	  a	  2.5	  %	  w.v	  bovine	  fibrillar	  collagen	  type	  1	  (Integra®	  Life	  
Sciences,	   Plainsboro,	   NJ)	   with	   a	   biologically	   active	   HA-­‐Lam	   luminal	   filler	  
(described	   in	  Chapter	   3)	   prior	   to	  delivery	  within	   a	   critically	   sized	   sciatic	   nerve	  
gap	   in	  vivo.	  NGCs	  were	  12	  mm	   long	  with	  a	  1mm	  cuff	  at	  each	  end	  to	   facilitate	  
perineurial	   suturing.	   Prior	   to	   implantation,	   5	   x	   105	   ONS	   cells	   at	   passage	   3	   in	  
DMEM/F12/FBS/PS	   were	   collected	   in	   20	   µl	   per	   NGC.	   Where	   NGF	   was	   used,	  
50ng/ml	   NGF	   was	   combined	   with	   the	   cell	   solute	   prior	   to	   seeding	   within	   the	  
NGC.	  
	  
4.3.2.	  Animal	  model	  and	  surgical	  procedure	  
	  
The	   design	   of	   the	   in	   vivo	   study	   incorporated	   one	   negative	   control	   group	   and	  
three	  experimental	   treatment	  groups,	   (i)	  NGC	  alone,	   (ii)	  ONS	  cell	   seeded	  NGC	  
(NGC	  &	  ONS),	  and	  (iii)	  NGF	  enhanced	  ONS	  cell	  seeded	  NGC	  (NGC,	  ONS	  &	  NGF).	  A	  
total	  of	  thirty-­‐six	  animals	  were	  required	  for	  the	  study	  with	  sample	  size	  analysis	  
using	   the	  Wilcox	  Mann	  Whitney	   test	  performed	  prior	   to	  application	   for	  ethics	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approval	  and	  licensing.	  The	  use	  of	  seven	  animals	  per	  experimental	  group	  gave	  a	  
power	   of	   95	  %,	   p	   value	   <	   0.05	   and	   confidence	   interval	   95	  %.	   To	   account	   for	  
potential	  losses	  in	  the	  perioperative	  phase	  of	  the	  surgery,	  it	  was	  decided	  to	  use	  
a	  total	  of	  nine	  (seven	  with	  an	  additional	  two	  per	  group)	  animals	  per	  treatment	  
group.	   	  An	  additional	  fifteen	  6-­‐week	  old	  rats	  of	  the	  same	  strain	  were	  required	  
for	   the	  purpose	  of	  harvesting	   the	  olfactory	  mucosal	  explants	   to	  generate	  ONS	  
cells	  for	  the	  study	  (this	  has	  been	  previously	  described	  in	  Chapter	  2).	  To	  confirm	  
the	  size	  of	   the	  critical	  defect,	  a	  10	  mm	   interstump	  defect	  of	   sciatic	  nerve	  was	  
created	  in	  negative	  control	  animals.	  In	  order	  to	  confirm	  the	  lack	  of	  spontaneous	  
regeneration	   through	   the	   critical	   defect	   selected,	   the	   negative	   control	   group	  
was	   maintained	   on	   study	   for	   an	   extended	   period	   of	   time	   (16	   weeks)	   whilst	  
experimental	  treatment	  groups	  were	  maintained	  on	  study	  for	  8	  weeks.	  
	  
All	   surgeries	  were	  performed	  using	   the	   same	   standard	  aseptic	   technique.	   The	  
surgical	   intervention	  was	  classified	  as	  clean.	  Therefore	  perioperative	  antibiotic	  
cover	   was	   not	   required.	   Animals	   were	   weighed,	   cleaned	   with	   chlorhexidine	  
antiseptic	   solution,	   and	   shaved	   at	   the	   incision	   site.	   Total	   anesthesia	   was	  
achieved	   with	   5	   %	   isofluorane	   in	   oxygen	   within	   a	   sealed	   induction	   chamber.	  
Once	   total	   anesthesia	  was	   confirmed	   by	   absent	   righting	   reflex	   and	   tail	   pinch,	  
animals	  were	  transferred	  to	  the	  operative	  area	  and	  maintenance	  of	  anesthesia	  
was	  achieved	  by	  administration	  of	  2	  –	  3	  %	  isofluorane	  via	  a	  sealed	  dual	   lumen	  
facemask	  with	  scavenging	  system.	  Procedures	  were	  performed	  on	  a	  heated	  mat	  
to	   maintain	   core	   body	   temperature	   at	   all	   times.	   Respiratory	   rate	   and	  
temperature	  were	  monitored	   at	   5-­‐minute	   intervals	   throughout	   the	  procedure	  
(with	   assistance	   from	   Dr	   Amos	   Matsiko	   RCSI)	   and	   during	   the	   postoperative	  
recovery	  period	  (with	  assistance	  from	  Dr	  Tijna	  Alekseeva	  RCSI).	  	  
	  
Once	  each	  animal	  was	  cleaned	  and	  appropriately	  draped,	  the	  right	  sciatic	  nerve	  
was	   approached	   via	   a	   posterior	   skin	   incision	   over	   the	   sciatic	   notch	   and	   a	  
posterior	  compartment	  muscle	  splitting	  technique.	  Impeccable	  hemostasis	  was	  
maintained	   at	   all	   time.	   The	   sciatic	   nerve	  was	   identified	   using	   a	   Zeiss®	   optical	  
microscope	   loaned	   by	   the	   Royal	   Victoria	   Eye	   and	   Ear	   Hospital,	   Dublin,	   and	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confirmed	  with	  a	  2mA	  disposable	  nerve	  stimulator	  set	  at	  0.5mA	  (donated	  by	  the	  
Department	   of	   Otolaryngology,	   Head	   &	   Neck	   Surgery	   at	   Beaumont	   Hospital,	  
Dublin).	  Once	  the	  sciatic	  nerve	  was	  identified	  and	  its	  conductivity	  confirmed,	  a	  
10	  mm	  critical	  interstump	  defect	  was	  created	  by	  sharp	  dissection	  with	  removal	  
of	   the	   segment	   of	   sciatic	   nerve.	   Muscle	   opposition	   was	   achieved	   with	   two	  
loosely	  placed	  interrupted	  vicryl	  4.0	  sutures	  and	  the	  skin	  was	  closed	  with	  three	  
to	   four	   interrupted	   4.0	   vicryl	   rapide	   sutures	   with	   derma	   bond	   tissue	   glue	   to	  
reinforce	   the	   wound.	   In	   the	   non-­‐interventional	   negative	   control	   group,	   this	  
marked	   the	   end	   of	   the	   procedure	   and	   the	   wound	   was	   closed,	   animals	   were	  
recovered	  and	  monitored	  as	  described	  in	  section	  4.3.3.	  	  	  
	  
In	   experimental	   treatment	   group	   animals,	   the	   critical	   gap	   in	   the	   sciatic	   nerve	  
was	  bridged	  with	  the	  NGC	  with	  or	  without	  NGF	  and	  ONS	  cells.	  The	  1mm	  cuff	  of	  
the	  external	  collagen	  conduit	  component	  of	  the	  NGC	  was	  fixed	  proximally	  and	  
distally	  to	  the	  perineurium	  of	  the	  nerve	  stumps	  with	  6-­‐0-­‐prolene	  sutures	  before	  
muscle	  opposition	  and	  skin	  closure	  as	  outlined	  above.	  9	  animals	  were	   treated	  
with	  the	  NGC	  alone,	  9	  animals	  were	  treated	  with	  the	  NGC	  &	  ONS	  (5	  x	  105	  ONS	  
cells	  at	  passage	  3	   in	  DMEM/F12/FBS/PS	  were	   seeded	  per	  NGC	  via	  a	  24	  gauge	  
needle	  -­‐	  see	  Chapter	  3	  Methods	  Section	  3.3.3),	  and	  9	  animals	  were	  treated	  with	  
the	  ONS	  cell	  seeded	  NGC	  to	  which	  50ng	  recombinant	  rat	  NGF	  was	  added	  (NGC,	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Figure	   4.1:	   	   Schematic	   representation	   of	   In	   vivo	   experimental	   design.	   A	   non-­‐
interventional	  negative	  control	  group	  of	  9	  animals	  was	  used	  to	  establish	  the	  size	  
of	  the	  critical	  defect	  prior	  to	  evaluating	  three	  experimental	  treatment	  groups	  	  
	  
4.3.3.	  Peri-­‐operative	  management	  
	  
Following	   closure,	   the	  wound	  was	   cleaned	  and	  dried.	  A	   local	   anesthetic	  block	  
using	  0.25	  %	  lignocaine	  was	  given	  before	  reversing	  the	  anesthetic	  and	  reviving	  
the	   animal.	   During	   the	   recovery	   period,	   animals	   were	   placed	   in	   a	   warmed	  
incubator	   within	   easy	   reach	   of	   softened	   food	   and	   water	   where	   they	   were	  
monitored	   closely	   for	   signs	   of	   stress	   or	   discomfort.	   Once	   the	   operative	  
procedure	  was	  complete,	  animals	  were	  monitored	  daily	  for	  signs	  of	  stress,	  pain	  
or	   wound	   infection.	   Particular	   attention	   was	   paid	   to	   levels	   of	   activity,	   food	  
consumption,	   weight	   gain,	   social	   interaction	   or	   aggression,	   and	   for	   physical	  
signs	   such	   as	   mobility,	   lack	   of	   grooming,	   piloerection,	   coat	   condition	   and	  
temperature	   changes.	   Additional	   analgesia	   was	   given	   as	   required.	   Animals	  
deemed	  to	  be	  suffering	  above	  the	  predicted	  discomfort	  banding	  were	  discussed	  
with	   the	  named	  veterinary	   surgeon	  and	  appropriate	   interventions	  were	   taken	  
as	  needed.	  Where	  ulceration	  or	  marked	  self-­‐mutilation	  by	  autophagy	  occurred,	  
a	   protocol	   of	   daily	  washing	  with	   chlorhexidine,	   application	   of	   local	   anesthetic	  
cream	   and	   maintenance	   of	   dry	   bedding	   was	   followed	   to	   prevent	   the	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development	   of	   secondary	   soft	   tissue	   infections	   such	   as	   cellulitis	   or	  
osteomyelitis.	  
	  
4.3.4.	  Evaluation	  of	  clinical,	  functional,	  electrophysiological	  and	  morphological	  
indicators	  of	  peripheral	  nerve	  regeneration	  following	  intervention	  
	  
Following	   the	   experimental	   procedure	   described,	   animals	   were	   compared	   in	  
terms	  of	  clinical,	  functional,	  electrophysiological	  and	  morphological	  recovery	  in	  
groups	   classified	   by	   intervention.	   A	   schematic	   representation	   of	   the	  
assessments	   performed	   is	   provided	   in	   Figure	   4.2	   and	   details	   of	   the	  methods	  
used	  are	  presented	  below.	  	  
Figure	   4.2:	   Schematic	   representation	   of	   endpoint	   outcomes	   including	   clinical,	  
functional,	  electrophysiological	  and	  morphologic	  evaluation	  
	  
4.3.4.1.	   Evaluation	   of	   clinical	   and	   functional	   indicators	   of	   peripheral	   nerve	  
regeneration	  following	  intervention	  
	  
Clinical	   signs	   of	   sciatic	   nerve	   injury	   including	   muscle	   atrophy,	   contracture	  
formation,	  presence	  of	  ulceration	  and	  self-­‐mutilation	  were	  recorded	  at	  week	  6	  
and	  week	  8	  post	   intervention.	  Animals	  were	  weighed	  and	  photographed	  on	  a	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clear	  plexi	  glass	  surface	  to	  allow	  evaluation	  of	  the	  condition	  of	  the	  sole	  of	  the	  
hind	   limb.	   Muscle	   atrophy	   was	   recorded	   if	   there	   was	   a	   clinically	   evident	  
decrease	  in	  the	  mass	  of	  the	  hind	  limb	  due	  to	  partial	  or	  complete	  wasting	  away	  
of	   the	   muscle.	   Contractures	   were	   recorded	   if	   there	   was	   clinical	   evidence	   of	  
abnormal	  persistent	  flexing	  of	  the	  hind	  limb	  muscles	  at	  the	  joints.	  Ulcers	  were	  
recorded	  where	  there	  was	  evidence	  of	  areas	  of	  circumscribed	  inflammatory	  or	  
suppurated	  regions	  of	  the	  skin	  of	  the	  plantar	  surface	  of	  the	  foot	  with	  resulting	  
necrosis.	   Autophagia,	   or	   self-­‐mutilation	   was	   documented	   if	   the	   animal	   had	  
chewed	  the	  toes	  resulting	  in	  partial	  or	  total	  amputation.	  
	  
Further	   to	   clinical	   observations,	   the	   presence	   of	   sensation	   was	   evaluated	   by	  
means	   of	   the	   nocioceptive	  withdrawal	   reflex	   (locomotion	   requires	   a	   dynamic	  
interaction	  between	  afferent	  sensory	  inputs	  and	  efferent	  spinal	  motor	  outputs	  
and	  evaluation	  of	  the	  sensory	  component	  of	  the	  sciatic	  nerve	  has	  been	  shown	  
to	  provide	  useful	   information	   in	  peripheral	  nerve	  regeneration	  studies379).	  The	  
reflex	  was	   evaluated	   by	   stimulating	   the	   lateral	   plantar	   surface	   of	   the	   footpad	  
using	   a	   sterile	   24-­‐gauge	   hypodermic	   needle	   (demonstrated	   in	   the	   schematic	  
presented	  in	  Figure	  4.3).	  Two	  members	  of	  the	  TERG	  team	  (Dr.	  Phoebe	  Roche	  &	  
Dr.	  Tijna	  Alekseeva),	  to	  ensure	  comparable	  results	  without	  noted	  inter-­‐observer	  
differences,	  recorded	  the	  withdrawal	  or	  vocalisation	  responses	  of	  the	  animals.	  	  
	  
	  
Figure	   4.3.	   Schematic	   representation	   of	   the	   evaluation	   of	   the	   nociceptive	  
withdrawal	  reflex	  (image	  modified	  from	  source:	  http://david-­‐bender.co.uk)380	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Next	   as	   part	   of	   the	   clinical	   assessment	   of	   recovery,	   animals	   without	   the	  
presence	   of	   autophagy	   (N=7)	   were	   compared	   in	   groups	   classified	   by	  
intervention	  in	  terms	  of	  static	  variant	  sciatic	  function	  index	  (SFI)	  as	  described	  by	  
Baptista	   at	   al381.	   Each	   animal	   was	   placed	   on	   a	   clear	   plexi	   glass	   surface	   and	  
distances	  between	  the	  points	  of	  maximum	  contact	  were	  measured	  as	  illustrated	  
in	   Figure	   4.4.	   	   Static	   SFI	   was	   calculated	   using	   the	   following	   formula:	  
SFI=118.9(TSF)	  –	  51.2(PLF)	  –	  7.5.	  Toe	  spread	  factor	  (TSF)	  and	  paw	  length	  factor	  
(PLF)	   of	   the	   operated	   limb	   was	   calculated	   with	   the	   formula	   (injured	   –	  




Figure	   4.4	   Diagram	   demonstrating	   the	   assessment	   parameters	   of	   the	   static	  
variant	  SFI	   (image	  source:	  Reis	  et	  al)382.	   ITS:	  distance	  between	   the	  second	  and	  
fourth	  toe;	  TS:	  spread	  between	  first	  and	  fifth	  toe	  and	  PL:	  paw	  length.	  The	  SFI	  is	  
calculated	   by	   the	   formula	   SFI=118.9(TSF)	   –	   51.2(PLF)	   –	   7.5.	   A:	   represents	   a	  
normal	  rat	  paw	  print.	  B:	  represents	  a	  denervated	  paw	  print	  
	  
4.3.4.2.	   Evaluation	   of	   electrophysiological	   indicators	   of	   peripheral	   nerve	  
regeneration	  following	  intervention	  
	  
Electrophysiological	  evaluation	  of	  peripheral	  nerve	  regeneration	  was	  performed	  
by	   means	   of	   compound	   muscle	   action	   potential	   (CMAP)	   measurement	   and	  
gross	  peak	  tensile	  and	  compressive	  force	  analysis	  in	  response	  to	  the	  application	  
of	  direct	  electrical	  stimulation	  to	  the	  treated	  nerve.	  At	  8	  weeks	  for	  experimental	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treatment	  groups,	  animals	  were	  placed	  under	  a	  second	  general	  anesthetic	  using	  
inhalation	   induction	   and	  maintenance	  with	   isofluorane	   (see	   Section	   4.3.1).	   As	  
outlined	  in	  Section	  4.3.3,	  animals	  in	  the	  negative	  control	  group	  were	  maintained	  
on	   study	   for	   an	   extended	   period	   of	   time	   to	   confirm	   the	   lack	   of	   spontaneous	  
regeneration	  across	  the	  critical	  defect.	  At	  second	  surgery,	  the	  sciatic	  nerve	  was	  
exposed	   in	   both	   the	   operated	   limb	   and	   the	   contralateral	   non-­‐operated	   limb.	  
CMAP	  evaluation	  was	  performed	  using	  a	  Neurosign	  100®	  two-­‐channel	  surgical	  
nerve	   monitor.	   The	   20mm	   needle	   receptor	   probes	   were	   inserted	   into	   the	  
medial	  and	  lateral	  belly	  of	  the	  gastrocnemius	  muscle	  of	  both	  the	  operated	  and	  
non-­‐operated	   limb	   with	   ground	   probes	   inserted	   into	   both	   sides	   of	   the	  
paramedian	  muscles	  of	  the	  spine	  as	  shown	  in	  Figure	  4.5.	  
	  
Figure	  4.5:	  Placement	  of	  the	  needle	  receptor	  probes	  into	  the	  medial	  and	  lateral	  
bellies	   of	   the	   gastrocnemius	   muscle	   of	   the	   right	   hind	   limb	   is	   shown.	   The	  
biomimetic	   biphasic	   NGC	   can	   be	   seen	   (blue	   dashed	   line)	   with	   intact	   prolene	  
sutures	   (yellow	   arrows)	   fixing	   the	   cuff	   of	   the	   tubular	   collagen	   conduit	  
component	  of	  the	  NGC	  to	  the	  perineurium	  of	  proximal	  and	  distal	  stumps	  of	  the	  
severed	  sciatic	  nerve	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A	   0.5mA	   electrical	   stimulus	   was	   passed	   from	   the	   stimulator	   probe	   of	   the	  
Neurosign	   100®	   first	   through	   the	   contralateral	   non-­‐operated	   sciatic	   nerve	   to	  
establish	  a	  baseline	  CMAP	  value	  for	  the	  normal	  functioning	  non-­‐operated	  sciatic	  
nerve	   of	   each	   animal.	   Once	   the	   baseline	   value	   was	   established,	   the	   same	  
current	  was	  passed	  through	  the	   interventional	  sciatic	  nerve	  from	  the	  proximal	  
stump,	   through	   the	  device	   to	   the	  muscle	   innervated	  by	   the	  distal	   segment	   to	  
evaluate	  the	  CMAP	  on	  that	  side.	  For	  each	  of	  these	  "conduction	  tests"	  both	  the	  
non-­‐operated	   and	   the	   treated	   nerve	   was	   stimulated	   three	   times	   with	   the	  
stimulator	   probe	   and	   the	   best	  measurement	   documented	   in	  mA.	   Because	   all	  
animals	  weights,	  size,	  nerve	  diameter	  and	  best	  non-­‐operated	  nerve	  conductivity	  
differed,	  the	  CMAP	  results	  of	  the	  treated	  nerve	  were	  reported	  as	  a	  percentage	  
of	   the	   value	   obtained	   from	   the	   animals	   contralateral	   non-­‐operated	   nerve.	  
Statistical	  analysis	  was	  performed	  on	  the	  percentages	  achieved.	  
	  
Following	   evaluation	   of	   CMAPs,	   assessment	   of	   the	   gross	   force	   generated	   in	  
response	   to	   the	   applied	   electrical	   stimulus	   was	   performed.	   Attaching	   a	   10	   N	  
digital	  push	  pull	  force	  gauge	  (accuracy	  +/-­‐	  0.1N)	  to	  the	  pad	  of	  each	  foot	  with	  a	  
2.0	   silk	   braided	   suture	   during	   nerve	   stimulation	   enabled	   the	   assessment	   of	  
maximum	  peak	  tensile	  and	  peak	  compressive	  gross	  mechanical	  force	  generated	  
by	   the	  hind	   limb	  movement	   in	   response	   to	   the	   stimulus	   along	   a	   standardised	  
anterior-­‐posterior	   vector.	   Once	   the	   force	   gauge	   was	   sutured	   to	   the	   foot,	   a	  
0.5mA	  stimulus	  was	  applied	  to	  the	  segment	  of	  nerve	  proximal	  to	  the	  implanted	  
NGC.	  Again	   size	   shape	  and	  weight	  differences	  meant	   vectors	   and	   forces	  were	  
slightly	  different	  for	  each	  experimental	  animal	  so	  a	  percentage	  of	  the	  value	  of	  
the	  non-­‐operated	   limb	  was	   calculated,	   allowing	  each	  animal	   to	  act	   as	   its	  own	  
positive	  control.	  	  On	  completion	  of	  the	  electrophysiological	  assessments,	  whilst	  
under	  the	  second	  anaesthesia,	  both	  the	  non-­‐operated	  and	  treated	  sciatic	  nerve	  
(including	  the	  implanted	  NGC)	  were	  removed	  and	  placed	  directly	  into	  formalin	  
for	   morphologic	   evaluation.	   Animals	   were	   then	   euthanised	   by	   cervical	  
dislocation	   and	   decapitation	   under	   deep	   anaesthesia	   in	   accordance	   with	   the	  
project	  approval	  granted	  by	   the	  Research	  Ethics	  Committee	  at	  RCSI	   (REC	  000-­‐
754).	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4.3.4.3.	   Evaluation	   of	   gastrocnemius	   muscle	   weight	   as	   an	   indicator	   of	  
peripheral	  nerve	  regeneration	  following	  intervention	  
	  
Following	   euthanasia,	   an	   evaluation	   of	   gastrocnemius	   muscle	   weight	   as	   an	  
indicator	   of	   peripheral	   nerve	   regeneration	   following	   intervention	   was	  
performed.	   To	   account	   for	  weight	   differences	   between	   the	   hind	   limb	  of	   each	  
experimental	   animal,	   a	   ratio	   of	   the	   wet	   weight	   of	   the	   medial	   and	   lateral	  
gastrocnemius	  on	  the	  operated	  side	  versus	  contralateral	  non-­‐operated	  side	  was	  
estimated.	  The	  upper	  insertion	  of	  both	  bellies	  of	  the	  gastrocnemius	  muscle	  was	  
carefully	   dissected	   on	   both	   the	   operated	   and	   non-­‐operated	   limb.	   Next,	   the	  
lower	   limbs	  were	   amputated	   at	   the	   tibiofemoral	   joint	   to	   allow	   assessment	   of	  
the	   gastrocnemius	  muscle	  weight	   of	   each	   limb.	  Mean	  weight	   loss	   values	   as	   a	  
percentage	  of	  the	  weight	  of	  the	  non-­‐operated	  limb	  were	  calculated.	  Statistical	  
analysis	  was	  performed	  on	  the	  percentages	  achieved.	  
	  
4.3.4.4.	   Histological	   evaluation	   of	   the	   degree	   of	  morphologic	   recovery	   from	  
peripheral	  nerve	  injury	  following	  intervention	  
	  
To	   evaluate	   the	   degree	   of	   morphologic	   recovery	   following	   intervention	   in	  
experimental	   treatment	   groups,	   excised	   nerve	   tissue	   was	   processed	   for	  
histological	  analysis.	  To	  confirm	  the	  absence	  of	  spontaneous	  regeneration	  in	  the	  
negative	   control	   group,	   samples	   were	   analysed	   with	   transmission	   electron	  
microscopy	   (TEM)	   using	   standard	   methodology	   established	   at	   the	   Crann	  
institute	   in	   Trinity	   College	   Dublin.	   To	   examine	   the	   extent	   of	   morphologic	  
recovery	   achieved	   following	   treatment,	   qualitative	   analysis	   by	   means	   of	  
immunofluorescence	   staining	   and	   quantitative	   analysis	   by	   means	   of	   a	   semi-­‐
automated	   axon	   counting	   image	   analysis	   software	   program	   was	   performed.	  
Nerve	   regeneration	   in	   the	   three	   treatment	   groups	   was	   assessed	   in	   terms	   of	  
marker	  expression,	  number	  calibre	  and	  alignment	  of	  axons.	  	  
	  
Specimens	  from	  experimental	  treatment	  group	  animals	  (treated	  with	  either	  the	  
NGC	  alone,	  the	  NGC	  &	  ONS	  or	  the	  NGC,	  ONS	  &	  NGF)	  and	  specimens	  from	  the	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contralateral	   non-­‐operated	   positive	   control	   nerve	   sections	   were	   fixed	   in	   10%	  
Normal	   Buffered	   Formalin	   (NBF)	   for	   24	   hours	   followed	   by	   5%	   NBF	   at	   which	  
point	   specimens	  were	   stored	   at	   4°C.	   Prior	   to	   cryosectioning,	   specimens	  were	  
transferred	  to	  30%	  sucrose	   in	  PBS	  solution	  overnight	  and	  flash-­‐frozen	   in	   liquid	  
nitrogen.	   	  The	   implant	  midpoint	  was	   isolated	  and	  sections	  at	  20	  µm	  thickness	  	  
were	  mounted	  onto	  PDL	  pre	  coated	  slides	  to	  ensure	  firm	  adhesion.	  Treatment	  
sections	   were	   placed	   on	   the	   same	   slide	   as	   the	   corresponding	   section	   of	   the	  
contralateral	   nerve.	   3	   sections	   per	   specimen	   were	   required	   to	   accommodate	  
staining	  for	  the	  different	  chosen	  markers	  of	  morphological	  recovery.	  Slides	  were	  
stored	  at	  4°C	  prior	  to	  staining.	  	  
	  
The	  following	  antibodies	  were	  used	  to	  determine	  neural	  and	  glial	  cell	  presence:	  
anti-­‐neurofilament,	   anti	   β-­‐tubulin	   3	   (axons)	   anti-­‐S100	   β	   and	   anti-­‐myelin	   basic	  
protein	   (MBP)	   (Schwann	   cells)	   anti	   laminin	   and	   anti	   fibronectin	   (basal	  
membrane	  proteins)	   .	   The	   required	  antibody	  dilutions	  were	  determined	  using	  
intact	  peripheral	  nerve.	   The	   following	  dilutions	  were	  used	   (anti-­‐neurofilament	  
1:40,	   anti	   β-­‐tubulin	   1:100,	   anti	   s100b	   1:100,	   anti	  mbp	   1:200	   and	   anti	   laminin	  
1:100	  anti	  fibrinogen	  1:100	  in	  dilution	  buffer.	  Non	  specific	  staining	  was	  blocked	  
as	  previously	  described	  (see	  chapter	  2	  section	  2.4.4.1).	  Sections	  were	  incubated	  
with	  primary	  antibody	  for	  2	  hrs	  at	  room	  temperature	  in	  a	  humidified	  chamber,	  
followed	  by	  washing	  in	  phosphate	  buffered	  saline	  (PBS)	  and	  incubation	  with	  the	  
secondary	  antibody	  solution	  	  for	  30	  minutes	  at	  room	  temperature	  in	  the	  dark	  in	  
a	   humidified	   chamber.	   After	   further	  washing,	   the	   sections	  were	   covered	  with	  
anti-­‐fading	  mounting	  media	  (Vecta	  Shield	  &	  DAPI;	  Sigma)	  and	  stored	  in	  the	  dark	  
before	  visualisation	  using	  a	   fluorescent	  Nicon	  Eclipse®	  90i	  Microscope.	   Images	  
were	  taken	  using	  Nicon	  DS-­‐Ri1®	  camera.	  
	  
Following	   imaging,	   the	   number	   of	   axons,	   calibre	   of	   axons	   and	   alignment	   of	  
axons	   at	   the	   the	  mid	   section	  of	  of	   the	  explanted	   tissue	  was	   assessed.	   Images	  
stained	   for	   axonal	   markers	   were	   processed	   for	   semiautomated	   quantitative	  
analysis	  using	  NIH	  Image	  J®	  software,	  which	  is	  an	  open	  source	  java	  based	  image	  
processing	  and	  analysis	  program,	  that	  has	  been	  validated	  for	  axon	  counting	  in	  a	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number	  of	  recent	  papers383	  384.	   Images	  of	  β-­‐tubulin	  and	  neurofilament	  stained	  
sections	  of	  the	  same	  scale	  and	  magnification	  were	  converted	  into	  an	  8-­‐bit	  gray	  
scale	   image.	   Manual	   adjustment	   of	   the	   contrast,	   brightness	   and	   threshold	  
values,	  allowed	  a	  representative	  image	  of	  the	  number	  of	  axons	  present	  per	  field	  
of	  view	  (425	  µm	  x	  300	  µm	  with	  50	  µm	  scale	  bar)	  to	  be	  generated.	  Areas	  of	  extra	  
axonal	   debris	   or	   clumping	  were	   identified	  by	   visual	   inspection	   and	  eliminated	  
from	   the	   analysis.	   In	   addition	   to	   the	   average	   number	   of	   axons	   present,	   the	  
average	   axon	   calibre	   (Feret	   diameter402)	   and	   the	   average	   alignment	   (Feret	  
Angle402)	  were	  quantified.	  Axonal	  alignment	  was	  identified	  as	  a	  deviation	  from	  
the	  alignment	  of	  the	  axons	  within	  the	  contralateral	  non-­‐operated	  nerve.	  
	  
4.3.5.	  Statistical	  analysis	  	  
	  
Data	   was	   presented	   as	   either	   a	   median	   or	   mean	   value	   ±	   SD	   with	   Tukey	  
dispersion	   box	   plots	   demonstrating	   the	   median	   values	   and	   the	   degree	   of	  
variability	   of	   results	   within	   each	   experimental	   arm.	   Statistical	   analysis	   was	  
performed	  using	  one-­‐way	  analysis	  of	  variance	  (ANOVA),	  and	  where	  statistically	  
significant	   results	   were	   obtained,	   post-­‐hoc	   pair-­‐wise	   comparison	   between	  














	   142	  
4.4.	  Results	  
	  
There	  was	  one	  peri-­‐operative	  death	  in	  the	  experimental	  treatment	  group	  due	  to	  
respiratory	   arrest	   following	   anesthesia.	   The	   remaining	   35	   animals	   recovered	  
from	  the	  procedure	  (demonstrated	  in	  Figure	  4.6)	  without	  event.	  	  
	  
	  
Figure	  4.6:	  Image	  demonstrating	  the	  site	  of	  insertion	  of	  the	  NGC	  in	  a	  cadaveric	  
male	   Sprague	   Dawley	   rat.	   The	   NGC	   was	   fixed	   in	   place	   using	   6.0	   prolene-­‐
unbraided	  sutures	  as	  shown	  
	  
4.4.1.	   A	   10	   mm	   critical	   defect	   gap	   in	   a	   right	   sciatic	   nerve	   does	   not	   heal	  
spontaneously,	  resulting	  in	  no	  detectable	  level	  of	  nerve	  conductivity	  	  
	  
In	  order	  to	  confirm	  the	  lack	  of	  spontaneous	  regeneration	  through	  a	  10	  mm	  gap	  
in	  the	  sciatic	  nerve,	  the	  negative	  control	  group	  was	  maintained	  on	  study	  for	  an	  
extended	  period	  of	  time	  (16	  weeks).	  Critical	  sized	  nerve	  defect	  Injury	  outcomes	  
including	   muscle	   atrophy,	   contracture	   formation,	   presence	   of	   ulceration	   and	  
self-­‐mutilation	  (autophagy),	  were	  recorded385	  386.	  	  By	  8	  weeks	  post-­‐surgery	  all	  9	  
animals	   in	   the	   negative	   control	   group	   demonstrated	   muscle	   atrophy	   and	  
contracture	   formation.	   A	   total	   of	   7	   animals	   had	   developed	   ulceration	   but	   of	  
these,	  5	  healed	  spontaneously	  and	  only	  2	  had	  open	  ulcers.	  Seven	  animals	  within	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the	  negative	  control	  group	  demonstrated	  moderate	   to	   severe	  autophagy	  with	  
between	  1.5	  and	  3	  digits	  missing.	  When	  placed	  under	  second	  anesthesia	  at	  the	  
16-­‐week	  time-­‐point,	  dense	  scar	  tissue	  was	  noted	  to	  have	  filled	  the	  defect	  sites.	  
The	  effects	  of	  prolonged	  sciatic	  nerve	  injury	  are	  illustrated	  in	  Figure	  4.7.	  	  
	  
	  
Figure	  4.7:	  Clinical	  photograph	  demonstrating	  the	  effects	  of	  a	  critical	  gap	  sciatic	  
nerve	   transection	   injury	   without	   intervention	   following	   16	   weeks	   in	   an	   adult	  
male	  Sprague	  Dawley	  rat.	  Muscle	  wasting	  and	  contracture	  formation	  in	  the	  hind	  
limb	   is	   illustrated	   within	   the	   blue	   square;	   ulceration	   can	   be	   seen	   within	   the	  
yellow	  circle	  and	   the	  blue	  arrow	  demonstrates	  autophagy	  of	   the	   lateral	  digits.	  
The	  red	  arrow	  indicates	  the	  contralateral	  non-­‐operated	  side	  
	  
Failure	   of	   recovery	   in	   the	   negative	   control	   group	   was	   confirmed	   by	  
electrophysiological	   testing	   at	   16-­‐weeks.	   No	   recordable	   electrical	   conductivity	  
was	  measured	  in	  any	  animal.	  Visual	  inspection	  of	  the	  defect	  site	  demonstrated	  
prolific	   scar	   tissue	   formation	   between	   the	   proximal	   and	   distal	   nerve	   stumps.	  	  
Analysis	  of	   the	   scar	   tissue	  using	  TEM	  revealed	  amorphous	  collagen	   rich	   tissue	  
with	   scant	   abnormal	   and	  poorly	  myelinated	  axons.	  Figure	  4.8	  B	  demonstrates	  
the	   accumulation	  of	   this	   amorphous	   collagen	   scar	   in	   the	   critical	   sciatic	   defect	  
zone	  16	  weeks	  after	   resection	   compared	   to	   the	  appearances	  of	  normal	  nerve	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(Figure	  4.8	  A).	   	   In	   summary,	   this	   study	   validated	   the	  model	  used	  and	   showed	  
that	  a	  10	  mm	  defect	  was	  critical	  sized	  and	  did	  not	  heal	  without	  intervention.	  
	  
	  
Figure	  4.8:	  A:	  Image	  demonstrating	  the	  typical	  appearance	  of	  normal	  peripheral	  
nerve	  tissue	  on	  TEM	  containing	  densely	  myelinated	  nerve	  fibers	  surrounded	  by	  
several	   unmyelinated	   fibers	   is	   shown	   (image	   source:	   Dr.	   D	   Fawcett/Visuals	  
Unlimited)387.	  B:	  Image	  demonstrating	  the	  accumulation	  of	  amorphous	  collagen	  
scar	   in	   a	   critical	   sciatic	   defect	   zone	   16	  weeks	   after	   resection.	   Scant	   abnormal	  
















	   145	  
4.4.2.	   Animals	   in	   all	   treatment	   groups	   demonstrated	   improved	   clinical	  
outcomes	  compared	  to	  the	  negative	  control	  
	  
Improved	   clinical	   outcomes	  were	   noted	   in	   all	   treatment	   groups	   compared	   to	  
the	  negative	  control	   (demonstrated	   in	  Table	  4.1	  and	  Figure	  4.9).	  By	  six	  weeks;	  
wasting	  contractures	  and	  autophagy,	  were	  noted	   to	  be	  more	  prevalent	   in	   the	  
NGC	  treated	  group	  when	  compared	  to	  the	  groups	  that	  were	  treated	  with	  NGCs	  
seeded	  with	  ONS	  with	  or	  without	  NGF.	  Ulceration	  was	  found	  in	  similar	  numbers	  
across	  all	  groups.	  	  
	  
Table	  4.1:	  Clinical	  endpoints	  at	  the	  6-­‐week	  time	  point:	  Table	  demonstrates	  the	  
number	  of	  incidents	  per	  group	  
	  
Figure	  4.9.	  	  Clinical	  endpoints	  at	  the	  6-­‐week	  time	  point:	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By	  8	  weeks,	  there	  was	  an	  increase	  in	  the	  presence	  of	  ulcers	  across	  all	  treatment	  
groups	  whilst	   the	   incidence	  of	  contractures	   remained	  stable	   (demonstrated	   in	  
Table	   4.2	   and	   Figure	   4.10).	   An	   increase	   in	   the	   incidence	   of	   autophagy	   was	  
observed	   in	  the	  NGC	  &	  ONS,	  and	  NGC,	  ONS	  &	  NGF	  treated	  animals	  but	  not	   in	  
NGC	   treated	  or	  negative	   control	   animals.	  Representative	   images	  of	  animals	   in	  
each	  experimental	  group	  are	  shown	  in	  Figure	  4.11.	  
	  
Table	  4.2:	  Clinical	  endpoints	  at	  the	  8-­‐week	  time	  point:	  Table	  demonstrates	  the	  
number	  of	  incidents	  per	  group	  
	  
	  
Figure	  4.10.	  Clinical	  endpoints	  at	  the	  8-­‐week	  time	  point	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Figure	  4.11:	  Representative	   images	  showing	  recovery	  of	  the	  nerve	  morphology	  
following	   treatment	   (A	   B	  &	   C)	   compared	   to	   the	   non-­‐operated	   positive	   control	  
(Left	  hind-­‐limb).	  Contractures	  (blue	  squares),	  ulcers	  (yellow	  circles)	  &	  autophagy	  
of	  the	  lateral	  toes	  (blue	  arrows)	  are	  highlighted.	  A:	  Animal	  treated	  with	  the	  NGC	  
alone.	  B:	  Animal	  treated	  with	  NGC	  &	  ONS.	  C:	  Animal	  treated	  with	  NGC,	  ONS	  &	  
NGF	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In	  addition	  to	  its	  presence	  or	  absence,	  autophagy	  was	  measured	  in	  terms	  of	  the	  
severity	  with	  which	  it	  occurred.	  Figure	  4.12	  A	  demonstrates	  the	  spread	  of	  digit	  
loss	  due	  to	  autophagia	  within	  each	  group	  at	  6	  weeks.	  As	  indicated,	  the	  highest	  
number	  of	  missing	  digits	  was	  detected	   in	   the	  negative	   control	   group,	  and	   the	  
lowest	  in	  the	  NGC,	  ONS	  &	  NGF	  treated	  group.	  NGC	  &	  ONS	  or	  NGC,	  ONS	  &	  NGF	  
treated	   animals	   demonstrated	   significantly	   less	   extensive	   autophagy	   at	   the	   6-­‐
week	  time	  point	  compared	  to	  the	  negative	  control	  group	  (p-­‐value	  =	  0.041).	  
	  
The	  difference	  between	  the	  degree	  of	  autophagy	   in	  all	  groups	  was	  reduced	  at	  
the	  8	  week	  time	  point	  (demonstrated	  in	  Figure	  4.12	  B),	  which	  occurred	  mostly	  
due	  to	  an	  increase	  in	  the	  number	  of	  missing	  digits	  in	  the	  NGC	  &	  ONS,	  and	  NGC,	  
ONS	  &	  NGF	  treated	  groups.	  There	  was	  no	  increase	  in	  autophagy	  detected	  within	  
the	  negative	  control	  group,	  and	  a	  small	   increase	   in	  the	  NGC	  treated	  group.	  As	  
indicated,	  the	  highest	  number	  of	  missing	  digits	  was	  still	  detected	  in	  the	  negative	  
control	  group,	  and	  the	  lowest	  number	  of	  missing	  digits	  was	  detected	  in	  the	  NGC	  
&	  ONS	  treatment	  group.	  The	  greatest	  spread	  was	  found	  within	  the	  NGC	  treated	  
group.	  The	  increase	  in	  the	  degree	  of	  autophagy	  detected	  in	  the	  NGC	  &	  ONS	  and	  
NGC,	   ONS	   &	   NGF	   treatment	   groups	   resulted	   in	   a	   reduction	   in	   statistical	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Figure	   4.12.	   Graph	   demonstrating	   dispersion	   and	   median	   number	   of	   missing	  
digits	   per	   group	   at	   A:	   6	  weeks,	   and	   B:	   8	  weeks.	   Asterisk	   indicates	   statistically	  
significant	  difference	  (p<0.05)	  at	  6	  weeks	   in	  the	  degree	  of	  autophagy	  between	  
the	  negative	  control	  groups	  (no	  intervention)	  and	  the	  ONC	  cell	  treated	  groups	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4.4.3.	  A	  degree	  of	  functional	  recovery	  was	  present	  in	  all	  treatment	  groups	  but	  
the	  addition	  of	  ONS	  cells	  with	  or	  without	  NGF	  improved	  outcomes	  
	  
4.4.3.1.	  The	  addition	  of	  ONS	  cells	  with	  and	  without	  NGF	  to	  the	  NGC	  resulted	  in	  
signs	  of	  early	  sensory	  re-­‐innervation	  
	  
A	  statistically	  significant	  improvement	  in	  sensory	  re-­‐innervation	  was	  detected	  in	  
animals	   treated	  with	   the	  NGC	  &	  ONS	   and	   the	  NGC,	  ONS	  &	  NGF	   compared	   to	  
untreated	  animals	  or	  animals	  treated	  with	  NGC	  alone	  between	  weeks	  6	  and	  8	  
(p-­‐value	  =	  0.014).	  The	  nociceptive	  withdrawal	  reflex	  was	  observed	  in	  3	  animals	  
within	  the	  NGC	  &	  ONS	  treatment	  group	  and	  4	  animals	  within	  the	  NGC,	  ONS	  &	  
NGF	  treatment	  group	  whilst	  no	  reflex	  was	  detected	  in	  animals	  treated	  with	  the	  
NGC	  alone.	  Table	  4.3	  describes	  incidence	  of	  the	  reflex	  detected,	  in	  each	  group.	  	  
	  
Table	  4.2:	  Presence	  of	  a	  nocioceptive	  withdrawal	  reflex	  at	  week	  8.	  A	  statistically	  




4.4.3.2.	   Average	   static	   variant	   sciatic	   function	   index	   (SFI)	   differed	   between	  
interventional	   groups	   but	   values	   were	   limited	   by	   the	   presence	   of	   marked	  
autophagy	  across	  all	  groups	  
	  
There	  was	  an	  increase	  in	  the	  incidence	  of	  autophagy	  in	  ONS	  cell	  treated	  animals	  
between	  the	  6	  and	  8	  post-­‐operative	  week.	  At	  the	  8-­‐week	  time	  point,	  only	  7	  of	  
35	  animals	  had	  not	  chewed	  their	  toes	  therefore	  only	  7	  animals	  were	  suitable	  for	  
SFI	  evaluation.	  The	  average	  static	  variant	  SFI	  for	  animals	  treated	  with	  the	  NGC	  &	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ONS	  was	  -­‐26.8.	  The	  average	  static	  variant	  SFI	  for	  animals	  treated	  with	  the	  NGC	  
alone	   was	   -­‐28.5.	   By	   comparison,	   the	   average	   static	   variant	   SFI	   for	   animals	  
treated	  with	  the	  NGC,	  ONS	  &	  NGF	  was	  -­‐50.09.	  The	  SFI	  is	  typically	  reported	  as	  a	  
scale	   from	   –	   10	   representing	   near	   normal,	   to	   –	   100	   representing	   severe	  
dysfunction.	   Although	   the	   assay	   was	   not	   found	   to	   be	   appropriate	   due	   to	  
exclusion	  because	  of	  the	  presence	  of	  autophagy	  a	  small	  improvement	  with	  the	  
addition	  of	  ONS	  cells	  without	  NGF	  was	  apparent	  as	  demonstrated	  in	  Table	  4.3.	  	  	  
	  
Table	  4.3:	  SFI	  calculations	  from	  animals	  without	  evidence	  of	  autophagy	  
	  
	  
4.4.4	   An	   improvement	   in	   electrophysiological	   recovery	   was	   detected	   in	   all	  
treatment	  groups	  compared	  to	  the	  negative	  control	  	  
	  
A	   statistically	   significant	   improvement	   in	   electrophysiological	   recovery	   was	  
detected	   in	   all	   treatment	   groups	   compared	   to	   the	  negative	   control	   (p-­‐value	  =	  
0.03).	   No	   readable	   CMAP	   response	   to	   the	   stimulus	   applied	   was	   detected	   in	  
animals	   within	   in	   the	   non-­‐operated	   control	   group	   with	   varying	   responses	  
detected	   in	   the	   three	   treatment	   groups.	   Post	   hoc	   analysis	   demonstrated	   that	  
animals	   treated	   with	   the	   NGC	   &	   ONS,	   or	   the	   NGC,	   ONS	   &	   NGF	   showed	   a	  
statistically	  significant	  improvement	  in	  CMAP	  values	  (as	  a	  %	  of	  the	  contralateral	  
non-­‐operated	  nerve)	  when	  compared	  to	  animals	  treated	  with	  the	  NGC	  alone	  (p-­‐
value	  0.034	  and	  0.013	  respectively).	  	  Specifically,	  the	  mean	  %	  CMAP	  detected	  in	  
NGC	  &	  ONS	  treated	  animals	  with	  or	  without	  NGF	  supplementation	  was	  60%	  (±	  
0.28	  %	  SD)	  of	   the	  CMAP	  of	   the	   contralateral	   non-­‐operated	   side,	   compared	   to	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just	   21	  %	   (±	   0.27	  %	   SD)	   in	   the	   NGC	   alone	   group.	   The	  median	   and	   dispersion	  
results	  of	  CMAP	  conductivity	  tests	  are	  summarised	  in	  Figure	  4.13.	  	  
	  
	  
Figure	  4.13:	  Graph	  demonstrating	  dispersion	  CMAP	  values	  (as	  a	  %	  of	  the	  values	  
from	   the	   contralateral	   non-­‐operated	   limb)	   in	   experimental	   treatment	   group	  
animals.	  A	  statistically	  significant	   improvement	  in	  electrophysiological	  recovery	  
was	  detected	   in	  all	   treatment	  groups.	  Asterisk	   indicates	   statistically	   significant	  
difference	  between	  treatment	  groups	  
	  
4.4.5	   The	   addition	   of	   ONS	   cells	   with	   NGF	   to	   the	   NGC	   improved	  
electrophysiological	  outcomes	  in	  terms	  of	  peak	  tensile	  and	  compressive	  force	  
generated	  
	  
Muscle	   responses	   to	   electrical	   stimulation	   of	   the	   implant	   were	   present	   in	   all	  
experimental	  treatment	  groups.	  Measured	  peak	  tension	  responses	  of	  the	  hind	  
limb	  to	  direct	  stimulation	  of	  the	  nerve	  demonstrated	  that	  a	  higher	  magnitude	  of	  
tensile	  force	  was	  generated	  in	  animals	  treated	  with	  the	  NGC	  &	  ONS	  (mean	  =	  47	  
%	  ±	  0.42	  SD)	  or	   the	  NGC,	  ONS	  &	  NGF	   (mean	  =	  52	  %	  ±	  0.27	  SD),	   compared	   to	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animals	  treated	  with	  the	  NGC	  alone	  (mean	  =	  18	  %	  ±	  0.22	  SD).	   	  The	  dispersion	  
box	  plot	  shown	  in	  Figure	  4.14A	  illustrates	  that	  a	  number	  of	  animals	  in	  the	  NGC	  
&	  ONS	  treated	  group,	  demonstrated	  equal	  peak	  tensile	  force	  to	  that	  generated	  
in	   the	   contralateral	   non-­‐operated	   limb.	   By	   comparison,	   the	   mean	   maximum	  
peak	  tension	  detected	  in	  the	  NGC	  alone	  group	  was	  45	  %	  of	  the	  value	  obtained	  
for	  the	  contralateral	  non-­‐operated	  side	  (demonstrated	  in	  Figure	  4.14	  A).	  
	  	  
Similarly,	   the	  peak	  compressive	   force	  generated	  was	  also	   improved	   in	  animals	  
treated	  with	  either	  the	  NGC	  &	  ONS	  (mean	  =	  52	  %	  ±	  42.1	  SD)	  or	  the	  NGC,	  ONS	  &	  
NGF	  (mean	  =	  64	  %	  ±	  29.7SD)	  compared	  to	  animals	  treated	  with	  the	  NGC	  alone	  
(mean	  =	  24	  %	  ±	  35.9	  SD).	  In	  the	  case	  of	  peak	  compressive	  force,	  the	  NGC	  &	  ONS	  
treatment	   group	   had	   a	   greater	   concentration	   around	   38	   %	   marked	  
improvement	  and	  a	  range	  between	  0	  %	  and	  100	  %,	  whilst	  the	  improvement	  to	  
the	  NGC	  ONS	  &	  NGF	  treatment	  group	  appeared	  to	  range	  between	  20	  %	  and	  100	  
%,	  concentrating	   in	  and	  around	  64	  %	  marked	   improvement.	  The	  dispersion	  of	  
the	   results	   indicated	   a	   trend	   towards	   a	   higher	   concentration	   of	   relative	   peak	  
compression	   in	   the	  NGC,	  ONS	  &	  NGF	   treated	   animals	  when	   compared	   to	   the	  
NGC	   alone.	   Further,	   pair	   wise	   evaluation	   of	   the	   differences	   across	   treatment	  
groups	   showed	   that	   there	  was	   a	   statistically	   significant	   improvement	   in	   peak	  
compressive	  force	  generated	  when	  NGF	  with	  ONS	  cells	  were	  added	  to	  the	  NGC	  
compared	  to	  the	  NGC	  alone	  (p-­‐value	  =	  0.01)	  suggesting	  that	  the	  addition	  of	  NGF	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Figure	  4.14:	  A:	  Peak	  tension	  force	  (N	  Force)	  as	  a	  %	  of	  the	  non-­‐operated	  limb.	  B:	  
Peak	  compression	  (N	  Force)	  as	  a	  %	  of	  the	  non-­‐operated	  limb.	  Asterisk	  indicates	  a	  
statistically	   significant	   difference	   in	   the	   force	   generated	   between	   animals	  
treated	  with	  the	  NGC,	  ONS	  &	  NGF	  compared	  to	  the	  NGC	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4.4.6.	  The	  addition	  of	  ONS	  cells	  with	  NGF	  to	  the	  NGC	   improved	  outcomes	   in	  
terms	  of	  gastrocnemius	  muscle	  weight	  measurements	  	  
	  
Animals	  treated	  with	  the	  NGC	  &	  ONS	  or	  the	  NGC,	  ONS	  &	  NGF	  demonstrated	  less	  
gastrocnemius	   muscle	   depletion	   in	   the	   operated	   limb	   compared	   to	   animals	  
treated	  with	   the	  NGC	  alone.	  The	  mean	  gastrocnemius	  muscle	  weight	   loss	  was	  
2.5	   g	   for	   NGC,	  ONS	  &	  NGF	   treated	   animals	   compared	   to	   3	   g	   for	   NGC	  &	  ONS	  
treated	  animals	  and	  4.78	  g	  for	  animals	  treated	  with	  the	  NGC	  alone.	  	  The	  mean	  
gastrocnemius	  weight	  loss	  by	  treatment	  group	  as	  a	  percentage	  of	  the	  weight	  of	  
the	   gastrocnemius	   muscle	   from	   the	   contra-­‐lateral	   non-­‐operated	   is	  
demonstrated	   in	   Figure	   4.15.	   There	  was	   a	   statistically	   significant	   reduction	   in	  
gastrocnemius	   muscle	   depletion	   in	   the	   NGC,	   ONS	   &	   NGF	   treated	   group	  
compared	   to	   the	   NGC	   indicating	   that	   the	   addition	   of	   NGF	   with	   ONS	   cells	  
significantly	  modulated	  the	  effect	  of	  the	  NGC	  alone	  (p-­‐value=0.003).	  
	  
Figure	  4.15.	  Gastrocnemius	  weight	  loss	  of	  the	  operated	  limb	  in	  grams	  compared	  
to	  the	  non-­‐operated	  limb	  in	  experimental	  animals.	  Tukey	  box	  plot	  demonstrates	  
dispersion	   of	   results	   across	   treatment	   groups.	   Asterisk	   indicates	   statistically	  
significant	  difference	  between	  NGC,	  ONS	  &	  NGF	  treatment	  and	  the	  NGC	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4.4.7.	  Evidence	  of	  morphological	  recovery	  was	  found	  in	  all	  treatment	  groups	  	  	  
	  
Representative	   histological	   images	   of	   the	   sections	   at	   the	   mid	   point	   of	   the	  
implant	   site	   from	   the	   three	   experimental	   groups	   after	   8	   weeks	   in	   vivo	   are	  
shown	  in	  Figures	  4.16.	  The	  unoperated	  contralateral	  nerve	  served	  as	  a	  positive	  
control	   for	   all	   markers.	   	   Both	   cellular	   and	   extracellular	   characteristics	   of	   the	  
positive	  control	  were	  present	   in	  all	   treatment	  groups.	   	  Histological	  analyses	   in	  
all	   treatment	   groups	   showed	   the	   presence	   of	   infiltrating	   cells	   (indicated	   by	  
nuclear	  staining),	  axonal	  ingrowth	  (indicated	  by	  neurofilament	  and	  β-­‐tubulin	  III	  
staining)	  and	  Schwann	  cells	  (indicated	  by	  S100	  β	  and	  myelin	  basic	  protein	  (MBP)	  
staining).	   Moreover,	   the	   sections	   from	   all	   groups	   were	   positive	   for	   the	  







	   157	  
	  
Figure	  4.16:	  Representative	   images	  showing	  recovery	  of	  the	  nerve	  morphology	  
following	  treatment	  with	  NGC	  (B,	  C	  &	  D)	  compared	  to	  the	  non-­‐operated	  positive	  
control	  (A).	  Mid-­‐conduit	  sections	  in	  all	  treatment	  groups	  (NGC,	  NGC	  &	  ONS	  and	  
NGC,	  ONS	  &	  NGF)	   showed	   signs	  of	  morphological	   recovery	   comparable	   to	   the	  
positive	   control.	   Red	   with	   green	   axons	   =	  MBP,	   Green	   with	   red	   axons	   =	   s100.	  
Nuclei	  =	  blue.	  Extracellular	  matrix	   laminin	  =	   red	  and	   fibronectin	  =	  green.	  Scale	  
bar	  in	  all	  images	  –	  50	  µm	  
	  
4.4.7.1.	  Significantly	  more	  axons	  were	  present	  following	  the	  addition	  of	  ONS	  
cells	  with	  and	  without	  NGF	  when	  compared	  to	  the	  NGC	  alone	  
	  
Statistically	   significant	   differences	   in	   axonal	   growth	   were	   observed	   between	  
ONS	  cell	   treated	  animals	  and	  cell	   free	  NGC	  treated	  animals.	  Furthermore	  NGF	  
enhancement	   of	   ONS	   cells	   had	   a	   significant	   impact	   on	   the	   same	   parameter.	  
There	   was	   a	   stepwise	   improvement	   in	   average	   axonal	   count	   across	   the	  
treatment	   groups.	   NGC	   treated	   animals	   yielded	   an	   average	   axonal	   count	   per	  
field	   of	   view	   4671	   ±	   0.077	   SD	   (equal	   to	   31%	   of	   the	   contralateral	   nerve)	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compared	  to	  the	  NGC	  &	  ONS	  or	  NGC	  ONS	  &NGF	  treated	  animals,	  which	  yielded	  
average	  axonal	   counts	  of	  6751	  ±	  0.099	  SD	   (equal	   to	  45	  %	  of	   the	  contralateral	  
nerve)	   and	   9925	   ±	   0.139	   SD	   (equal	   to	   66%	   of	   the	   contralateral	   nerve)	  
respectively.	   The	   differences	   in	   axonal	   counts	   between	   the	   treatment	   groups	  
(NGC	  alone,	  NGC	  &	  ONS	  or	  NGC,	  ONS	  &	  NGF)	  were	  each	  statistically	  significant	  
(p-­‐value	  <	  0.05)	  as	  demonstrated	  in	  Figure	  4.17.	  
	  
	  
Figure	  4.17.	  Axon	  count	  as	  a	  %	  of	  the	  axon	  counts	  from	  the	  contralateral	  non-­‐
operated	  side	  across	  the	  groups.	  Tukey	  box	  plot	  demonstrates	  the	  dispersion	  of	  
results	   across	   treatment	   groups	   and	  median	   values.	   The	   addition	   of	  ONS	   cells	  
with	  or	  without	  NGF	  significantly	  improved	  axonal	  counts	  compared	  to	  the	  NGC	  
alone.	   Asterisk	   indicates	   statistically	   significant	   differences	   in	   axon	   counts	  
compared	  the	  NGC	  
	  
4.4.7.2.	  Axons	  of	  similar	  calibre	  were	  detected	  across	  all	  treatment	  groups	  
	  
The	  average	  calibre	  of	  axons	  in	  the	  non-­‐operated	  nerve	  specimens	  was	  2.14µm	  
±	   0.98	   µm	   SD,	   whilst	   the	   average	   calibre	   of	   axons	   generated	   in	   the	   NGC	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treatment	  group	  was	  3.6µm	  ±	  1.7	  µm	  SD.	  By	  comparison,	  the	  average	  calibre	  of	  
axons	  generated	   in	   the	  NGC	  &	  ONS	   treatment	  group	  was	  4	  µm	  ±	  0.59	  µm	  SD	  
and	  the	  average	  calibre	  of	  axons	  generated	  in	  the	  NGC,	  ONS	  &	  NGF	  treatment	  
group	  was:	   3.61	   µm	   ±	   0.79	   µm	   SD.	   	   The	   difference	   in	   average	   axonal	   calibre	  
between	  the	  contralateral	  non-­‐operated	  sciatic	  nerve	  and	  all	  treatment	  groups	  
was	   statistically	  different	   (overall	   p-­‐value	  =	  0.035)	   however,	   the	  post	  hoc	  pair	  
wise	  analysis	  demonstrated	  that	  axonal	  calibre	  in	  NGC	  treated	  animals	  was	  not	  
significantly	   different	   from	   axonal	   calibre	   in	   the	   contralateral	   non-­‐operated	  
nerve	  (p	  value	  =	  0.0203))	  as	  demonstrated	  in	  Figure	  4.18.	  
	  
	  
Figure	   4.18:	   Axonal	   calibre	   across	   treatment	   groups.	   Tukey	   box	   plot	  
demonstrates	   the	   dispersion	   of	   results	   across	   treatment	   groups	   and	   median	  
values.	   Axonal	   calibre	   in	   NGC	   treated	   animals	   was	   not	   significantly	   different	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4.4.7.3.	   A	   high	   degree	   of	   axonal	   alignment	   was	   observed	   in	   all	   treatment	  
groups;	  alignment	  was	  modulated	  by	  the	  addition	  of	  ONS	  cells	  with	  NGF	  
	  
There	  was	   a	   high	   degree	   of	   axonal	   alignment	   in	   all	   treatment	   groups	   ranging	  
from	  79	  %	  -­‐	  93	  %.	  There	  was	  an	  improvement	  in	  alignment	  with	  the	  addition	  of	  
ONS	  cells	  and	  NGF	   to	   the	  NGC.	  Axonal	  alignment	   in	  NGC,	  ONS	  &	  NGF	   treated	  
animals	   was	   not	   significantly	   different	   from	   axonal	   alignment	   in	   the	   normal	  




Figure	   4.19:	   Axonal	   alignment	   compared	   to	   axonal	   alignment	   of	   the	   non-­‐
operated	   side.	  Mean	   values	  were:	  NGC,	  ONS	  &	  NGF	   treatment	   –	   91%	  aligned	  
axons,	   NGC	   &	   ONS	   treatment	   –	   89	   %	   aligned	   axons,	   NGC	   treatment	   –	   87	   %	  
aligned	  axons.	  The	  Tukey	  box	  plot	  demonstrates	  the	  dispersion	  of	  results	  across	  
treatment	   groups	   and	   median	   values.	   Axonal	   alignment	   in	   NGC,	   ONS	   &	   NGF	  
treated	   animals	   was	   not	   significantly	   different	   from	   axonal	   alignment	   in	   the	  
contralateral	  non-­‐operated	  nerve	  (p	  =	  0.86)	  
	  
	   161	  
4.5	  Discussion.	  
	  
The	   results	   of	   this	   study	   demonstrate	   that	   a	   novel	   tissue	   engineered	   triad	   of	  
NGF	  enhanced	  ONS	  cells	  within	  a	  biomimetic	  biphasic	  NGC,	   fabricated	  using	  a	  
2.5	  %	   collagen	   conduit	   and	  HA-­‐Lam	   luminal	   filler,	   can	   be	   successfully	   used	   to	  
promote	  peripheral	  nerve	  regeneration	   in	  vivo.	  The	  analyses	  found	  statistically	  
significant	  evidence	  of	  functional	  and	  morphological	  regeneration	  (most	  notably	  
the	  nocioceptive	  withdrawal	   reflex,	  CMAP	  measurement	  and	  axonal	   count)	  of	  
the	  injured	  nerve	  across	  all	  experimental	  treatment	  groups.	  Histomorphological	  
analysis	  indicated	  statistically	  significant	  differences	  in	  axon	  counts	  between	  the	  
treatment	  groups	  with	  improved	  counts	  achieved	  in	  the	  NGC	  &	  ONS	  and	  NGC,	  
ONS	   &	   NGF	   treated	   animals.	   The	   trend	   in	   the	   data	   indicated	   that	   the	   NGC	  
promoted	  regeneration	  and	  that	  its	  effects	  were	  enhanced	  with	  the	  addition	  of	  
ONS	  cells	   and	  NGF	  across	  almost	  all	  parameters	   tested.	  Moreover	  a	   return	  of	  
the	   nocioceptive	   withdrawal	   reflex	   in	   ONS	   cell	   treated	   animals	   (indicating	  
regeneration	  of	  both	  efferent	  and	  afferent	  axons),	  which	  was	  not	  detected	   in	  
animals	   treated	  with	   the	  NGC	   alone,	   indicated	   an	   advanced	   repair	   stage	   at	   a	  
relatively	  early	  time	  point	  of	  8	  weeks	  post	  implantation.	  Improvement	  in	  terms	  
of	  CMAP	  and	  morphological	  repair	  (axon	  count,	  axonal	  calibre	  and	  anisotropy)	  
clearly	   demonstrated	   that	   the	   addition	   of	   ONS	   cells	   with	   and	   without	   NGF	  
modulated	  the	  functional	  regenerative	  effects	  of	  the	  developed	  NGC.	  
	  
In	   terms	  of	   the	  current	  state	  of	   the	  art,	   there	  are	   typically	   two	  approaches	   to	  
peripheral	  nerve	  regeneration;	  cell-­‐free	  tissue-­‐engineered	  nerve	  grafts	  and	  cell	  
based	   therapeutic	   approaches.	   The	   results	   described	   herein	   (summarised	   in	  
Table	   4.4)	   compare	   very	   favorably	   to	   the	   evidence	   from	   recent	   literature	  
(summarised	  in	  Table	  4.5).	  Morphologically,	  the	  NGC	  alone	  performed	  well	  -­‐	  the	  
luminal	   filler	   supported	   cell	   infiltration,	   axonal	   alignment	   and	   Schwann	   cell	  
migration	  compared	  to	  alternatives	  such	  as	  matrigel,	  saline,	  or	  non	  alligned	  HA,	  
and	  the	  addition	  of	  ONS	  cells	  and	  NGF	  enhanced	  its	  biological	  effect	  resulting	  in	  
improved	   clinical,	   functional	   and	   electrophysiological	   outcomes	   when	  
compared	  to	  the	  NGC	  alone.	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In	  comparison	  to	  other	  cell	  free	  tissue	  engineered	  nerve	  grafts	  reported	  in	  the	  
recent	  literature,	  the	  NGC	  performed	  competitively.	  Costa	  et	  al	  reported	  on	  the	  
effectiveness	   of	   a	   combined	   polyglycolic	   acid	   tube	   autografting	   technique	  
versus	   autografting	   or	   polyglycolic	   acid	   tube	   alone	   as	   a	   treatment	   for	   5mm	  
sciatic	   nerve	   defect	   in	   8-­‐week-­‐old	   Lewis	   rats	   over	   a	   6-­‐week	   study388.	   In	   that	  
study,	  the	  authors	  reported	  axon	  counts	  of:	  4225.2	  ±	  376.8	  in	  rats	  treated	  with	  
a	   polyglycolic	   acid	   tube	   alone;	   and	   7488.4	   ±	   384.5	   in	   rats	   treated	   with	   a	  
combined	  polyglycolic	  acid	  tube	  autografting	  technique.	  In	  2008,	  de	  Ruiter	  et	  al	  
reported	   the	   results	   of	   a	   12-­‐week	   study	   on	   axonal	   regeneration	   across	  
autograft,	   single	   lumen,	   or	   multichannel	   poly	   (lactic-­‐co-­‐glycolic	   Acid)	   (PLGA)	  
nerve	  tubes	  in	  a	  1	  cm	  sciatic	  nerve	  gap	  in	  Sprague	  Dawley	  Rats.	  In	  that	  study	  the	  
authors	  reported	  mid	  graft	  axonal	  counts	  of:	  3024	  ±	  1	  in	  animals	  treated	  with	  a	  
single	   lumen	  PLGA	   tube	   and	  2929	   ±	   2	   in	   animals	   treated	  with	   a	  multichannel	  
PLGA	  tube.	  The	   results	  generated	   in	   the	  evaluation	  of	   the	  NGC	   in	   the	  present	  
study	  gave	  better	  outcomes	   in	   terms	  of	   total	  axon	  count	  and	  critically,	  axonal	  
calibre	  compared	  to	  de	  Ruiters	  study	  which	  reported	  axonal	  calibre	  at	  the	  mid	  
graft	  point	  as:	  3.80	  ±	  0.3	  µm	  in	  animals	  treated	  with	  a	  single	  lumen	  PLGA	  tube	  
and	   4.01	   ±	   0.4	   µm	   in	   animals	   treated	   with	   a	   multichannel	   PLGA	   tube.	  
Interestingly,	   in	  the	  present	  study	  a	  statistically	  significant	  difference	  in	  axonal	  
calibre	  between	  the	  NGC	  treatment	  group	  and	  the	  calibre	  of	   the	  axons	  of	   the	  
contralateral	   non-­‐operated	   nerve	  was	   not	   detected.	   Because	   of	   this	   result,	   it	  
could	  be	  assumed	  that	  axons	  had	  the	  same	  diameter.	  However,	  the	  presence	  of	  
cross	  group	  differences	  could	  also	  not	  be	  entirely	  excluded	  when	  observing	  the	  
actual	  data.	  The	  variances	  in	  axon	  diameter	  the	  NGC	  treatment	  group	  suggested	  
that	   regenerated	   axons	   were	   wider	   than	   the	   mature	   axons	   found	   in	   the	  
contralateral	   non-­‐operated	   limb,	   reflecting	   the	   results	   of	   de	   Ruiters	   study	   in	  
which	   the	   authors	   reported	   that	   regenerating	   axons	   demonstrated	   variable	  
calibres	  in	  a	  12-­‐week	  study	  on	  axonal	  regeneration	  in	  Sprague	  Dawley	  Rats	  (see	  
Table	   4.5)389.	   There	   are	   a	   number	   of	   possible	   explanations	   for	   why	   this	   may	  
have	  occurred,	  including	  target	  specific	  signals,	  the	  effect	  of	  cellular	  extensions	  
on	  regenerating	  growth	  cones	  (the	  mobile	  extensions	  of	  developing	  neurons	  as	  
they	   seek	   their	   synaptic	   targets),	   configurational	   alterations	   in	   axonal	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microtubules	   (which	   are	   typically	   bundled	   together	   in	   the	   axon	   shaft)	   due	   to	  
extension	  of	  growth	  cones390	  or	  differences	   in	   the	  biophysical	  environment391.	  
From	  this	  study,	  it	  was	  not	  possible	  to	  ascertain	  the	  precise	  reason	  behind	  the	  
variation	  in	  calibre	  but	  given	  the	  importance	  of	  axonal	  diameter	  on	  the	  speed	  of	  
neuronal	  impulse	  transmission,	  it	  is	  a	  finding	  that	  warrants	  closer	  investigation.	  	  
	  
In	   terms	   of	   the	   cell	   based	   therapeutic	   approaches	   described	   in	   the	   recent	  
literature,	   the	   ONS	   groups	   in	   this	   study	   performed	   exceptionally	   well.	   As	  
outlined	   in	   Chapter	   1	   (see	   Section	   1.5),	   a	   number	   of	   recent	   published	   papers	  
have	   also	   reported	   improved	   outcomes	   in	   peripheral	   nerve	   repair	   using	   stem	  
cells.	  Di	  Summa	  et	  al	   compared	  axonal	  distance	  outcomes	   in	  peripheral	  nerve	  
repair	  with	  Schwann	  cells	  (SCs),	  bone	  marrow	  derived	  mesenchymal	  stem	  cells	  
(MSCs)	  and	  adult	  adipose	  derived	  stem	  cells	  (ADCs)	  in	  fibrin	  conduits392.	  In	  that	  
study,	   the	   authors	   reported	   statistically	   significant	   axonal	   regeneration	   across	  
all	   groups,	   and	   concluded	   that	   ADCs	   provided	   an	   effective	   cell	   population,	  
without	  the	  limitations	  of	  the	  donor	  site	  morbidity	  associated	  with	  isolation	  of	  
Schwann	  cells.	  Similar	  work	  by	  the	  Matthes’	  group	  in	  Hanover,	  found	  that	  using	  
mesenchymal	   stromal	   cells	   in	   a	   peripheral	   nerve	   model	   improved	   functional	  
outcomes	  and	  morphological	   appearances	  of	   regenerated	  nerve	   tissue	  after	  a	  
three	   week	   in	   vivo	   study	   in	   rats393,	   whilst	   Georgiou	   et	   al	   found	   a	   3.5	   fold	  
increase	  in	  axon	  number	  in	  engineered	  neural	  tubes	  containing	  adipose	  derived	  
stem	   cells	   (ADCs)	   compared	   to	   empty	   tube	   controls	   in	   a	   study	   in	   Sprague	  
Dawley	  rats394.	  In	  recent	  times,	  there	  have	  also	  been	  a	  number	  of	  studies	  using	  
central	  and	  peripherally	  derived	  olfactory	  ensheathing	  cells	  (OECs)	  in	  peripheral	  
nerve	  and	  spinal	  cord	  regeneration395.	  In	  2014,	  Lokenathan	  et	  al	  demonstrated	  
improved	  neurophysiological	  recovery	  in	  peripheral	  nerve	  repair	  using	  a	  muscle	  
stuffed	   vein	   graft	   seeded	   with	   OECs	   compared	   autografts396,	   whilst	   in	   2009	  
Radke	  et	  al	  reported	  results	  of	  a	  study	  on	  OEC	  enhanced	  microsurgical	  repair	  of	  
sciatic	  nerve	  transection	  in	  rats	  after	  21	  days397.	  	  
	  
The	  NGC	  &	  ONS	   treated	   group	   generated	  on	   average	   6751	   axons	   per	   field	   of	  
view	  with	  a	  mean	  calibre	  of	  4	  µm,	  whilst	   the	  NGC,	  ONS	  &	  NGF	   treated	  group	  
	   164	  
generated	  on	  average	  9925	  axons	  per	  field	  of	  view	  with	  a	  mean	  axonal	  calibre	  
of	   3.61	   µm	   compared	   to	   Radke’s	   study	   (in	   which	   the	   authors	   reported	   axon	  
counts	  of	  831	  ±	  200	  distal	  to	  a	  microsurgical	  repair	  site,	  and	  2076	  ±	  238	  with	  an	  
OEC	  enhanced	  microsurgical	   repair	   group).	   Further	   to	   increasing	   axon	   counts,	  
improved	  alignment	  was	  demonstrated	  with	  the	  addition	  of	  ONS	  cells	  and	  NGF.	  
This	   was	   an	   important	   finding	   because	   peripheral	   nerve	   regeneration	   is	   a	  
process,	   which	   intuitively	   requires	   anisotropy	   (appropriate	   alignment	   or	  
geometric	   configuration	   of	   an	   axon).	   It	   supported	   Bellamkonda’s	   hypothesis	  
that	   alignment	   is	  not	   solely	   governed	  by	   the	  microstructure	  of	   a	   luminal	   filler	  
scaffold,	   and	   that	   cell	   and	   growth	   factor	   inclusion	   in	   a	   tissue	   engineered	  
approach	  in	  peripheral	  nerve	  regeneration	  has	  a	  potential	  role	  in	  directing	  new	  
axons	  and	  neurons	  towards	  the	  target	  organ,	  facilitating	  the	  brains	  ability	  to	  re-­‐
learn	  to	  control	  the	  target	  organ	  to	  a	  greater	  degree398.	  Further,	  whilst	  Radkes	  
study	   (described	   above)	   reported	   SFI	   results	   of	   –	   60	   for	   their	   microsurgical	  
repair	  alone	  group	  and	  –	  40	  for	  their	  OEC	  enhanced	  repair	  group	  compared	  to	  
the	  NGC	  treated,	  NGC	  &	  ONS	  treated,	  and	  NGC	  ONS	  &	  NGF	  treated	  animals	  of	  
this	   study	   which	   generated	   SFI	   results	   of	   -­‐28.5,	   -­‐26.7	   and	   -­‐55.5	   respectively.	  
Although	  the	  exclusion	  of	  animals	  with	  autophagy	  from	  SFI	  analysis	  prevented	  
statistical	   interpretation	   of	   the	   true	   value	   of	   the	   results,	   where	   values	   were	  
obtained,	   the	   values	   for	   the	   NGC	   treated	   and	   NGC	   &	   ONS	   treated	   animals	  
surpassed	  the	  values	  reported	  in	  Radkes	  study.	  
	  
Table	   4.4:	   Summary	   of	   histomorphologic	   results	  with	  withdrawal	   reflex	  &	   SFI.	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An	  interesting	  point	  on	  review	  of	  the	  literature	  is	  that	  whilst	  there	  is	  typically	  a	  
large	   focus	  on	  quantitative	   indicators	  of	  morphological	   regeneration,	  very	   few	  
studies	  deal	  comprehensively	  with	  the	  impact	  that	  morphologic	  recovery	  might	  
have	   on	   the	   end	   clinical	   or	   functional	   outcomes	   achieved.	  Where	   studies	   do	  
attempt	   to	  address	   the	   issue	  of	   the	   functionality	  of	   regenerated	  nerve	   tissue,	  
the	  SFI	   is	  probably	   the	  most	   commonly	  used	   tool.	  However,	   in	   the	   context	  of	  
this	   study,	   the	   SFI	   findings	   that	   were	   obtained	   per	   group	   did	   not	   sufficiently	  
correlate	  with	  either	  the	  electrophysiological	  or	  morphological	  findings	  to	  make	  
it	   a	   valuable	   indicator	   of	   recovery.	   This	   was	   in	   contrast	   with	   much	   of	   the	  
literature,	  which	  has	   supported	   the	  use	  of	   the	   SFI	   as	   a	   diagnostic	  measure	  of	  
peripheral	   nerve	   regeneration	   since	   De	   Medinaceli	   et	   al	   first	   devised	   it	   in	  
1982399.	   Drawbacks	   notwithstanding,	   where	   SFI	   values	   were	   obtained	   in	   this	  
study,	  they	  surpassed	  the	  results	  of	  both	  Radkes	  and	  Costas	  (which	  reported	  SFI	  
results	  of	  -­‐51	  with	  autograft)	  studies.	  In	  terms	  of	  functional	  recovery	  the	  return	  
of	   the	   nocioceptive	   withdrawal	   reflex	   was	   found	   to	   be	   a	   more	   valuable	  
prognostic	   indicator	   in	   this	   study.	   NGC	   &	   ONS	   treated	   animals	   indicated	  
regeneration	  of	  both	  efferent	  and	  afferent	  axons,	  which	  were	  not	  detected	   in	  
animals	  treated	  with	  the	  NGC	  alone.	  The	  comparison	  of	  NGC	  treatment	  with	  the	  
ONS	   treated	   groups	   clearly	   indicated	   that	   regrowth	   of	   sensory	   fibers	   was	  
supported	   to	   a	   higher	   extent	   with	   the	   cell	   based	   therapeutic	   approach.	   This	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implied	   that	   animals	   demonstrating	   the	   reflex,	  were	   demonstrating	   advanced	  
repair	  at	  a	  relatively	  early	  time	  point	  (8	  weeks).	  	  
	  
The	   electrophysiological	   functionality	   of	   regenerated	   peripheral	   nerve	   tissue	  
was	  analysed	  by	  means	  of	  CMAP	  Assessment	  and	  peak	  tensile	  and	  compressive	  
force	  examination	  at	  8	  weeks	  post	   implantation.	  The	  measured	  CMAP	  passing	  
through	  the	  regenerative	  implant	   into	  the	  gastrocnemius	  muscle	  was	  found	  to	  
reflect	   both	   the	   number	   of	   axons	   counted	   and	   the	   alignment	   of	   axons	   at	  
definitive	  morphological	  assessment.	  	  In	  the	  case	  of	  CMAP	  evaluation,	  the	  ONS	  
treated	  animals	  performed	  better	  then	  animals	  that	  were	  treated	  with	  the	  NGC	  
alone.	  	  
Similar	  to	  the	  findings	  related	  to	  sensory	  recovery,	  evidence	  of	  re-­‐innervation	  of	  
distal	  muscle	  targets	  and	  subsequent	  motor	  recovery	  was	  present	  in	  a	  number	  
of	  animals	  from	  all	  experimental	  treatment	  groups.	  Motor	  neurons	  are	  efferent	  
nerves,	  which	  carry	  instructions	  from	  the	  CNS	  to	  their	  target	  end	  organ	  to	  effect	  
movement	   and	   mechanical	   force	   measurement	   of	   the	   gross	   tension	   and	  
compression	   responses	   of	   the	   hind	   limb	   to	   a	   standardised	   electrical	   stimulus	  
can	   be	   utilised	   to	   identify	   the	   return	   of	   sciatic	   nerve	   motor	   function	   in	  
peripheral	  nerve	  regeneration	  studies400.	  The	  results	  from	  the	  mechanical	  force	  
analysis	   indicated	   that	   the	  NGC,	  ONS	  &	  NGF	   treated	   group	   had	   a	   statistically	  
significant	   improvement	   in	   terms	  of	  peak	   tensile	  and	  compressive	   force	  when	  
compared	   to	   the	   group	   treated	   with	   the	   NGC	   alone	   hence,	   axons	   of	   motor	  
neurons	  re-­‐innervated	  the	  target	  muscle	  to	  some	  degree.	  Although	  the	  ANOVA	  
test	   demonstrated	   a	   non-­‐significant	   difference	   between	   the	   NGC	   &	   ONS	   and	  
NGC	   treatment	   groups,	   the	   results	   suggested	   that	   treatment	   with	   ONS	   cells	  
supplemented	  with	  NGF	  promoted	  greater	   improvement	   then	   treatment	  with	  
the	  NGC	  alone	  (P	  =	  0.01).	  	  
The	  degree	  of	  reduction	  in	  muscle	  atrophy	  of	  the	  gastrocnemius	  muscle	  of	  the	  
treated	   limb	   compared	   to	   the	   non-­‐operated	   side	   reflected	   the	   degree	   of	  
peripheral	  nerve	   regeneration	   in	   the	  context	  of	   this	   study.	  The	  gastrocnemius	  
muscle	   represents	   the	  major	  muscle	  bulk	  of	   the	  calf	  of	   the	   lower	  hind	   limb	   in	  
	   167	  
the	  rat401.	  It	  is	  predominantly	  innervated	  by	  the	  tibial	  branch	  of	  the	  sciatic	  nerve	  
thus	   it	   is	   intuitive	   that	   measurement	   of	   its	   wet	   weight	   can	   be	   used	   as	   an	  
indicator	  of	  the	  degree	  of	  sciatic	  injury402.	  Treatment	  with	  the	  NGC,	  ONS	  &	  NGF	  
resulted	   in	   significantly	   less	   muscle	   weight	   loss	   than	   was	   found	   in	   the	   NGC	  
treatment	  group	  (corroborating	  the	  results	  of	  the	  peak	  tensile	  and	  compressive	  
force	   analysis	   described	   above).	   Analysis	   of	   the	   gastrocnemius	  muscle	  weight	  
indicated	   a	   step-­‐wise	   reduction	   of	   muscle	   atrophy	   attributable	   to	   muscle	   re-­‐
innervation.	  
	  
Taken	  together,	  the	  results	  of	  this	  study	  suggest	  that	  the	  NGC	  alone	  performed	  
well	   in	   promoting	  nerve	   regeneration	   and	   that	   the	   addition	  of	  ONS	   cells	  with	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4.6.	  Conclusions	  
	  
The	  results	  described	  herein	  demonstrate	   that	  a	  novel	   tissue	  engineered	  triad	  
of	   ONS	   cells	   within	   an	   NGF	   enhanced	   biphasic	   NGC,	   consisting	   of	   a	   collagen	  
conduit	   and	   HA-­‐Lam	   luminal	   filler,	   can	   be	   successfully	   used	   to	   promote	  
peripheral	   nerve	   regeneration	   in	   vivo.	   While	   the	   NGC	   promoted	   good	  
regeneration	  and	   restoration	  of	   function,	  when	  combined	  with	  ONS	  cells	  with	  
and	   without	   NGF,	   evidence	   of	   enhanced	   functional	   and	   morphological	  
peripheral	  nerve	  regeneration	  was	  found	  	  
	  
The	  key	  findings	  of	  this	  in	  vivo	  study	  are	  summarised	  as	  follows:	  
	  
• A	   10	   mm	   critical	   defect	   gap	   in	   a	   rat	   sciatic	   nerve	   does	   not	   heal	  
spontaneously,	  resulting	  in	  no	  detectable	  level	  of	  nerve	  conductivity	  	  
• Implantation	   of	   the	   NGC	   into	   a	   critical	   size	   peripheral	   nerve	   defect	  
improved	  electrophysiological	  outcomes	  compared	  to	  untreated	  animals	  
• Implantation	   of	   the	   NGC	   resulted	   in	   high	   degree	   of	   axonal	   infiltration	  
into	   the	   defect	   site	   with	   a	   high	   degree	   of	   alignment	   compared	   to	  
untreated	  animals.	  
• Implantation	   of	   ONS	   cell	   seeded	   NGCs	   improved	   electrophysiological	  
outcomes	  compared	  to	  NGC	  treated	  animals	  	  
• Implantation	   of	   ONS	   cell	   seeded	   NGCs	   resulted	   in	   better	   axonal	  
infiltration	   into	   the	   defect	   site	   with	   improved	   alignment	   compared	   to	  
NGC	  treated	  animals	  	  
• Supplementing	  ONS	  cell	  seeded	  NGCs	  with	  recombinant	  NGF	  enhanced	  
functional	  and	  morphological	  outcomes	  	  
• ONS	  cells	  facilitate,	  support	  and	  induce	  peripheral	  nerve	  regeneration	  in	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5.1	  Introduction	  
	  
Peripheral	   nerve	   injury	   is	   a	   life	   altering	   problem	   which	   presents	   significant	  
therapeutic	  challenges	   for	  millions	  of	  patients	  worldwide.	  Despite	  advances	   in	  
microsurgical	  repair	  techniques,	  patients	  with	  nerve	  injury	  gaps	  exceeding	  5mm	  
require	  autologous	  grafts	  as	  the	  current	  reference	  standard	  approach	  to	  tension	  
free	  repair403.	  To	  date,	  the	  best	  clinical	  and	  functional	  recovery	  rates	  have	  only	  
reached	   70	   –	   80	   %	   for	   nerve	   injuries	   treated	   using	   autografts404.	   Although	  
tissue-­‐engineering	  strategies	  for	  regeneration	  of	  the	  peripheral	  nervous	  system	  
have	  placed	  a	  strong	  emphasis	  on	  the	  identification	  of	  potential	  alternatives	  to	  
the	  nerve	  graft	  over	  the	  past	  three	  decades,	  an	  effective	  means	  of	  regenerating	  
nerves	  post	  critical	  defect	  which	  obviates	  the	  need	  for	  the	  secondary	  injury	  due	  
to	  autografting	  has	  eluded	  clinicians	  and	  scientists405	  406.	  	  
	  
Since	   the	   1970’s	   there	   have	   been	   significant	   shifts	   in	   tissue	   engineered	  
approaches	   to	   peripheral	   nerve	   regeneration.	   The	   paradigm	   that	   scaffold	  
biomaterials	   are	   merely	   passive	   vehicles	   with	   which	   to	   either	   study	  
relationships	  between	  gene	  expression	  and	  cell	  function,	  or	  provide	  mechanical	  
support	   no	   longer	   exists.	   	   For	   the	   neural	   tissue-­‐engineered	   process	   to	   be	  
successful,	  it	  is	  now	  widely	  accepted	  that	  the	  interaction	  between	  cells	  and	  the	  
microenvironment	   of	   regenerating	   axons	   plays	   a	   pivotal	   role407.	   Bellamkonda	  
outlined	   the	   rationale	   for	   tissue	   engineered	   scaffolds	   to	   promote	   axonal	  
regeneration	   and	   anisotropy	   in	   peripheral	   nerve	   regeneration,	   incorporating	  
four	   essential	   components	   of	   tissue	   engineered	   grafts	   which	   enhance	  
regeneration:	   cells,	   luminal	   fillers,	   extracellular	   matrix	   proteins	   and	   growth	  
factors	  408.	  In	  that	  context,	  the	  focus	  of	  this	  research	  thesis	  was	  to	  utilise	  a	  novel	  
triad	  of	  olfactory	  neuroepithelial	   derived	   stem	  cells	   (ONS	   cells)	   in	   conjunction	  
with	   a	   nerve	   growth	   factor	   enhanced,	   purpose	   designed	   biomimetic	   biphasic	  
collagen-­‐hyaluronic	   acid	   nerve	   guidance	   conduit	   for	   peripheral	   nerve	  
regeneration	  in	  a	  pre-­‐clinical	  rat	  model.	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In	  order	   to	  enhance	   the	  ability	  of	   tissue-­‐engineered	  nerve	  grafts	   to	  mimic	   the	  
body’s	   intrinsic	   repair	   mechanisms,	   scientists	   are	   advocating	   cell	   and	   growth	  
factor	  based	  therapeutic	  approaches	  to	  peripheral	  nerve	  repair409	  410	  411	  412	  413.	  
Historically,	  Schwann	  cells	  were	  considered	  the	  reference	  standard	  cells	  to	  use.	  
However,	   in	   large	   gap	   injury	   zones	   they	   have	   been	   found	   to	   be	   inadequate	  
(extensive	  loss	  of	  axonal	  contact	  renders	  their	  effects	  obsolete	  through	  the	  loss	  
of	   extracellular	   matrix-­‐integrin	   interactions	   and	   oxidative	   stresses)	   and	   the	  
extraction	  processes	  required	  to	  harvest	  them	  have	  for	  many	  an	  unacceptable	  
morbidity	  profile.	  Therefore	  stem	  cells	  are	  becoming	  a	  preferable	  option414	  415.	  
Stem	  cell	  isolation	  however	  is	  not	  without	  risk.	  Less	  invasive	  sources	  that	  retain	  
clonogenicity	  whilst	   demonstrating	   preferential	   differentiation	   towards	   neural	  
and	  glial	  lineages	  are	  highly	  desirable.	  In	  this	  regard,	  ONS	  cells	  derived	  from	  the	  
neuroepithelium	  of	  the	  nasal	  cavity	  represent	  a	  clear	  opportunity	  to	  provide	  a	  
less	   invasive,	   more	   patient-­‐centered	   means	   of	   sourcing	   multipotent	   cells	  
without	  the	  ethical	  implications	  surrounding	  the	  use	  of	  embryonic	  stem	  cells.	  In	  
addition	  to	  possessing	  an	  unparalleled	  capacity	  for	  regeneration,	  ONS	  cells	  have	  
been	   shown	   to	   express	   nerve	   growth	   factor	   receptors,	   successfully	   survive	  
transplantation	   into	   different	   environments	   and	   produce	   extracellular	   matrix	  
receptors,	  which	  are	  not	  present	  in	  other	  neural	  stem	  cells416	  417	  418.	  	  
	  
The	   traditional	   engineered	   approach	   to	   peripheral	   nerve	   repair	   has	   involved	  
cylindrical	   conduits	   fabricated	   from	   synthetic	  materials	   but	   newer	   biomimetic	  
approaches	   incorporate	   extracellular	  matrix	   based	   luminal	   fillers	   with	   growth	  
factors	  to	  more	  closely	  mimic	  the	  internal	  homeostatic	  environment	  of	  naturally	  
regenerating	   tissue,	   providing	   physical	   and	   chemical	   cues	   to	   stem	   cells	  
embedded	   within419	   420.	   Taking	   the	   natural	   extracellular	   matrix	   into	   account,	  
laminin,	  hyaluronic	  acid	  and	  collagen	  were	  incorporated	  into	  the	  design	  of	  the	  
nerve	  guidance	  conduit.	  Whilst	  ONS	  cells	  have	  been	  shown	  to	  express	  integrin	  
receptors	  for	  attachment	  to	  laminin	  and	  collagen,	  the	  combination	  of	  ONS	  cells	  
within	  a	  laminin	  functionalised	  collagen-­‐hyaluronic	  acid	  nerve	  guidance	  conduit	  
for	  peripheral	  nerve	  regeneration	  has	  previously	  been	  unreported.	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It	  was	  apparent	  from	  the	  two-­‐dimensional	  analysis	  described	  in	  Chapter	  2	  that	  
ONS	   cells	  proliferated	  and	  differentiated	   in	   response	   to	   laminin	  and	   following	  
on	   from	   those	   results,	   a	   novel	   three-­‐dimensional	   nerve	   guidance	   conduit	  
produced	  by	  the	  combination	  of	  an	  outer	  tubular	  type	  1	  collagen	  conduit	  with	  a	  
biologically	   active	   laminin	   functionalised	   hyaluronic	   acid	   hydrogel	   was	  
developed	  which	  harnessed	  the	  pro-­‐differentiation	  effects	  observed.	  The	  effect	  
of	  further	  enhancing	  the	  system	  with	  growth	  factors	  was	  also	  evaluated.	  Several	  
potential	   neurotrophic	   factors	   were	   considered	   for	   incorporation	   because	  
research	   has	   shown	   that	   improved	   functional	   and	  morphologic	   outcomes	   can	  
be	   achieved	   in	   vivo	   when	   tissue	   engineered	   scaffolds	   are	   supplemented	  with	  
growth	  factors	  such	  as	  nerve	  growth	  factor,	  brain	  derived	  nerve	  growth	  factor	  
and	  insulin-­‐like	  growth	  factor421	  422.	  However,	  nerve	  growth	  factor	  was	  selected	  
because	   it	   is	   the	  original	   and	  most	  widely	   studied	  growth	   factor	   in	  peripheral	  
nerve	   studies.	   It	   is	   critical	   to	  both	   the	   survival	  of	   sensory	  neurons,	  and	   to	   the	  
promotion	   of	   axonal	   elongation423.	   It	   promotes	   myelinisation,	   prevents	  
neuronal	   degeneration	   after	   injury	   and	   has	   a	   pro	   differentiation	   effect	   on	  
olfactory	  cells	  so	  its	  inclusion	  in	  the	  system	  proposed	  in	  this	  thesis	  was	  intuitive.	  
Studies	   have	   also	   suggested	   that	   nerve	   growth	   factor	  may	   serve	   two	   distinct	  
functions	  in	  peripheral	  nerve	  repair.	  These	  include:	  supporting	  implanted	  stem	  
cell	   differentiation,	   and	   promoting	   out-­‐sprouting	   of	   native	   axons	   from	   the	  
proximal	   stump	   in	  vivo.	   The	   results	  described	   in	  Chapter	  3	  demonstrated	   that	  
ONS	   cells	   within	   a	   laminin	   functionalised	   collagen-­‐hyaluronic	   acid	   nerve	  
guidance	  conduit	  expressed	  neuronal	  and	  glial	  marker	  expression	   in	   vitro,	  but	  
when	   supplemented	  with	   nerve	   growth	   factor,	   the	  ONS	   cells	   demonstrated	   a	  
distinct	  elongated	  morphology	  and	  expressed	  cytoskeletal	  proteins	  essential	  for	  
the	  formation	  of	  inter-­‐cellular	  synapse	  formation.	  Those	  results	  were	  translated	  
to	  a	  clinical	  context	   in	  Chapter	  4	  when	  the	  novel	   triad	  was	  shown	  to	  enhance	  
axonal	   regeneration,	   alignment,	   and	   calibre	   as	   well	   as	   promoting	   significant	  
improvement	   in	   clinical,	   functional	   and	   electrophysiological	   outcomes	   in	   vivo.	  
The	   following	   sections	   summarise	   the	   main	   findings	   of	   each	   chapter,	   and	  
discuss	  their	  potential	  implications	  in	  terms	  of	  future	  clinical	  applications.	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5.2.	  Multipotent	  stem	  cells	  (ONS	  cells)	  can	  be	  derived	  from	  rat	  neuroepithelial	  
explants	   and	   differentiation	   marker	   expression	   can	   be	   manipulated	   by	   the	  
application	  of	  certain	  biomaterials	  and	  growth	  factors	  
	  
The	   objective	   of	   the	   first	   study	   of	   this	   thesis	   was	   to	   isolate	  multipotent	   ONS	  
cells	   from	  nasal	  explants	  from	  rats	  and	  to	   identify	  whether	  differentiation	  and	  
proliferation	   could	  be	  manipulated	   through	   the	  use	  of	   certain	  biomaterials	   or	  
growth	  factors.	  Stem	  cells	  were	  derived	  from	  two	  distinct	  donor	  sources,	  young	  
6-­‐week	   old	   rats,	   and	   older	   12-­‐week	   old	   rats.	   A	   comparative	   analysis	   using	  
immunofluorescence	  imaging	  and	  flow	  cytometry,	  demonstrated	  that	  stem	  cells	  
derived	   from	   younger	   animals	   possess	   a	   similar	   neuro-­‐differentiation	   marker	  
expression	  profile	   to	  human	  derived	  ONS	  cells,	  and	  are	  more	   likely	   to	  express	  
those	   markers	   under	   differentiation	   conditions	   than	   cells	   derived	   from	   older	  
animals.	  It	  is	  thought	  that	  in	  human	  olfactory	  stem	  cells,	  a	  reduced	  regenerative	  
capacity	   occurs	   due	   to	   a	   gradual	   replacement	   of	   neuroepithelial	   respiratory	  
type	   epithelium	   through	   life424.	   Another	   possible	   explanation	   for	   the	   reduced	  
neurogenic	   and	   glial	   potential	   detected	   in	   the	   ONS	   cells	   derived	   from	   older	  
animals,	   is	   that	   stem	   cells	   derived	   from	   older	   animals	   enter	   a	   phase	   of	  
senescence,	  where	  they	  cease	  to	  divide	  as	  reported	  by	  Ahlenius	  et	  al	  in	  2009425.	  	  
	  
The	   second	   finding	   of	   the	   study	  was	   that	   laminin	   promoted	   cell	   proliferation	  
and	   expression	   of	   neural	   and	   glial	   differentiation	   markers.	   Laminin	   is	   a	  
basement	   membrane	   protein,	   which	   has	   been	   shown	   to	   interact	   with	   cell	  
surface	   integrins	   to	   activate	   signaling	   pathways	   and	   regulate	   cell	   function.	   Its	  
pro-­‐differentiation	   effect	   is	   well	   documented;	   without	   the	   support	   of	   a	  
basement	   membrane,	   cells	   can	   have	   nothing	   to	   attach	   to	   and	   without	  
attachments,	  cells	  cannot	  migrate	  or	  multiply426.	  A	  possible	  explanation	  for	  the	  
findings	  of	  this	  study	  therefore,	  was	  that	  cell	  signaling	  pathways	  within	  the	  ONS	  
cells	   were	   triggered	   by	   integrin	   receptors	   such	   as	   intercellular	   adhesion	  
molecule-­‐1	   (ICAM-­‐1),	  𝛼 	  1	   -­‐6	   and	  𝛽 	  1-­‐3	   integrins	   which	   they	   are	   known	   to	  
express427.	  	  In	  addition	  to	  laminin,	  the	  presence	  of	  nerve	  growth	  factor	  was	  also	  
found	   to	   have	   a	   pro	   differentiation	   effect	   on	   the	   ONS	   cells	   obtained.	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Furthermore	  the	  ONS	  cells	  were	  demonstrated	  to	  express	  nerve	  growth	  factor	  
receptor	   proteins.	   Therefore,	   although	   the	   effects	   did	   not	   appear	   to	   be	  
synergistic	   with	   laminin	   in	   two-­‐dimensional	   culture	   studies,	   it	   was	   deemed	  



























	   175	  
5.3.	   An	   optimised	   collagen	   and	   hyaluronic	   acid	   based	   biomimetic	   biphasic	  
nerve	  guidance	  conduit	  facilitates	  ONS	  differentiation	  in	  three-­‐dimensional	  in	  
vitro	  culture	  conditions	  
	  
The	  objective	  of	  the	  second	  major	  study	  of	  this	  thesis	  was	  to	  develop,	  optimise	  
and	  characterise	   the	  resultant	   response	  of	  a	  biomimetic	  biphasic	  collagen	  and	  
hyaluronic	  acid	  nerve	  guidance	  conduit	  for	  delivery	  of	  ONS	  cells	  in	  a	  peripheral	  
nerve	  defect.	  There	  were	  two	  components	  to	  this	  study.	  First,	  the	  development	  
of	  a	  tubular	  collagen	  outer	  conduit,	  and	  second,	   identification	  of	  an	  optimised	  
functionalised	  hyaluronic	  acid	  hydrogel	  luminal	  filler,	  for	  use	  within	  the	  core	  of	  
the	   outer	   conduit.	   Previous	   work	   at	   the	   Tissue	   Engineering	   Research	   Group	  
facility	   in	   RCSI	   has	   demonstrated	   that	   collagen	   is	   both	   biomimetic	   and	  
biodegradable	   in	   tissue	   engineering	   applications428.	   Based	   on	   that	   previous	  
work,	   three-­‐prototype	   tubular	   collagen	   conduits	   were	   produced	   by	  
lyophilisation.	  The	  density	  of	  collagen	  used	  to	  produce	  the	  tubular	  conduits	  was	  
found	  to	  have	  an	  affect	  both	  on	  retention	  of	  shape	  and	  ONS	  cell	  viability.	  Whilst	  
it	  was	  clear	  that	  cell	  viability	  was	  essential,	  the	  main	  role	  of	  the	  outer	  conduit	  
component	  of	   the	  end	  product	  nerve	  guidance	  conduit	  was	   to	  entubulate	   the	  
ends	   of	   the	   transected	   nerve	   and	   to	   provide	   a	   protective	   structure,	   which	  
retained	  the	  bioactive	  luminal	  filler	  with	  entrapped	  cell	  within	  the	  regenerative	  
zone.	   Therefore	   identifying	   a	   variant	   that	   would	   retain	   its	   shape,	   facilitate	  
retention	   of	   surgical	   suture	   material	   and	   withstand	   prolonged	   hydration	   was	  
critically	   important	   to	   the	   success	   of	   the	   nerve	   guidance	   conduit.	   The	   results	  
demonstrated	   that	   a	   conduit	   fabricated	  with	   2.5	  %	  w.v	   bovine	   fibrillar	   type	   1	  
collagen	  was	  found	  to	  be	  best	  in	  terms	  of	  both	  cell	  viability	  and	  shape	  retention;	  
therefore	  it	  was	  included	  in	  the	  final	  nerve	  guidance	  conduit	  prototype.	  	  	  
	  
As	  previously	  outlined,	  there	  is	  growing	  support	  in	  the	  literature	  for	  the	  use	  of	  
both	   extracellular	   matrix	   molecules	   and	   growth	   factors	   in	   tissue-­‐engineered	  
nerve	  graft	   alternatives429.	   Inherent	   signals	   from	   the	  extracellular	  matrix	  have	  
been	  shown	  to	  influence	  both	  the	  differentiation	  capacity	  of	  stem	  cells	  and	  the	  
ability	   of	   growth	   cones	   to	   facilitate	   axonal	   outsprouting	   following	   transection	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injury430.	   In	   the	   second	  phase	  of	   this	   study	   it	  was	   demonstrated	   that	   an	  ADH	  
crosslinking	  process,	  produced	  hydrogels	  with	  a	  low	  mechanical	  strength	  which	  
when	   functionalised	   with	   laminin,	   promoted	   both	   cell	   extension	   and	   the	  
expression	   of	   neuro	   differentiation	   markers	   by	   ONS	   cells.	   In	   contrast	   to	   the	  
results	  of	   the	   two-­‐dimensional	   study	   reported	   in	  Chapter	  2,	   the	   results	  of	   the	  
three-­‐dimensional	  analysis	  suggested	  that	  nerve	  growth	  factor	  supplementation	  
had	   a	   marked	   positive	   effect	   on	   the	   phenotype	   of	   the	   cells	   seeded	   on	   the	  
laminin	  functionalised	  hydrogels,	  demonstrating	  the	  importance	  of	  considering	  
the	  third	  dimension	  when	  investigating	  culture	  conditions	  for	  peripheral	  nerve	  
applications.	   A	   further	   finding	   of	   the	   study	  was	   that	   cytoskeleton	   production	  
and	   luminal	   migration	   of	   ONS	   cells	   could	   occur	   when	   the	   cells	   were	   actively	  
seeded	  in	  the	  core	  of	  a	  nerve	  guidance	  conduit	  produced	  by	  combining	  an	  outer	  
tubular	   collagen	   conduit	  with	   a	   laminin	   functionalised	   hyaluronic	   acid	   luminal	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5.4.	   Clinical	   functional	   and	  morphologic	   neurogenesis	   is	   induced	   in	   a	   critical	  
sized	  rat	  sciatic	  nerve	  Injury	  model	  as	  a	  result	  of	  treatment	  with	  an	  ONS	  cell	  
seeded	  nerve	  guidance	  conduit	  enhanced	  by	  nerve	  growth	  factor	  
	  
The	   final	   ONS	   and	   nerve	   guidance	   conduit	   system	   developed	   in	   Chapter	   3	  
showed	   great	   potential	   for	   neurogenesis	   in	   vitro.	   A	   recurring	   theme	   in	   the	  
literature	  however	  is	  that	  scaffolds	  which	  demonstrate	  potential	  in	  vitro,	  do	  not	  
necessarily	   translate	   those	   optimum	   outcomes	   to	   in	   vivo	   applications.	   As	   a	  
result,	   animal	   studies	   were	   necessary	   if	   the	   proposed	   system	   were	   to	   be	  
considered	  for	  translation	  to	  future	  clinical	  applications.	  The	  study	  described	  in	  
Chapter	  4	  of	  this	  thesis	  aimed	  to	  evaluate	  the	  effects	  of	  translating	  the	  in	  vitro	  
results	  to	  the	  in	  vivo	  environment	  in	  as	  refined	  a	  way	  as	  possible,	  in	  adherence	  
to	  the	  3Rs	  principles	  of	  ethical	  research	  in	  animals.	  First,	  a	  16-­‐week	  pilot	  study	  
of	   9	   animals	   was	   used	   to	   clearly	   establish	   a	   suitable	   negative	   control.	   	   This	  
demonstrated	   that	   a	   baseline	   10	   mm	   critical	   sciatic	   nerve	   deficit	   did	   not	  
regenerate	   in	   the	  absence	  of	  any	   intervention	  over	  prolonged	   study	  duration.	  
This	  was	  an	   important	   factor	   to	  clarify	  since	  small	  gap	  nerve	   injury	   in	   rats	  has	  
been	   shown	   to	   heal	   spontaneously.	   Second,	   an	   experimental	   analysis	  
comparing	  the	  effects	  of	  three	  distinct	  interventions,	  (i)	  nerve	  guidance	  conduit	  
alone,	  (ii)	  nerve	  guidance	  conduit	  &	  ONS	  cells	  and	  (iii)	  nerve	  guidance	  conduit,	  
ONS	  cells	  &	  nerve	  growth	  factor,	  was	  performed.	  The	  results	  demonstrated	  that	  
the	   three	   components	   of	   the	   proposed	   system	   had	   incrementally	   positive	  
effects	   on	   nerve	   regeneration.	   The	   nerve	   guidance	   conduit	   promoted	   good	  
axonal	   regeneration	   and	   restoration	   of	   function	   on	   its	   own	   but	   the	   analysis	  
clearly	  demonstrated	  that	  delivery	  of	  ONS	  cells	   (with	  or	  without	  nerve	  growth	  
factor	   enhancement)	   within	   the	   nerve	   guidance	   conduit	   promoted	   increased	  
axonal	   regeneration	   and	   enhanced	   axonal	   alignment.	   The	   evaluation	   of	  
electrophysiological	   and	   functional	   recovery	   showed	   that	   the	   regenerated	  
tissue	  was	  performing	  its	  essential	  functions	  (force	  generation,	  maintenance	  of	  
muscle	  mass	  and	  sensation)	  to	  a	  better	  degree	  in	  animals	  treated	  with	  ONS	  cells	  
than	   in	   animals	   treated	   with	   the	   cell	   free	   nerve	   guidance	   conduit.	   Taken	  
together	  the	  results	  suggested	  that	  ONS	  cells	  enhanced	  the	  biological	  function	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of	   the	   nerve	   guidance	   conduit.	   They	   facilitated	   supported	   and	   induced	  
peripheral	   nerve	   regeneration	   in	   vivo	   raising	   the	   possibility	   that	   they	   can	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5.5.	  Future	  work	  
	  
1.	   This	   thesis	   has	   demonstrated	   that	   a	   novel	   tissue	   engineering	   triad	   of	   ONS	  
cells	  with	  a	  nerve	  growth	  factor	  enhanced	  nerve	  guidance	  conduit	  can	  be	  used	  
to	  regenerate	  functional	  nervous	  tissue	  across	  a	  critical	  sized	  defect	  in	  rat	  sciatic	  
nerve.	   Further	   animal	   trials	   examining	   longer	   sciatic	   gaps	   and	   central	   to	  
peripheral	   nervous	   system	   intersection	   injuries	   are	   warranted.	   Studies	   on	   a	  
larger	  scale	  rabbit	  model	  might	  provide	  good	  insight	  into	  larger	  gap	  injuries.	  
	  
2.	   Nerve	   growth	   factor	   was	   shown	   to	   significantly	   modulate	   the	   neurogenic	  
potential	   of	   implanted	   ONS	   cells	   in	   this	   study.	   Further	   work	   evaluating	   the	  
method	   of	   growth	   factor	   incorporation	   within	   the	   nerve	   guidance	   conduit	   is	  
warranted	  to	  allow	  a	  more	  controlled	  and	  sustained	  release	  over	  time.	  
	  
3.	   A	   number	   of	   authors	   have	   suggested	   that	   using	   nerve	   growth	   factor	   with	  
other	   growth	   factors	   such	  as	   insulin	   like	   growth	   factor	  or	  brain-­‐derived	  nerve	  
growth	   factor	   can	   have	   a	   synergistic	   affect	   on	   axonal	   outgrowth431	   432.	  
Therefore	  an	  evaluation	  of	  the	  effects	  of	  the	  system	  with	  the	  addition	  of	  either	  
an	  alternative	  growth	  factor	  or	  with	  a	  second	  synergistic	  growth	  factor	  should	  
be	  evaluated	  in	  the	  future.	  
	  
3.	  In	  addition	  to	  the	  findings	  in	  this	  study	  that	  ONS	  cells	  can	  promote	  peripheral	  
neurogenesis,	   ONS	   cells	   and	   their	   progeny	   have	   been	   shown	   to	   co-­‐exist	  with	  
central	  nervous	  system	  astrocytes	  unlike	  Schwann	  cells	  and	  other	  neural	  stem	  
cells433.	  This	  benefit	  could	  be	  applied	  to	  central	  nervous	  system	  applications	  for	  
example	  spinal	  crush	  injuries	  or	  traumatic	  brain	  injury.	  Trials	  examining	  the	  cell-­‐
hydrogel	  component	  in	  central	  nervous	  system	  applications	  are	  warranted.	  
	  
4.	   Translation	   towards	   the	   treatment	   of	   peripheral	   nerve	   injury	   in	   human	  
patients	   would	   be	   an	   admirable	   goal	   and	   the	   Tissue	   Engineering	   Research	  
Group	   at	   RCSI	   has	   experience	   in	   translating	   its	   research	   findings	   to	   clinical	  
applications.	   The	   findings	   of	   this	   study	   demonstrated	   significant	   functional	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regeneration	   using	   ONS	   cells	   with	   the	   designed	   nerve	   guidance	   conduit.	  
Developments	   in	   treatment	   options	   in	   peripheral	   nerve	   injury	   are	   especially	  
timely	  as	  the	  incidence	  of	  traumatic	  peripheral	  nerve	  injury	  is	  on	  the	  rise.	  With	  
advances	   in	   critical	   care	  management	  algorithms,	   increasing	  numbers	  of	  poly-­‐
trauma	   victims	   are	   surviving	   the	   initial	   critical	   period.	   The	   potential	   for	  
regenerating	   peripheral	   nerve	   tissue	   using	   this	   model	   should	   therefore	   be	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5.6.	  Conclusions	  
	  
Peripheral	   nerve	   injury	   is	   a	   significant	   source	  of	  morbidity,	   reduced	  quality	  of	  
life	   and	   lost	   work	   capacity	   for	   many	   patients434.	   There	   is	   a	   need	   for	  
supplementing	  conventional	  bioengineered	  peripheral	  nerve	  repair	   techniques	  
with	   progenitor	   cells	   and	   neurotrophic	   factors.	   This	   research	   thesis	  
demonstrates	   the	   possibility	   of	   developing	   a	   biomimetic	   biphasic	   nerve	  
guidance	  conduit	  capable	  of	  delivering	  progenitor	  cells	  and	  neurotrophins	  to	  a	  
critical	  sized	  peripheral	  nerve	  defect.	  Significantly,	  it	  has	  also	  demonstrated	  the	  
potential	  of	  ONS	  cells	  to	  promote	  neurogenesis	  and	  glial	  differentiation	  in	  both	  
in	   vitro	   and	   in	   vivo	   conditions.	   The	   in	   vivo	   studies	   described,	   demonstrated	  
improved	   outcomes	   through	   the	   use	   of	   synergistically	   functioning	   ONS	   cells	  
with	  a	   laminin	   functionalised	  collagen-­‐hyaluronic	  acid	  nerve	  guidance	  conduit.	  
The	   addition	   of	   nerve	   growth	   factor	   significantly	   modulated	   the	   neurogenic	  
potential	  of	  this	  novel	  system	  in	  vivo.	  	  
	  
Overall	   this	   thesis	   has	   highlighted	   the	   potential	   of	   the	   ONS	   cell	   to	   act	   as	   an	  
efficient	   graft	   material	   in	   the	   repair	   of	   surgically	   ablated	   peripheral	   nerves,	  
demonstrating	   the	   exciting	   prospects	   that	   can	   flow	   from	   closer	   cooperation	  
between	  surgical	  and	  tissue	  engineering	  research.	  	  	  
	  
	  The	  ease	  of	  access	  to	  the	  olfactory	  neuroepithelium	  means	  that	  a	  simple	  nasal	  
mucosal	  biopsy	  under	  local	  anesthetic	  has	  the	  potential	  to	  provide	  patients	  with	  
his	  or	  her	  own	  bank	  of	  pluripotent	  stem	  cells.	  These	  can	  be	  used	  as	  and	  when	  
required,	  without	   the	  need	   for	   painful	   bone	  marrow	  aspirations,	   requirement	  
for	   cross	   matching,	   or	   additional	   immune	   suppression	   therapy,	   offering	   new	  
hope	   that	   science	   may	   be	   a	   step	   closer	   to	   solving	   the	   challenges	   faced	   by	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In	  summary,	  the	  key	  findings	  of	  this	  thesis	  are:	  
	  
• Multipotent	   ONS	   cells	   with	   similar	   neuro	   differentiation	   capacity	   to	  
human	   derived	   ONS	   cells	   may	   be	   isolated	   from	   primary	   olfactory	  
neuroepithelial	  tissue	  explants	  in	  Sprague	  Dawley	  rats	  
• ONS	   cells	   proliferation	   and	   differentiation	   potential	   is	   dependent	   on	  
biomaterials	  and	  growth	  factors,	  but	  to	  varying	  degrees	  
• Functionalising	  hyaluronic	  acid	  hydrogels	  promotes	  expression	  of	  neuro	  
differentiation	  markers	  and	  phenotypic	  extension	  by	  ONS	  cells	  	  
• A	   10	   mm	   critical	   defect	   gap	   in	   a	   rat	   sciatic	   nerve	   does	   not	   heal	  
spontaneously	  	  
• Treatment	  of	  a	  critical	  sized	  nerve	  injury	  with	  a	  nerve	  guidance	  conduit	  
results	   in	   a	   high	   degree	   of	   axonal	   infiltration	   with	   a	   high	   degree	   of	  
alignment	  	  
• Treatment	   of	   a	   critical	   sized	   nerve	   injury	   with	   ONS	   cell	   seeded	   nerve	  
guidance	   conduits	   results	   in	   increased	   axonal	   infiltration,	   improved	  
alignment	   and	   better	   electrophysiological	   outcomes	   compared	   to	  
treatment	  with	  a	  cell	  free	  nerve	  guidance	  conduit	  	  
• Treatment	   of	   a	   critical	   sized	   nerve	   injury	   with	   ONS	   cell	   seeded	   nerve	  
guidance	   conduits	   enhanced	   with	   nerve	   growth	   factor	   improves	  
functional	  and	  morphological	  outcomes	  	  
• ONS	  cells	  facilitate,	  support	  and	  induce	  peripheral	  nerve	  regeneration	  in	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